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SUMMARY
In many bacteria, LuxS functions as a quorum sensing (QS) molecule synthase. Its 
product, auto-inducer-2 (AI-2) plays a role in regulation of various bacterial activities 
in concert with cell population density. LuxS also has a second more central metabolic 
function in the activated methyl cycle (AMC) which generates the S-
adenosylmethionine (SAM) required by methyltransferases and recycles the product 
via methionine. Helicobacter pylori lacks an enzyme catalysing homocysteine to 
methionine conversion, rendering the AMC incomplete and thus making any 
metabolic role of LuxSHp uncertain. Consequently, the mechanism underlying 
phenotypic changes upon luxS inactivation is not always clear.  
 
The aims of this project were to define the metabolic role of LuxS in H. pylori; to 
assess whether LuxSHp effects on bacterial motility were through metabolic effects or 
via production of the signalling molecule AI-2; and to explore the mechanism 
underlying motility phenotypic changes upon luxSHp inactivation. 
 
luxSHp is located next to genes annotated as cysKHp and metBHp, which are involved in 
cysteine and methionine metabolism in other bacteria. This study showed that isogenic 
mutants in luxSHp, cysKHp and metBHp could not grow without added cysteine (whereas 
wild-type could), suggesting roles in cysteine synthesis. Together with data from 
metabolite analyses, it confirmed that cysK-metB-luxS encode the capacity to generate 
cysteine from products of the incomplete AMC of H. pylori in a process of reverse 
transsulphuration. Consequently, the misnamed genes cysKHp and metBHp were 
recommended to be renamed mccAHp (methionine-to-cysteine-conversion gene A) and 
mccBHp, respectively.  
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Data presented in this thesis also showed that disruption of luxS in H. pylori renders it 
non-motile, whereas disruption of mccA or mccB does not, implying that the loss of 
phenotype is not due to disruption of cysteine provision. The motility defect of the 
ǻluxSHp mutant could be genetically complemented with luxSHp and also by addition 
of in vitro synthesised AI-2, but not by addition of cysteine. Microscopy and immuno-
blotting further revealed that the motility defect of the ǻluxSHp mutant likely resulted 
from a reduction in the number and length of flagella due to loss of AI-2. This is 
supported by data obtained from quantitative RT-PCR (qRT-PCR).  
 
In conclusion, this study looked into the metabolic capacity of a three-gene cluster in 
H. pylori, including luxS. It showed that LuxSHp has a previously undescribed 
metabolic function in a cysteine provision pathway through a process of reverse 
transsulphuration. It also defined the precise steps in this pathway, and re-defined the 
roles of and renamed the two previously misnamed genes in the luxSHp cluster. It then 
addressed the controversial topic of the role of LuxS in bacteria: apart from being a 
central metabolic enzyme, is it a QS signalling molecule synthase? This study 
distinguished between the mechanisms underlying the alteration in motility of H. 
pylori ¨luxS mutants, and clarified whether this originated from a disruption of 
cysteine metabolism or signalling. Results showed that LuxS and its product, AI-2, 
influence motility via regulating flagellar gene transcription, suggesting the existence 
of an additional role for LuxS in H. pylori as a signalling molecule synthase.  
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 2 
1 Introduction 
1.1 Helicobacter pylori pathogenesis 
1.1.1 General information 
Spiral bacteria were identified on the human gastric mucosa as early as 1896, but it 
was not until 1982 that Helicobacter pylori was isolated by Barry Marshall and 
Robin Warren from the stomach of gastritis patients, and research into its 
implications for human health was initiated.  
 
H. pylori, a Gram-negative plylum is now recognised as one of the most prevalent 
bacterial pathogens in humans. Phylogeographic studies indicate that humans have 
been colonized by H. pylori since over 58,000 years ago (Blaser et al., 2008, Cover 
& Blaser, 2009). The bacteria that inhabit the gastric epithelium under the mucus 
layer can survive in the harsh environment of the stomach (McGee & Mobley, 1999). 
Most people infected with H. pylori have no important clinical sequelae. In a small 
proportion, however, upper gastrointestinal diseases including peptic ulcerations, and 
more rarely, gastric adenocarcinoma or gastric mucosa-associated lymphoid tissue 
(MALT) lymphoma arise as a consequence of infections (Atherton, 2006, Cover & 
Blaser, 2009, Kusters et al., 2006). H. pylori infection is present in almost all patients 
with duodenal ulcers and 50-90% of patients with gastric ulcers, though gastric and 
duodenal ulcerations can be caused by other factors, mainly the use of nonsteroidal 
anti-inflammatory drugs (NSAIDs), such as aspirin (Atherton, 2006).  
 
The discovery of H. pylori has attracted a great deal of attention in the fields of 
medicine including bacterial pathogenesis, but much of the biology of this bacterium 
is still poorly understood. In the last two decades, many studies on H. pylori have 
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focused on identifying genes and the functions of their protein products which allow 
this bacterium to colonize and cause disease in humans.  
1.1.2 Prevalence of H. pylori  
H. pylori is present in human populations throughout the world. Approximately a 
half of the worlds population is infected by H. pylori, with a prevalence rate of 20-
25% in most developed countries and more than 90% in some developing countries 
(Atherton, 2006, Dunn et al., 1997, Pounder & Ng, 1995, Santos et al., 2005). In 
most of North America and Western Europe, prevalence of H. pylori increases with 
age throughout childhood and middle adulthood. In most areas of Africa, Latin 
America, Eastern Europe, India, and the Middle East, prevalence increases rapidly 
through childhood to approximate 80% by young adulthood, and then remains high 
throughout adulthood. This can be explained by an age cohort phenomenon 
(Fischbach et al., 2002, Pounder & Ng, 1995, Salih & Ipek, 2007). In Japan and parts 
of China, the association with age is changing to become more similar to that seen in 
Europe and the USA (Pounder & Ng, 1995, Salih & Ipek, 2007). 
 
In both developed countries and developing countries, H. pylori infections begin in 
childhood in most people and can cause gastric diseases, for instance, peptic ulcers or 
gastric carcinoma later in life. However, in developed countries, although infections 
also occur mainly in childhood, children are much less likely to acquire the infection 
now compared to in the past. This might be due to the improved hygiene or increased 
antibiotic use in childhood (Fischbach et al., 2002, Pounder & Ng, 1995). 
Consequently, more sixty year olds are infected than thirty year olds because it was 
much more common for the sixty year olds to become infected during their 
childhood.  
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Taking available data together, higher prevalence of H. pylori is associated with 
increasing age, non-Caucasian ethnicity, lower family income, lower education level, 
higher size of the family, poorer hygiene, low socio-economic conditions in 
childhood, higher numbers of siblings and attendance of day-care centres in 
childhood (Atherton, 2006, Moayyedi et al., 2002, Neri et al., 1996). Generally, H. 
pylori acquisition is thought to be related to overcrowding and poor hygiene in 
childhood. The lower prevalence in developed countries is thought mostly to be due 
to better living conditions.  
1.1.3 Pathogenicity factors 
H. pylori causes gastritis, which in itself does not cause any major adverse effects, 
but is associated with an increased risk of noncardia gastric adenocarcinoma, gastric 
lymphoma, and peptic ulcer (Cover & Blaser, 2009). Though H. pylori persists 
lifelong in the human stomach, only approximately 15% of infections result in peptic 
ulceration and only 0.5%-2% in gastric adenocarcinoma (Atherton, 2006). 
Development of disease after infection is determined by several factors including the 
virulence of the infecting H pylori strain, the susceptibility of the host and 
environmental co-factors. The virulence of the infecting H. pylori strain is the major 
disease determinant (Atherton, 2006, Cover & Blaser, 2009). H. pylori virulence 
factors include the vacuolating cytotoxin (VacA), the cytotoxin-associated antigen 
(CagA), the duodenal ulcer promoting protein (DupA) and the blood-group-antigen-
binding adhesin (BabA). These virulence products of H. pylori may damage 
epithelial cells directly or stimulate these cells to produce proinflammatory cytokines, 
inducing inflammation (Atherton, 2006, Cover & Blaser, 2009, Prinz et al., 2003).  
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1.2 Quorum sensing 
1.2.1 General overview 
Bacteria were originally thought to have no means of communication with each other. 
However, all bacteria produce extracellular molecules. Some are the products of 
metabolism, some play a role in the ecology of the organism (such as toxins), and 
some are utilised by quorum sensing (QS) systems as a tool for communication. QS 
is an inter-bacterial communication behaviour utilising small diffusible hormone-like 
molecules as auto-inducers to regulate aspects of bacterial activity in concert with 
cell population density, including modulation of cell population density, response to 
changes of cellular phenotypes, interaction with hosts and expression of genes 
crucial for bacterial survival or virulence (Hardie & Heurlier, 2008, Sperandio et al., 
2003, Vendeville et al., 2005).  
 
As a novel means of genetic regulation in bacteria, QS has attracted a great deal of 
attention in recent years. This type of bacterial cell-to-cell signalling which occurs 
through QS is similar to eukaryotic cell-to-cell signalling which occurs through 
hormones. The QS system may represent a language that bacteria use to 
communicate between bacterial cells, and possibly between bacteria and host cells. 
As the bacterial population density increases, the concentration of QS signalling 
molecules increases. Once a threshold concentration has been attained, QS auto-
inducers bind the corresponding receptors such that the auto-inducer-receptor 
complex activates or represses QS target genes, including those required for 
synthesis of QS signalling molecules (Bassler, 2002, Camilli & Bassler, 2006, 
Sperandio et al., 2003, Winzer et al., 2002b, Ng & Bassler, 2009). 
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 So far, different types of QS systems in various bacterial species have been 
determined and analysed. Examples include but are not restricted to Vibrio fischeri, 
Vibrio harveyi, Vibrio cholerae, enterohaemorrhagic Escherichia coli (EHEC) 
O157:H7, enteropathogenic Escherichia coli (EPEC), Porphyromonas gingivalis, 
Pseudomonas aeruginosa, Staphylococcus aureus and S. enterica Serovar 
Typhimurium (Camilli & Bassler, 2006, Vendeville et al., 2005, Williams, 2007). 
1.2.2 Quorum sensing in Vibrio fischeri and Vibrio harveyi 
Vibrio fischeri 
Bioluminescence was first described in V. fischeri, a marine bacterium commensally 
living in the light organs of the Hawaiian Bobtail Squid. The initial explanation for 
bioluminescence was that the culture media contained an inhibitor of luminescence, 
but later it was hypothesised that the luminescence was initiated by the accumulation 
of auto-inducers (Eberhard, 1972, Nealson & Hastings, 1979, Nealson et al., 1970). 
Bioluminescence only occurs when V. fischeri is at high cell density, when the 
signalling molecules (auto-inducers) accumulate to a sufficient concentration that V. 
fischeri is able to detect them (Bassler, 2002). This mechanism of cell density 
sensing was termed QS. Analysis of QS in V. fischeri was first carried out by 
Engebrecht et al. (1983). This leads to the basic model for QS in V. fischeri and later 
this was applied to other species of bacteria.  
 
V. fischeri possesses a classic QS system in which signalling molecules called N-
acyl-L-homoserine lactones (AHLs) are produced by a biosynthesis protein LuxI. 
The LuxI/AHL QS system plays an important role in the regulation of expression of 
bioluminescence genes and in bacterial colonization. As the bacterial cell density 
increases, signalling AHLs diffuses freely in and out of the cell, and they accumulate 
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and bind to the cytoplasmic receptor protein LuxR. LuxR also acts as the 
transcriptional activator of the luciferase operon luxICDABE. The AHL/LuxR 
complex recognises a consensus binding sequence (lux box) upstream of the 
luxICDABE operon and activates its transcription so that the bacteria emit light 
(Figure 1.1). AHLs are produced by the synthesis protein LuxI, and expression of 
luxI is also activated by the AHL/LuxR complex, this consequently forms an auto-
inducing positive feedback loop. Therefore, when QS circuit engages, the signalling 
molecules are accumulated in the surrounding environment, and the population of 
cells switches progressively from low-cell-density mode to high-cell-density QS 
mode (Ng & Bassler, 2009). 
 
AHLs are primarily involved in intraspecies communication. The production of AHL 
is widespread in Gram-negative bacteria isolated, from marine and fresh water, 
plants and animals, and including a variety of pathogens. Many of these Gram-
negative bacteria utilise QS systems similar to that of LuxI/LuxR system from V. 
fischeri, for example, Aeromonas hydrophila, Agrobacterium vitiae, Burkholderia 
cenocepacia, Burkholderia pseudomallei, Chromobacterium violaceum, 
Pseudomonas aureofaciens, Pseudomonas syringae, Rhizobium leguminosarum, 
Yersinia enterocolitica and Yersinia pseudotuberculosis (Williams, 2007). Many of 
these bacteria produce multiple AHLs and possess more than one AHL synthase 
which are usually members of the LuxI protein class. The AHL receptor gene of 
these AHL producers is usually a member of the LuxR family, which is in most cases 
located adjacent to the AHL synthase gene (Williams, 2007). 
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Figure 1.1 The LuxI/LuxR quorum sensing system of V. fischeri 
Two proteins LuxI and LuxR control quorum sensing in V. fischeri and most Gram-
negative bacteria. The LuxI proteins are the auto-inducer synthases that catalyse the 
formation of a specific auto-inducer molecule AHL. The auto-inducer freely diffuses 
through the cell membrane and accumulates at high cell density. At high auto-inducer 
concentration, the LuxR-like proteins bind their cognate auto-inducers. The LuxR-AHL 
complexes recognise the luciferase promoter and activate transcription of luxICDABE, 
forming a positive feedback on LuxI. 
Periplasm 
 
luxICDABE 
LuxI 
LuxR 
LuxR 
Cytoplasm 
AHLs  
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Vibrio harveyi 
Studies of interspecies communication or QS originated with the free-living 
bioluminescent marine bacterium Vibrio harveyi, in which a new signalling molecule 
auto-inducer-2 (AI-2) was identified (Bassler et al., 1993). Different from V. fischeri 
whose QS system is composed of LuxI/AHL (AI-1) and a regulator LuxR, V. harveyi 
produces at least three distinct auto-inducers to control bioluminescence, biofilm 
formation, Type III Secretion (TTS), and protease production (Henke & Bassler, 
2004, Mok et al., 2003). One involves the production of AI-1 by the LuxLM protein. 
Two additional auto-inducer molecules called AI-2 and CAI-1(Figure 1.3 c and d, 
respectively). AI-2 is an interconverting molecule derived from the precursor 4, 5-
dihydroxy-2, 3-pentanedione (DPD), which is synthesised by the enzyme LuxS 
(Vendeville et al., 2005). CAI-1 is presumed to be related to CAI-1 produced by V. 
cholera. CAI-1 has not been purified from V. harveyi, but in V. cholera it has been 
identified as (S)-3-hydroxytridecan-4-one. CAI-1 is synthesised by the CqsA 
synthase, and cqsA shows sequence homology to aminotransferases (Henke & 
Bassler, 2004). In V. harveyi, AI-1 is detected by the LuxN histidine kinase. AI-2 is 
detected by the periplasmic protein LuxP in complex with the LuxQ histidine kinase. 
CAI-1 is detected by the CqsS histidine kinase. LuxN, LuxQ, and CqsS are bi-
functional two-component enzymes that possess both kinase and phosphatase 
activities. The three systems work with an activator LuxR which differs from the V. 
fischeri LuxR protein (Henke & Bassler, 2004, Ng & Bassler, 2009).  
 
At low cell density, LuxN, LuxQ and CqsS act as kinases and transfer phosphate to a 
shared integrator protein LuxU. LuxU transmits the signal in the form of phosphate 
to the response regulator protein LuxO (Schauder & Bassler, 2001). LuxO belongs to 
the NtrC family of response regulators and requires phosphorylation to act as a 
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transcriptional activator. 7RJHWKHU ZLWK WKH DOWHUQDWLYH VLJPD IDFWHU ı54, phospho-
LuxO activates the transcription of genes encoding five small regulatory RNAs 
(sRNAs) called Qrr15. The main target of the Qrr sRNAs is the mRNA which 
encodes the QS master transcriptional regulator LuxR. At low cell density, LuxR 
protein is not produced. As a result, the luciferase structural operon luxCDABE is not 
transcribed so that no light is produced (Figure 1.2a) (Lenz et al., 2004, Tu & Bassler, 
2007, Ng & Bassler, 2009).  
 
At high cell density, V. harveyi AI-1, AI-2 and CAI-1 accumulate to a critical 
concentration and are detected by protein sensors LuxN, LuxPQ and CqsS, 
respectively. During this stage, LuxN, LuxPQ, and CqsS receptors function as 
phosphatases because binding of auto-inducers to the receptors switches them from 
kinases to phosphatases. Phosphate flow through the signal transduction pathway is 
reversed, resulting in dephosphorylation and inactivation of LuxO. Consequently, 
dephospho-LuxO inactivates and terminates the expression of Qrr sRNAs and LuxR 
protein is produced (Ng & Bassler, 2009). In V. harveyi LuxR is demonstrated to be 
a dual functional protein (both an activator and a repressor). In addition to the 
luciferase operon, LuxR regulates at least another 50 genes including those encoding 
the type III secretion system and metalloproteases (Pompeani et al., 2008, Ng & 
Bassler, 2009). 
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Figure 1.2 The hybrid quorum sensing circuit of V. harveyi*
(a) At low cell density, auto-inducer levels are low and the LuxN, LuxPQ, and CqsS 
receptors function as kinases. LuxO is phosphorylated, the Qrr15 sRNAs are 
transcribed, and LuxR protein is not produced. (b) At high cell density, auto-inducer 
levels are high and the LuxN, LuxPQ, and CqsS receptors function as phosphatases. 
 
                                                 
* Figure 1.2 is from Ng and Bassler, 2009. 
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LuxO is unphosphorylated, Qrr15 sRNAs are not transcribed, and LuxR protein is 
produced. Solid and dotted lines denote regulatory factors that are produced and not 
produced, respectively (Ng & Bassler, 2009). Details of the signalling mechanism are 
given in the text.  
 
 
 
1.2.3 Categorisation of quorum sensing systems and auto-inducers 
1.2.3.1 General information 
Different types of QS systems are widely utilised in either Gram-positive or Gram-
negative bacteria or both. Single or multiple auto-inducers may be utilised to 
coordinate cell actions. Figure 1.3 shows structures of different bacterial auto-
inducers. Essentially, Gram-positive bacteria primarily use modified as auto-
inducing oligopeptides (AIPs) in QS controlled gene expression systems. Acyl 
homoserine lactones (AHLs) are a major class of auto-inducer signal used by Gram-
negative proteobacteria for intraspecies QS. AI-2 signal is shared by both Gram-
negative and Gram-positive bacteria (Ng & Bassler, 2009). In addition, 
Pseudomonas aeruginosa possesses the alkyl quinolone signal (PQS) based system. 
It controls the expression of numerous virulence factors (Pesci et al., 1999).  
 
AHLs are composed of homoserine lactone rings carrying acyl chains of C4 to C18 in 
length (Fuqua et al., 2001). Bacterial cell membranes are permeable to most AHLs. It 
is observed that most short-chain AHL auto-inducers are freely permeable to the 
Gram-negative cell membrane, similar to what has been demonstrated for the V. 
fischeri AHL, and long-chain AHLs are actively transported (Pearson et al., 1999). 
However, in contrast to this, AIPs, AI-2s and some AHLs are impermeable to 
biological membranes, and secretion of these molecules is usually mediated by 
specialised transporters. In addition, modifications to the initially synthesised 
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molecules, such as processing and cyclisation (for example DPD), are often 
associated with secretion (Ng & Bassler, 2009). 
 
There are issues of diffusibility and membrane penetrating ability of many QS 
signalling molecules that may influence their solubility and the possibility of active 
transport mechanisms in movement of these molecules out of and into bacterial cells. 
This can be due to molecular characteristics of different auto-inducing signals, which 
include the hydophobicity, polarity and amphipathic properties. Therefore, some 
auto-inducing signals may need particular transport apparatus to be inserted into and 
transported out through the lipid membrane. For example, in the case of the P. 
aeruginosa auto-inducer N-(3-oxododecanoyl)-L-homoserine lactone, there is 
evidence suggesting that the MexAB-OprM multidrug efflux pump is involved in 
export of the particular AHL signal (Pearson et al., 1999, Maseda et al., 2004).  
1.2.3.2 Gram-negative bacteria use homoserine lactones as words  
Cell-to-cell communication via the QS system encoded by V. fischeri luxI-luxR 
homologues is the standard mechanism by which Gram-negative bacteria talk to 
each other. In these bacteria, acylated homoserine lactones (AHLs, or AI-1) are the 
signalling molecules which are synthesised by LuxI-like synthase. A LuxR-like 
protein is responsible for recognition of the corresponding AHL auto-inducers and 
subsequent activation of expression of target genes (Williams, 2007)..  
 
A. tumefaciens, a pathogen that causes crown gall tumors in plants employs the tra 
QS system to control the process of virulence (White & Winans, 2007). The 
regulatory proteins TraI/TraR play the same role in A.  tumefaciens as LuxI/LuxR in 
V. fischeri, in which the circuits stimulate expression of target genes and induce 
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subsequent QS activities. P. aeruginosa, the most common Gram-negative bacterium 
found in nosocomial infections, has two LuxI/LuxR homologue pairs, which are 
named LasI/LasR and RhlI/RhlR (Gambello & Iglewski, 1991, Ochsner et al., 1994, 
Latifi et al., 1995). The LasI/LasR and RhlI/RhlR QS systems control the expression 
of partially overlapping sets of genes. Many of the regulated genes are implicated in 
virulence and biofilm formation of this opportunistic pathogen (Smith & Iglewski, 
2003). The las system induces the transcription of virulence factors at high cell 
density. The rhl system further activates genes that have been under LasI/LasR 
control and activates other target genes. LasI/LasR also activates the transcription of 
rhlI/rhlR (Latifi et al., 1996, Latifi et al., 1995). A third LuxR homologue termed 
OscR which was shown to regulate the transcription of both lasI and rhlI was 
identified afterward (Chugani et al., 2001). 
 
Following identification of some of the AHL synthases, subtle differences between 
the structures of some AHL subtypes were analysed. It is generally known that N-(3-
hydroxybutanoyl)-L-homoserine lactone is used by V. fischeri and V. harveyi; N-(3-
oxooctanoyl)-L-homoserine lactone is utilised by A. tumefaciens; in P. aeruginosa, at 
least two different types of AHLs exist. They are N-(3-oxododecanoyl)-L-homoserine 
lactone and N-butyryl-L- homoserine lactone (Figure 1.3a) (Camilli & Bassler, 2006, 
Williams, 2007).  
1.2.3.3 Gram-positive bacteria talk using oligopeptides 
Gram-positive bacteria also possess QS mechanisms, by which the control of a 
variety of functions, including virulence, genetic competence and production of 
antimicrobial components can be modulated in a co-ordinated and population 
density- or growth phase-dependent manner (Ng & Bassler, 2009). In contrast to 
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Gram-negative bacteria, signals of intercellular communication in Gram-positive 
bacteria are usually auto-inducing oligopeptides secreted via an ATP-Binding 
Cassette (ABC) transporter complex and sensed at a critical concentration by 
corresponding membrane located receptors (Kleerebezem et al., 1997, Schauder & 
Bassler, 2001, Ng & Bassler, 2009). The detector of the auto-inducing peptides is a 
sensor kinase, which transfers the phosphoryl signals to the response regulator, 
inducing the expression of population density-controlled target genes (Sturme et al., 
2002). Occasionally, the auto-inducing oligopeptide has dual functions, working both 
as a signalling pheromone involved in QS and also as an antimicrobial peptide 
(Sturme et al., 2002).  
 
A number of Gram-positive QS systems have been or are being studied. One of the 
most intensively analysed systems is the agr system in S. aureus (Williams, 2007). S. 
aureus utilises an accessory gene regulator (agr) QS system to enable cell-to-cell 
communication and modulate the expression of colonization and virulence factors 
(Abdelnour et al., 1993). In S. aureus the biosynthesis of AIP requires AgrD, the 
peptide precursor of AIP, and the integral membrane endopeptidase AgrB (Yarwood 
& Schlievert, 2003, Ng & Bassler, 2009). Other examples of AIP-based QS systems 
include the ComD/ComE system of Streptococcus pneumoniae that controls 
competence development, and the ComP/ComA system of Bacillus subtilis that 
controls competence and sporulation (Ng & Bassler, 2009). Structures of AIPs 
produced in these bacterial QS systems are shown in Figure 1.3b.  
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Figure 1.3 Different categories of auto-inducers
Structures of different bacterial auto-inducers. (a) Acyl homoserine lactone auto-inducers 
produced by Gram-negative bacteria. (b) Amino acid sequences of three different auto-
inducing peptides (AIPs) produced by Gram-positive bacteria. The underlined tryptophan 
in B. subtilis ComX is isoprenylated; and the four different AIPs produced by S. aureus. (c) 
DPD, the precursor of AI-2. AI-2 exists as S-THMF-borate by the presence of boron, and 
 
                                                 
 Figure 1.3 is from the paper Ng and Bassler, 2009. 
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exists as R-THMF by the absence of boron. (d) Structures of V. cholerae CAI-1 and 
Amino-CAI-1. (e) Structure of the quinolone signal PQS auto-inducer of P. aeruginosa (Ng 
& Bassler, 2009).  
 
 
1.2.3.4 The universal LuxS-dependent language in multilingual bacteria 
Many bacteria utilise multiple languages. V. harveyi is such a species in which it 
employs typical characteristics of both LuxLM/AI-1 system and LuxS/AI-2 system 
to communicate cell-to-cell. Like V. harveyi, some bacteria that contain luxS 
homologues also possess another QS circuit, for example, Bacillus subtilis 
(Lombardia et al., 2006). luxS homologues and the dependent production of AI-2 
have been found in around half of all bacterial genomes sequenced, including V. 
cholerae, E. coli, Salmonella typhi, S. Typhimurium, B. subtilis, Neisseria 
meningitidis, Yersinia pestis, Campylobacter jejuni, Mycobacterium tuberculosis, S. 
aureus, Clostridium perfringens, Klebsiella pneumoniae and H. pylori (Sun et al., 
2004, Tomb et al., 1997, Vendeville et al., 2005). This indicates that the synthase 
LuxS and AI-2 signalling may define the most widely utilised bacterial language 
known to date. Some of the examples of luxS/AI-2-related QS effects in bacteria are 
listed in Table 1.1. 
 
AI-2 is involved not only in intraspecies signalling, but also has been proposed to 
serve as a universal signal forming the basis of interspecies communication (Surette 
et al., 1999). The precursor of the molecule AI-2, 4, 5-dihydroxy-2, 3-pentanedione 
(DPD) (Figure 1.3c) is generated as a by-product in the conversion of S-
ribosylhomocysteine to homocysteine by the enzyme LuxS. The molecule DPD is 
unstable and can spontaneously cyclise to a range of furanone derivatives (Winzer et 
al., 2002a). The chemical structure of AI-2 was analysed by co-crystallising this 
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ligand with its receptor, V. harveyi LuxP. The crystallographic analysis reveals that 
the term AI-2 embraces a group of  furanonsyl borate diesters (Chen et al., 2002, 
Schauder et al., 2001, Winzer et al., 2003). Two of these derivatives, (2S,4S)-2-
methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-THMF-borate) and (2R,4S)-2-
methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R-THMF) are recognised by specific 
periplasmic binding receptors in V. harveyi and S. Typhimurium (Figure 1.3c) (in 
which AI-2-binding protein is LsrB but not LuxP), respectively (Chen et al., 2002, 
Miller et al., 2004). Another derivative, 4-hydroxy-5-methyl-3(2H)-furanone (MHF) 
as well as two other one-carbon analogues of MHF (structures are not shown) which 
have been successfully synthesised by LuxS in vitro, is capable of inducing 
bioluminescence in V. harveyi (Schauder et al., 2001, Vendeville et al., 2005). 
 
1.2.3.5 The Pseudomonas quinolone signal 
It was reported that P. aeruginosa produced a third intercellular signal in addition to 
the two homoserine lactone-type
 
auto-inducers. The third P. aeruginosa signalling 
molecule was identified as 2-heptyl-3-hydroxy-4-quinolone that has been designated 
as the Pseudomonas quinolone signal (PQS) (Figure 1.3e) (Pesci et al., 1999). This 
unique cell-to-cell signal controls multiple virulence factors in the QS
 
cascade, where 
it appears to be a regulatory link between the
 
las and rhl QS systems (McKnight et 
al., 2000, Diggle et al., 2003). However, it has been proposed that the rhl system can 
be activated independently of the las system, and that PQS system controls this 
activation (Diggle et al., 2003). This was further supported by a more recent paper, 
where the authors provided evidence that rhl system is able to overcome the absence 
of the las system by activating specific LasR-controlled functions, including 
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production of N-(3-oxododecanoyl)-L-homoserine lactone and PQS (Dekimpe & 
Deziel, 2009). 
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Table 1.1 LuxS regulated quorum sensing effects in varieties of bacterial species 
 
  
Bacterial species LuxS-dependent QS effects References 
V. harveyi 
Bioluminescence (Bassler et al., 
1997) 
V. cholerae Expression of virulence factors (Miller et al., 2002) 
Vibrio alginolyticus 
Expression of virulence factors, 
motility and flagella biogenesis 
(Ye et al., 2008, 
Tian et al., 2008)     
Vibrio vulnificus 
Expression of virulence factors and 
in vivo survival 
(Kim et al., 2003)   
Staphylococcus 
epidermidis 
Regulation of biofilm formation 
and virulence 
(Xu et al., 2006, Li 
et al., 2008b) 
Serratia marcescens 
Regulation of virulence and 
production of carbapenem and 
prodigiosin 
(Coulthurst et al., 
2004) 
EHEC E. coli and 
EPEC E. coli 
Regulation of TTSS, motility, 
flagellar biogenesis and expression 
of virulence factors 
(Sperandio et al., 
1999, Sperandio et 
al., 2002) 
C. jejuni 
Biofilm formation, growth 
characteristics and motility 
(Reeser et al., 2007, 
He et al., 2008) 
Salmonella enterica 
Biofilm formation and expression 
of virulent genes   
(Choi et al., 2007) 
P. gingivalis 
Modulation of  protease and 
haemagglutinin activities, 
regulation of genes encoding 
hemin and iron acquisition 
(Burgess et al., 
2002, James et al., 
2006)  
Shigella flexneri 
Modulation of virB expression  (Day & Maurelli, 
2001) 
Borrelia burgdorferi 
Expression of virulence factors of  
lyme disease spirochetes 
(Stevenson & Babb, 
2002) 
Streptococcus anginosus 
Biofilm formation (Petersen et al., 
2006) 
Streptococcus mutans 
Acid and oxidative stress tolerance 
and biofilm reduction 
(Merritt et al., 2003, 
Wen & Burne, 2004) 
Streptococcus gordonii 
Biofilm formation and control of 
carbohydrate metabolism 
(McNab et al., 2003) 
Streptococcus pneumoniae 
Expression of virulence factors (Stroeher et al., 
2003) 
Streptococcus pyogenes 
Control of growth and 
virulence factor expression  
(Lyon et al., 2001, 
Marouni & Sela, 
2003) 
N. meningitidis 
Full meningococcal virulence (Winzer et al., 
2002c) 
C. perfringens Toxin production (Ohtani et al., 2003) 
Actinobacillus 
actinomycetemcomitans 
Biofilm formation, modulate of 
virulence and the uptake of iron 
(Fong et al., 2001) 
Actinobacillus 
pleuropneumoniae 
Biofilm formation and virulence 
regulation 
(Li et al., 2008a) 
Y. pestis 
Biofilm formation and protein 
expression 
(Bobrov et al., 
2007) 
H. pylori 
Biofilm formation, flagellar gene 
expression and motility 
(Cole et al., 2004, 
Lee et al., 2006, 
Rader et al., 2007) 
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Sperandio et al. (2003) reported that EHEC senses another LuxS-dependent auto-
inducer, auto-inducer-3 (AI-3) which serves as the QS signal for virulence genes. 
The authors stated that AI-3 is chemically distinct from AI-2 and able to regulate the 
transcription of genes encoding the locus of enterocyte effacement (LEE) in a type 
III secretion system (TTSS) in EHEC, whereas AI-2 does not possess such a function. 
In contrast, AI-2 induces bioluminescence in V. harveyi but AI-3 does not appear to 
have this capacity (Sperandio et al., 2003). Additionally, the mammalian (host) 
hormones epinephrine and norepinephrine may substitute for AI-3 in regulation of 
EHEC virulence factors when AI-3 is absent and have been suggested to cross talk 
with the AI-3 system (Sperandio et al., 2003). 
 
Later on, Walters, et al. (2006) reported that AI-3 synthesis is not dependent on LuxS 
in E. coli, and that the AI-3 production defect in the ǻluxS mutant might be due to 
disruption of the AI-3 synthetic pathway caused by LuxS inactivation. Commensal E. 
coli, as well as several other intestinal bacterial species, including Klebsiella 
pneumoniae, Shigella sp., Salmonella sp., and Enterobacter cloacae was found to 
produce both AI-2 and AI-3, suggesting that AI-3 may serve as another interspecies 
QS signal (Walters & Sperandio, 2006, Ryan & Dow, 2008). Nevertheless, to date no 
evidence has been shown further to support related theories. 
1.2.4 Why study quorum sensing? 
For many pathogens, the outcome of the interaction between host cells and bacteria 
is strongly affected by the bacterial population density. For example, production of 
bacterial virulence factors only at a critical cell population density prevents the 
mammalian host building up an effective defence against bacterial attack (Winzer & 
Williams, 2001). QS-deficient biofilms are more unstable compared to those of wild-
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type biofilms, and have lower colonization capacities in many bacteria, suggesting 
that QS might promote cell resistance by protecting the biofilm (Henzter M & 
Givskov M, 2003). In S. aureus, the QS gene agr controls virulence and is required 
for invasive infection in the lung (Heyer et al., 2002). In E. coli O157:H7 (EHEC), 
colonization can be induced by QS signals produced by nonpathogenic E. coli in 
normal intestinal flora (Sperandio et al., 1999). This indicates that regulation of 
intestinal colonization factors by QS may play an important role in the pathogenesis 
of disease. 
 
Disruption of the signalling pathway (QS gene mutagenesis) has been shown to 
attenuate virulence in many pathogenic bacteria. Current known contributions of cell 
density dependent-QS to the regulation of bacterial virulence include biofilm 
formation (surface-associated communities), protease production, spore formation, 
conjugal transfer of plasmid DNA and transformation competence (Vendeville et al., 
2005, Williams, 2007, Ryan & Dow, 2008). All these suggest that interference with 
QS represents a possible strategy for the control of infections, and that QS systems of 
bacteria could be a potential target for the design of novel antibiotic
 
drugs 
(Donabedian, 2003, Hentzer & Givskov, 2003, Hentzer et al., 2003). The QS 
antibiotic targets could be the QS receptors (e.g. the LuxR family for AHLs, the 
species-dependent receptors for AI-2) or the signalling molecules (e.g. AHLs, AIPs, 
AI-2). Disruption of QS by plants and bacteria could be another target. The principle 
is that some species of plants and bacteria produce chemicals that
 
disrupt the QS of 
other species. Manefield et al. (1999) found halogenated furanone compounds 
produced by the macroalga Delisea
 
pulchra inhibit AHL-dependent gene expression 
through accelerated LuxR turnover. Other examples include: AIPs of strains of S.
 
aureus inhibit the
 
QS of other strains (Miller & Bassler, 2001); and the soil
 
bacterium 
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B. subtilis secretes
 
the enzyme AiiA which inactivates the AHL auto-inducer of E.
 
carotovora (Dong et al., 2000). 
 
Another approach of developing new antibiotic drugs is to design QS antagonists. 
The proposal is interference with either the biosynthesis or transmission of QS 
signals by the so called QS antagonists (Finch et al., 1998). The QS molecular 
antagonists or QS blockers are synthetic non-native compounds which compete with 
native auto-inducers and intercept the interaction between the native signals and the 
response regulators (Manefield et al., 1999, Manefield et al., 2001, Rasmussen et al., 
2000, Givskov et al., 1996). For example, the structural
 
analog of the P. aeruginosa 
auto-inducer, N-3-oxo-dodecanoyl
 
homoserine lactone, competes with its real auto-
inducer binding to the receptor LasR
 
and results in varied agonist activities (Passador 
et al., 1996). Kim et al. (2008) found that the furanone derivatives as QS antagonists 
could remarkably inhibit both P. aeruginosa QS signalling and biofilm formation. 
Also, an AI-2 analogue, ascorbic acid results in AI-2 assay inhibition and was 
evaluated to control growth, sporulation, and enterotoxin production in Clostridium 
perfringens (Novak & Fratamico, 2004).  
 
In summary, QS is essential for intra- and inter-bacterial communication which leads 
to aspects of bacterial behaviours including gene regulation, keeping colonies intact 
(biofilms) and allowing resident bacteria to enhance survival of the group. The QS 
system involving enzymes, transporters and auto-inducer-receptor interactions may 
present classic antibiotic targets for drug discovery. QS signalling process can be 
utilised to develop inhibitor drugs that have novel mechanisms of anti-bacterial 
action and might be more effective against bacterial strains that are currently 
antibiotic-resistant. 
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1.3 The role of LuxS in bacteria 
1.3.1 Metabolic role of LuxS in the activated methyl cycle (AMC) 
The LuxS/AI-2-dependent QS is the only known mechanism shared by both Gram-
negative and Gram-positive bacteria, suggesting that AI-2 can be a universal 
language for interspecies communication (Schauder et al., 2001, Henke & Bassler, 
2004, Vendeville et al., 2005). On the other hand, LuxS has an alternative important 
role in cells, in which it works as an metabolic component in the activated methyl 
cycle (AMC) (Winzer et al., 2003). The metabolic function of LuxS may provide an 
explanation for the widespread presence of luxS and AI-2 in bacteria. 
 
In all organisms, methylation reactions are a crucial means of detoxification and 
nucleic acid stabilisation. However, methyl transfer reactions are relatively difficult 
to perform due to the inherent stability of the methyl group hence its use as a 
stabilising adduct (Zappia et al., 1969). To address this biochemical problem, methyl 
groups with a higher transfer potential generated via the AMC are utilised by 
organisms. Methyl groups enter the AMC by the conversion of homocysteine to 
methionine (Zappia et al., 1969, Duerre & Walker, 1977). As a part of the AMC, 
methionine is then converted to S-adenosylmethionine (SAM) in a reaction catalysed 
by SAM synthetase (MetK), in which the methyl group in methionine is activated by 
formation of SAM. In the following methyltransferase reactions, SAM is converted 
to S-adenosylhomocysteine (SAH), a potentially toxic methyl-transferase inhibitor 
which is then subsequently detoxified by Pfs and then the substrate of LuxS, S-
ribosylhomocysteine (SRH) is generated. In the following step, SRH is cleaved by 
LuxS to homocysteine, a key metabolite in re-synthesis of methionine and then SAM. 
The precursor of AI-2, 4, 5-dihydroxy-2, 3-pentanedione (DPD) is generated as a by-
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product during the conversion of SRH to homocysteine (Figure 1.4) (Duerre & 
Walker, 1977). Through a process of dehydration and spontaneous cyclisation, some 
or all of the DPD molecules are rearranged to a furanosyl borate derivative (as AI-2) 
and function as signalling molecules in micro-organisms (Winzer et al., 2002a, 
Winzer et al., 2003). There are two versions of the AMC. Many organisms, in 
particular eukaryotes, use a single enzyme, SAH-hydrolase, instead of the combined 
Pfs-LuxS to convert toxic SAH to homocysteine, hence no DPD (AI-2) is produced 
(Figure 1.4) (Duerre & Walker, 1977). The Pfs-LuxS reactions are conserved in the 
majority of bacteria.  
 
If either SAH-hydrolase or Pfs is sufficient for the detoxification of SAH in the two 
different versions of AMC, why is the Pfs-LuxS variant of AMC employed in some 
micro-organisms? Two hypotheses may explain this: i) the Pfs-LuxS coupled 
reaction allows AI-2 signals to be generated and perform as a QS factor; and ii) LuxS 
is required for the completion of the conversion of SAH to homocysteine, acting as a 
mechanism for recycling of metabolic precursors (Winzer et al., 2003). The latter 
hypothesis is built on a bio-energetic perspective. Since all intermediates through the 
AMC are reduced sulphur compounds; and sulphur is a highly reactive element, 
which is energetically costly to incorporate into biological systems, processes 
enabling the recycling of these intermediates are energetically advantageous to the 
cells (Winzer et al., 2003). 
 
In conclusion, the AMC pathway mainly functions in the following aspects: 
generation of the major methyl donor, SAM, production of AI-2 and the 
detoxification and re-utilisation of SAH (Winzer & Williams, 2003, Winzer et al., 
2003). The metabolic roles of LuxS in the AMC include i) to act as an enzyme to 
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catalyse the conversion of SRH to homocysteine; and ii) to produce AI-2. The 
function of LuxS to generate homocysteine plays an important role in bacterial 
metabolism due to homocysteines three main fates: to be remethylated to 
methionine, to enter the cysteine biosynthesis pathway, and to be released into the 
extracellular environment (Medina et al., 2001). 
 
 
 
 
Figure 1.4 The Activated Methyl Cycle utilised by microorganisms 
The activated methyl cycle (AMC) regenerates the active methyl donor SAM from the toxic 
methyl transferase product SAH. SAH is metabolised in one of two routes, depending on 
the organism; many bacteria, including H. pylori, generate homocysteine from SAH in a 
two step manner: a nucleosidase, Pfs, converts SAH to SRH, then LuxS converts this to 
homocysteine and the precursor of AI-2, DPD. The alternative route produces 
homocysteine directly from SAH in a one step reaction requiring SAH hydrolase. 
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1.3.2 LuxS-dependent quorum sensing in bacteria 
1.3.2.1 E. coli (EHEC) O157:H7and E.coli (EPEC) 
Currently, there are five recognised classes of enterovirulent E. coli that cause 
gastroenteritis in humans. Among these are strains designated E. coli O157:H7 and 
EPEC. EHEC O157:H7 is a normal inhabitant of the intestines and the agent 
responsible for outbreaks of bloody diarrhoea and haemolytic-uraemic syndrome 
throughout the world (Kaper, 1998). EPEC is a major cause of diarrhoea in infants 
by adhering to intestinal epithelial cells (Sherman et al., 1989).  
 
Both EHEC and EPEC form a characteristic histopathological feature known as the 
attaching and effacing (A/E) lesion on the surface of intestinal epithelial cells. The 
genes necessary for formation of AE lesion are encoded on the locus of enterocyte 
effacement (LEE) Pathogenicity Island (McDaniel et al., 1995, Elliott et al., 1998). 
The LEE region mainly encodes a type III secretion system (TTSS), which is 
essential for signal transduction in host cells and A/E lesion development. The 
majority of the LEE genes are organised into five polycistronic operons, LEE (1-4) 
and tir (LEE5) (McDaniel et al., 1995, Elliott et al., 1998). 
 
Two transcriptional regulators, QseA (quorum sensing E. coli regulator A) and Ler 
(LEE-encoded regulator) participate in LEE operon regulation in EHEC and EPEC. 
EPEC has an additional plasmid-encoded regulator, Per, which is also regulated 
indirectly by QS (Sircili et al., 2004). In EHEC, QS was initially proposed to directly 
activate expression of the LEE1 and LEE2 operons and indirectly influences 
expression of LEE3 and the tir operon via Ler (Sperandio et al., 2001). In EPEC, QS 
was proposed to directly activate expression of the LEE1 and LEE2 operons and 
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indirectly activate expression of the LEE3, LEE4 and tir operons via Ler. This model 
was refined afterwards and QS now is suggested to function through QseA in both 
strains (Figure 1.5) (Sperandio et al., 1999, Sircili et al., 2004).   
 
Mutations of luxS in both EHEC and EPEC show decreased TTSS gene expression 
and decreased flagellation and motility (Sperandio et al., 1999). The loss of qseA in 
EPEC causes increased flagellin production and motility, whereas qseA in EHEC has 
no effect on the flagellar regulon (Sperandio et al., 1999). Instead, a novel QseB-
QseC complex has been suggested to regulate flagellar synthesis and motility in 
EHEC. Also, a previous microassay analysis suggested that around 10% of all genes 
in EHEC are affected by luxS-dependent QS regulation, indicating that luxS/AI-2 is a 
global regulatory system in EHEC (Sperandio et al., 2001, Sperandio et al., 2002).  
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Figure 1.5 Model for LuxS-dependent QS in enterohaemorrhagic (EHEC) and 
enteropathogenic (EPEC) Echerichia coli 
The histidine kinase QseC (quorum sensing E. coli regulator C), together with its cognate 
response regulator QseB, activates the flagellar master operon flhD/flhC. Regulation of 
type III secretion is mediated through QseA and, indirectly, through Ler. Together, the 
two proteins activate the expression of the five important lee operons (lee1-5), encoding 
components of the type III secretion apparatus as well as an adhesin (intimin, Eae), the 
intimin adhesin receptor Tir, and other proteins. Transcription of ler (LEE-encoded 
regulator) (the first gene in the lee1 operon) is activated by QseA. In EPEC, the plasmid-
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LuxS-dependent quorum sensing in EHEC 
QseB 
QseC 
flhD/flhC 
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encoded Per is also thought to mediate quorum-sensing (QseA)-dependent regulation of 
ler and bfp (bundle forming pilus).  
 
1.3.2.2 Salmonella typhimurium  
Salmonella enterica subspecies I, serovar Typhimurium (S. Typhimurium), is a 
leading cause of food-borne gastroenteritis (Baumler et al., 1998). Like many Gram-
negative bacteria, S. Typhimurium also utilise luxS/AI-2-dependent QS to regulate 
expression of a range of genes (Surette & Bassler, 1998).  
 
In S. Typhimurium, AI-2 production is tightly correlated with pfs transcription, which 
could be explained by a raised level of Pfs giving a response to increase the need for 
SAH detoxification, in turn resulting in a higher level of SRH and LuxS activity 
(Beeston & Surette, 2002). This indicates that AI-2 is more likely to be a metabolic 
component instead of a QS molecule in the S. Typhimurium system. At earlier stage, 
the only genes known to be regulated by AI-2 in S. Typhimurium were a seven-gene 
lsr operon, which encodes the ATP binding cassette (ABC) transporter (Taga et al., 
2001). Mutations in the lsr operon render S. Typhimurium unable to eliminate AI-2 
from the extracellular environment, indicating a role of the Lsr transporter in taking 
up AI-2 and the use of AI-2 as a metabolite, and that metabolic changes in the ¨luxS 
mutant consequently affect gene regulation (Taga et al., 2001).  
 
In S. Typhimurium, a number of virulence proteins are translocated into host cells via 
a type III secretion system encoded by genes in Salmonella pathogenicity island 1 
(SPI-1) (Zhou & Galan, 2001, Hapfelmeier et al., 2005, Choi et al., 2007). In 
transcriptional assays, a S. Typhimurium strain lacking luxS showed reduced 
transcription of a regulator gene, invF and InvF-regulated genes from SPI-1. The 
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decreased expression of genes from SPI-1 in the ¨ luxS mutant was restored 
genetically and also by addition of synthetic AI-2 (Choi et al., 2007).  
 
Salmonella swims by using flagella made from two different flagellar subunits, either 
FliC (phase 1) or FljB (phase 2) (McClelland et al., 2001). Karavolos et al. (2008) 
demonstrated that a S. Typhimurium luxS mutant polarises flagellar phase variation 
bias toward expression of the more immunogenic phase 1 flagellin. Interestingly, this 
effect in the ¨luxS mutant can be restored genetically, but not by addition of either 
AI-2 or other diffusible signals, indicating that the contributions of luxS to flagellar 
phase variation might be signal- or QS- independent and further implying that it is 
secondary to metabolic changes rather than QS (Karavolos et al., 2008).   
1.3.2.3 Porphyromonas gingivalis 
The Gram-negative bacterium, P. gingivalis, is an etiologic agent of severe 
periodontal diseases, including gingivitis and periodontitis which can lead to tooth 
loss and has been associated with diseases like cardiovascular disease and adverse 
pregnancy outcomes (Lamont & Jenkinson, 1998). 
 
As reported in previous studies, P. gingivalis possesses a luxS-dependent QS system 
(Chung et al., 2001). LuxS, along with its AI-2 product in P. gingivalis, exhibits a 
function of modulating protease and haemagglutinin activities (Burgess et al., 2002). 
Mutation of luxS in P. gingivalis leads to reductions in expression of some potential 
virulence determinants, including two extracellular cysteine proteases and 
haemagglutinating activity. However, it seems that luxS in P. gingivalis has no 
influence on proven virulence factors (Burgess et al., 2002).  
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A P. gingivalis ¨luxS mutant showed reduced transcription of a tonB homologue, 
which is responsible for energising transport of iron from the outer-membrane into 
the cytoplasm. The regulation of genes involved in such iron metabolism implies that 
AI-2 might be used as a signal in P. gingivalis for labeling nutrient limitation (James 
et al., 2006). Also, data from a microarray analysis suggests that luxS might be 
involved in promoting survival of P. gingivalis in the host by regulating its response 
to host-induced stresses, including raised temperature, hydrogen peroxide (H2O2) and 
high pH (Yuan et al., 2005).  
 
1.4 The role of luxS in H. pylori 
1.4.1 The incomplete activated methyl cycle (AMC) in H. pylori 
The activated methyl cycle (AMC) exists in many organisms, but H. pylori is not 
predicted to have a complete AMC since it lacks a gene encoding the homologue to  
enzymes that direct the production of methionine from homocysteine (Figure 1.6). 
This has been corroborated phenotypically, with all H. pylori strains tested being 
auxotrophic for methionine (Mendz & Hazell, 1995, Nedenskov, 1994). As a 
metabolic component in the AMC, the main metabolic role of LuxS is to convert 
SRH to generate homocysteine, to remove toxic SAH with the enzyme Pfs and to 
produce the signalling molecule AI-2 (Winzer et al., 2002a, Winzer et al., 2003). 
These functions of LuxS are predicted to exist in H. pylori. The main difference is 
that in H. pylori homocysteine is not converted to methionine and so cannot be 
recycled back to SAM hence it is not a source for further methylation reactions.  
 
 
 
 
 CHAPTER 1. INTRODUCTION 
 
 33 
 
 
Figure 1.6 The incomplete activated methyl cycle in H. pylori  
H. pylori has a luxS homologue and possesses an integral homocysteine and DPD (AI-2) 
biosynthesis pathway but it is not able to convert homocysteine to methionine because it 
does not contain a MetH/MetE homologue gene. 
 
1.4.2 LuxS-dependent quorum sensing in H. pylori  
luxS homologues and production of AI-2 exist widely in both Gram-positive and 
Gram-negative bacteria. However, it remains unclear whether LuxS is just a 
metabolic enzyme, or also performs as a QS factor in microorganisms.  
 
The first work on LuxS in H. pylori was by  Forsyth and Cover (2000) who found 
that H. pylori possesses the luxS gene and releases AI-2 at mid log phase, which 
induces bioluminescence in the V. harveyi reporter strain. They also expressed luxS 
from H. pylori in E. coli DH5D
                                                 
 E. coli DH5D is aluxS-negative strain 
 and restored AI-2 production in this strain using the 
heterologous gene. The report from Joyce et al. (2000) came out at almost exactly 
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the same time as Forsyths paper, and is very similar to Forsyths, but they described 
maximal AI-2 production during early log phase. They found that luxS mutagenesis 
had no effect on virulence factor or protein expression profiles, as determined by 
two-dimensional gel electrophoresis (Joyce et al., 2000). However, in neither study, 
was a phenotype convincingly attributed to the disruption of QS through luxSHp 
inactivation (Forsyth & Cover, 2000, Joyce et al., 2000). 
 
In later work, two ǻluxS mutants (SD3, SD14) of H. pylori were reported to form 
biofilms more efficiently than the parent strain, indicating a possible role of luxSHp in 
biofilm reduction (Cole et al., 2004). Next, ǻluxS mutants in J99 and 22695 strains 
are reported to lose growth phase dependent regulation of expression of the flagellar 
gene, flaA (Loh et al., 2004). Subsequent studies by two independent groups looked 
at fitness of ǻluxS mutants in vivo using mouse and gerbil models, respectively. They 
showed that mutated luxS in H. pylori strains SS1 and TK1402 diminished motility 
on soft agar and reduced fitness/competitiveness in co-infection experiments (Lee et 
al., 2006, Osaki et al., 2006). Nevertheless, Lee et al. (2006) reported that a ǻluxS 
mutant constructed in H. pylori strain X47 did not show any of the defects described 
above, indicating that after mutagenesis motility might be altered in a strain 
dependent manner (Lee et al., 2006). More recently, Rader et al. (2007) found 
reduced motility of a H. pylori *ǻluxS strain on soft agar and that loss of luxS 
altered flagellar morphogenesis in a strain background lacking flagellar associated 
genes flgM, flgS and fliA. They also reported that loss of luxS down-regulated the 
transcription of the master flagellar regulator gene flhA, which was complementable 
by addition of DPD, implying a likely role of luxSHp/AI-2 in QS (Rader et al., 2007). 
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1.5 Sulphur amino acid metabolism in bacteria 
1.5.1 General routes for the metabolism of methionine and cysteine 
The metabolism of sulphur in organisms involves three different aspects: synthesis of 
the sulphur-containing amino acids (cysteine and methionine), along with the 
sulphur-containing coenzyme groups; catabolism and equilibration of the sulphur 
metabolite pool; and methionine recycling (since methionine is the first residue of all 
proteins) (Cooper, 1983). 
 
Methionine and cysteine serve as initiators of protein synthesis and play a central 
role in cellular functions in all forms of life (Cooper, 1983, Griffith, 1987). Cysteine 
and methionine availability influences a range of cellular processes essential to 
bacterial survival and growth in the host (Cooper, 1983). Two different methionine 
biosynthetic pathways exist in organisms. One assimilates inorganic sulphur into 
cysteine, providing the sulphur source for methionine biosynthesis via the 
transsulphuration pathway (Droux, 2004). This pathway is unique to microorganisms 
and plants, rendering the enzyme an attractive target for the development of 
antimicrobials and herbicides (Droux, 2004, Cherest et al., 1993). The other pathway 
bypasses the transsulphuration reactions via direct sulphhydrylation of O-succinyl (-
acyl)-homoserine to homocysteine, and then to methionine (e.g. in P. aeruginosa, P. 
putida and Corynebacterium glutamicum) (Figure 1.7) (Foglino et al., 1995, Lee & 
Hwang, 2003, Vermeij & Kertesz, 1999).  
 
For cysteine biosynthesis, some organisms utilise a mechanism by which sulphur is 
reduced and incorporated into organic compounds, called the sulphate assimilatory 
cysteine biosynthesis pathway (SACBP) (eg. in S. Typhimurium, E. coli, Lactococcus 
lactis, M. tuberculosis, Azospirillum brasilense, plants and fungi) (Kredich & 
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Tomkins, 1966, Droux, 2004, Sperandio et al., 2005, Wheeler et al., 2005, Ramirez 
et al., 2006). This pathway involves transport and reduction of inorganic sulphate to 
sulphide in one branch and the synthesis of O-acetyl-serine (OAS) in another. Some 
organisms synthesise cysteine via an alternative reverse transsulphuration pathway 
(RTSP) which generates homocysteine through the central metabolic AMC, followed 
by its cleavage with specific enzymes via the intermediary formation of cystathionine 
to yield cysteine (eg. mammals, B. subtilis, P. aeruginosa, and M. tuberculosis) 
(Figure 1.7) (Gunther et al., 1979, Griffith, 1987, Vermeij & Kertesz, 1999, Wheeler 
et al., 2005, Hullo et al., 2007). 
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Figure 1.7 Bacterial methionine and cysteine interconversion pathways  
Many bacteria synthesise cysteine through the sulphate assimilatory cysteine biosynthetic 
pathway which uses inorganic sulphur as substrate (pathway bounded by an orange 
triangle). The reactions of the transsulphuration (shown in green) and reverse 
transsulphuration (shown in blue) pathways connect the AMC and the SACBP. The 
intermediate product in cysteine interconversion, homocysteine, is generated by the AMC. 
Key interconversions are described in the text. &%/ F\VWDWKLRQLQH ǃ-lyase; CBS, 
F\VWDWKLRQLQH ǃ-V\QWKDVH &*/ F\VWDWKLRQLQH Ǆ-O\DVH &*6 F\VWDWKLRQLQH Ǆ-synthase; 
DPD, 4,5-dihydroxy-2,3-pentanedione; LuxS, S-ribosylhomocysteinase/auto-inducer-2 
synthase; MetE/MetH, Methionine synthase; MetK, S-adenosylmethionine synthase; Pfs, 
5'-methylthioadenosine nucleosidase/S-adenosylhomocysteine nucleosidase; SAH, S-
adenosylhomocysteine; SAM, S-adenosylmethionine ; SRH, S-ribosylhomocysteine.  
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1.5.2 The transsulphuration and reverse transsulphuration pathways 
and their main enzymes  
The transsulphuration and reverse transsulphuration pathways (the TSP and RTSP) 
are part of the main routes of biosynthesis and consumption of sulphur-containing 
amino acids in organisms (Messerschmidt et al., 2003). In the TSP, cysteine is the 
sulphur donor and is transformed into homocysteine via the intermediate, 
cystathionine. The conversion of cysteine to cystathionine and the cleavage of 
cystathionine to yield homocysteine are catalysed respectively by enzymes 
cystathionine Ȗ-synthase (CGS) and cystathionine E-lyase (CBL) (Lee & Hwang, 
2003, Sperandio et al., 2005, Lee et al., 2007). In the RTSP, cystathionine is 
generated by cystathionine ȕ-synthase (CBS) using homocysteine as substrate, and is 
then cleavHGWRF\VWHLQHE\WKHHQ]\PHF\VWDWKLRQLQHȖ-lyase (CGL) (Gunther et al., 
1979, Chang & Vining, 2002, Sperandio et al., 2005, Wheeler et al., 2005, Hullo et 
al., 2007). Homocysteine is a key metabolite in both pathways due to its role either 
as a substrate to be re-methylated to methionine or as an intermediate involved in the 
cysteine biosynthesis via the RTSP, joining the AMC and other sulphur metabolism 
together (Figure 1.7).   
 
CGS, CBL; CBS and CGL are 4 classic enzymes that act in the TSP or RTSP. CGS, 
CGL and CBL belong to a protein family, including enzymes involved in cysteine 
and methionine metabolism. The following are members: CGS, CGL, CBL, 
PHWKLRQLQH Ȗ-lyase (MGL), O-acetylhomoserine (OAH) / O-acetylserine (OAS) 
sulfhydrylase, O-succinylhomoserine (OSH) sulphhydrylase. All these enzymes use 
PLP (pyridoxal-5'-phosphate) as a co-enzyme (NCBI 
database http://www.ncbi.nlm.nih.gov/sites/entrez). Members of this group are 
widely distributed among all forms of life. 
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CBS belongs to a second family. This subgroup includes CBS, cysteine synthase and 
O-phosphoserine sulfhydrylase. CBS is a unique haem-containing enzyme that 
catalyses a pyridoxal 5'-phosphate (PLP)-dependent condensation of serine and 
homocysteine to give cystathionine. Cysteine synthase on the other hand catalyses 
the final step of cysteine biosynthesis. The O-phosphoserine sulphhydrylase is an 
enzyme which is able to produce cysteine directly from sulphide (NCBI 
database http://www.ncbi.nlm.nih.gov/sites/entrez).  
 
The four enzymes CGS, CBL; CBS and CGL involvd in the TSP and RTSP are very 
similar to each other. Therefore, functions of these enzymes in transsulphuration in a 
specific organism are very difficult to predict. In most cases, the combination of 
CGS-CBL participates in the TSP, forward to the formation of methionine, while the 
combination of CBS-CGL usually acts the other way round to synthesise cysteine 
(Gunther et al., 1979, Wheeler et al., 2005, Hullo et al., 2007, Lee et al., 2007).  
1.5.3 Sulphur metabolism and related genes in bacteria 
1.5.3.1 Cysteine recycling in E. coli  
E. coli utilises the sulphate assimilatory cysteine biosynthetic pathway (SACBP) to 
synthesise cysteine. The reaction catalysed by serine acetyltransferase (encoded by 
cysE) condenses an acetyl group from acetyl CoA on the hydroxyl group of serine, 
forming O-acetyl-serine (Kredich & Tomkins, 1966). Sulphur, reduced as S
2-
, reacts 
with O-acetyl-serine (catalysed by O-acetyl-serine sulphhydrylase) to give cysteine. 
In the following step, CGSE. coli (encoded by metB) converts cysteine to cystathionine 
using O-succinyl homoserine as one of the substrates. Cystathionine is then cleaved 
by CBLE. coli (encoded by metC) to homocysteine and subsequently via methylation 
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to methionine. The conversion of homocysteine to methionine in E. coli is catalysed 
by methionine synthase encoded by metH. Cysteine is recycled by sulphate which is 
produced in consumption of methionine (Kredich & Tomkins, 1966, Sekowska et al., 
2000).  
 
Generally, E coli synthesises cysteine directly via the normal sulphate assimilation 
route and consumes cysteine via the TSP. Although the bacteria grow well in the 
presence of methionine as the sulphur source, they do not contain the RTSP (Figure 
1.8) (Sekowska et al., 2000). 
 
 
 
Figure 1.8 Pathways of cysteine and methionine metabolism in E. coli and 
P. aeruginosa§
E. coli utilises an ACSP to synthesise cysteine and a TSP to synthesise methionine. P. 
aeruginosa possesses all known routes of methionine or cysteine metabolic pathways. 
Details of interconversions are described in the text. Enzymes involved: 1, O-acetyl-L-
serine sulphhydrylase; 2, cystathionine Ǆ-synthase; 3, cystathionine ǃ-lyase; 
4, methionine synthase; 5, O-succinyl-L-homoserine sulphhydrylase; 6, SAM synthase-
 
                                                 
§ Figure 1.8 is from the paper Vermeij & Kertesz, 1999. 
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methyltransferases-SAH hydrolase pathway; 7, cystathionine ǃ-synthase; 8, cystathionine 
Ǆ-lyase (Vermeij & Kertesz, 1999).  
 
 
1.5.3.2 Methionine and cysteine biosynthesis in P. aeruginosa 
P. aeruginosa possesses the pathway of direct sulphhydrylation of O-
succinylhomoserine to synthesise methionine and also contains substantial levels of 
O-acetylserine sulphhydrylase (cysteine synthase) activity (Foglino et al., 1995). 
Both the TSP and RTSP are involved in P. aeruginosa (Figure 1.8) (Foglino et al., 
1995, Gunther et al., 1979). When cysteine is present as the sole sulphur source, 
enzymes involved in the TSP, CGS and CBL, are strongly upregulated during growth; 
when the bacterium grows with multiple sulphur sources, the two enzymes are 
expressed at low levels (Foglino et al., 1995). P. aeruginosa is able to grow with 
methionine as the sole sulphur source due to the presence of the RTSP (Gunther et 
al., 1979). Interestingly, the pathway between homocysteine and cysteine, with 
cystathionine produced as the intermediate, are shown to be necessary for rapid P. 
aeruginosa growth (Foglino et al., 1995, Gunther et al., 1979).  
1.5.3.3 Methionine and cysteine biosynthesis in M. tuberculosis 
Sulphur metabolic pathways in M. tuberculosis are one of those which have been 
well-studied (Figure 1.9). In M. tuberculosis, CBS and CBL are encoded by cysM 
and metC, respectively. The four genes metZ, metB, metC, and metA, encoding 
enzymes of the appropriate protein family in the genome of M. tuberculosis were 
annotated without a gene to encode CGL (Cole et al., 1998, Hacham et al., 2003, 
Wheeler et al., 2005). However, one of these genes, metB has been shown to encode 
a bifunctional enzyme (with both CGS and CGL activities), indicating that metB is 
involved in the production of cystathionine from cysteine in the TSP and also the 
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conversion of cystathionine to cysteine in the RTSP (Wheeler et al., 2005). Like P. 
aeruginosa, this bacterium contains almost all known routes for biosynthesis and 
utilisation of methionine and cysteine (Wheeler et al., 2005). However, in M. 
tuberculosis, CGS activity is not always needed to incorporate the sulphur of 
cysteine into methionine because sulphide can be recycled by O-succinyl-homoserine 
sulphhydrylase (metZ) to give homocysteine directly, thus by-passing the metB 
encoded pathway (Wheeler et al., 2005). 
 
 
 
 
 
 
Figure 1.9 Biosynthesis and interconversions of sulphur amino acids in the M. 
tuberculosis complex**
All known pathways and related genes or proteins are shown in this figure. A color code is 
used to denote the different pathways as follows: orange, sulphur recycling, with 
inorganic sulphur as product or substrate; magenta, the transsulphuration pathway from 
cysteine to methionine; blue, the reverse transsulphuration pathway from methionine to 
 
                                                 
** Figure 1.9 is from the paper Wheeler et al., 2005. 
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cysteine; black, the activated methyl cycle and other relevant pathways and reactions 
shared by more than one pathway. Genes and enzyme names are as follows: red, shown 
functionally; turquoise, present, discussed in this report; black with red strikethrough, 
shown to be absent. Cysteine desulphhydrase was not annotated in the M. tuberculosis 
genome (Wheeler et al., 2005).  
 
 
 
1.6 Sulphur-containing amino acid metabolism in H. pylori 
Most microorganisms bear the central metabolic pathway, the activated methyl cycle 
(AMC), in which LuxS converts SRH to homocysteine, providing the substrate, 
homocysteine, either to form cysteine through the RTSP, or to re-generate 
methionine, completing the recycling of the AMC (Duerre & Walker, 1977, Winzer 
et al., 2003, Hullo et al., 2007). Interestingly, the pathway of re-formation of 
methionine does not exist in H. pylori due to a lack of the gene encoding methionine 
synthase (Tomb et al., 1997, Doig et al., 1999).  
 
In H. pylori, luxS is next to two housekeeping genes metB and cysK, and is located 
downstream on the putative operon cysK-metB-luxS (Tomb et al., 1997). The 
fuctions of cysK and metB in H. pylori have not been identified clearly to date. 
However, both metB and cysK are involved in cysteine or methionine metabolism in 
many other bacteria (Thompson et al., 1982, Thanbichler et al., 1999, Vermeij & 
Kertesz, 1999, Wheeler et al., 2005). According to the genome data of Genbank, 
metBHp is predicted to encode a CGS; while cysK is predicted to encode a cysteine-
synthase or CBS-like protein. Both are required for the operation of a classic route 
for the interconversion of homocysteine and cysteine (Figure 1.7).  
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H. pylori lacks the enzyme to incoporate sulphide into sulphate, consequently it is 
not able to synthesise cysteine directly via the sulphate assimilatory cysteine 
biosynthesis pathway (Kong et al., 2008). On the other hand, homocysteine 
accumulates with continuing methylation from SAM in the incomplete AMC. 
Accordingly, the RTSP, a sulphur-metabolic pathway generating cysteine from 
homocyseine via the intermediate product, cystathionine, is very likely to be the 
main (or can be the only) cysteine provision pathway utilised by H. pylori, involving 
the conserved genes metBHp and cysKHp (Figure 1.10) (Hullo et al., 2007).  
 
H. pylori is predicted to lack general machineries for sulphur metabolism, implying 
that genes associated with sulphur metabolism in H. pylori may be very limited 
(Tomb et al., 1997, Doig et al., 1999). Therefore, enzymes encoded by luxS, metB 
and cysK are likely to catalyse the most important sulphur metabolic pathway in H. 
pylori. By studying the metabolic function of luxSHp, cysKHp and metBHp, it is likely 
to find a cysteine provision pathway encoded by the gene cluster cysKHp-metBHp-
luxSHp, and importantly, the effect of luxSHp in metabolism distinct from the other 
effect in QS signalling. 
 
 
 
 
 
 
 
 
 CHAPTER 1. INTRODUCTION 
 
 45 
 
 
Figure 1.10 The incomplete activated methyl cycle (AMC) of H. pylori and our 
hypothesis on cysteine provision 
H. pylori does not contain a MetH/MetE homologue gene, thus is not able to convert 
homocysteine to methionine. Homocysteine subsequently accumulates with continuing 
methylation from SAM in the incomplete AMC. LuxSHp is an enzyme in the conversion of 
SRH to homocysteine, which is linked to two housekeeping genes cysKHp and metBHp. 
Both are involved in cysteine and methionine metabolism in many other bacteria. This 
leads to a hypothesis: H. pylori is able to convert homocysteine to cysteine via the 
intermediate cystathionine through the RTSP.  
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1.7 Objectives 
luxS homologues and the production of AI-2 exist widely in bacteria. Nevertheless, 
the role of LuxS remains unclear in many microorganisms due to its dual function 
both in amino acid metabolism and QS signalling. Some previous publications 
suggest that AI-2 may not act as a QS molecule in many bacteria, but may just be a 
by-product of central metabolic AMC, secreted during exponential phase and 
degraded at later stage. In other words, production of AI-2 may only be associated 
with metabolic purpose, and not with regulatory significance (Doherty et al., 2006).  
 
H. pylori is one of the controversial cases. Although H. pylori possesses luxS and 
releases AI-2 that is able to induce bioluminescence in the V. harveyi reporter strain, 
evidence for the phenotypic changes that are attributed to disruption of luxS is 
limited. Like many other microorganisms, H. pylori possesses the central metabolic 
pathway AMC (but incomplete), in which LuxSHp is responsible for producing 
homocysteine, the key intermediate metabolite for biosynthesis of methionine or 
cysteine, and also AI-2. The dual products by LuxSHp lead to a few questions: Is 
LuxSHp a pure metabolic enzyme in amino acid metabolism? Is AI-2 only a 
metabolite generated as a by-product in the incomplete AMC, or also a QS signal 
utilised by H. pylori? If productions of both homocysteine and AI-2 are disrupted by 
loss of luxSHp, are corresponding phenotypic alterations induced by inactivation of 
luxSHp due to loss of AI-2 or the disrupted amino acid metabolism, or both?  
 
To answer these questions, firstly, it is needed to clarify the role of LuxSHp in 
metabolism. To do this, the relative contribution of luxSHp with linked metBHp and 
cysKHp to biosynthesis of sulphur-containing amino acids had to be analysed. 
Drawing known information on luxSHp and genome data of cysKHp and metBHp, it 
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was hypothesised that proteins encoded by the operon cysKHp-metBHp-luxSHp catalyse 
a metabolic pathway for cysteine biosynthesis. In this study, amino acid requirements 
of H. pylori wild-types and all mutants were examined in different chemically 
defined media (CDM). Next, metabolite pools of cells of wild-types and each mutant 
were analysed, by which the only cysteine biosynthetic pathway in H. pylori was 
confirmed, and the precise steps in this pathway were defined. For details see 
Chapter 3 and 4.   
 
To investigate whether LuxSHp is also a functional QS signal synthase, varieties of 
experiments were performed, including motility bioassays, microscopy, gene 
transcriptional testing and microarrays. Importantly, due to the alternative role of 
LuxSHp in proposed cysteine metabolism, careful studies were carried out to exclude 
the possibility that the contribution of LuxSHp to QS was in fact due to non-specific 
metabolic effects of LuxSHp. To do this, specific conditions were set up, in which the 
luxSHp-required cysteine metabolic pathway and the production of AI-2 were isolated 
from each other. For details see Chapter 5 and 6.  
 
In summary, the aims of this project were to: 
1) Identify  the cysteine biosynthetic pathway in H. pylori;  
2) Clarify the metabolic role of the operon cysKHp-metBHp-luxSHp in the cysteine 
biosynthetic pathway; 
3) Confirm whether motility of H. pylori is luxS/AI-2 dependent; 
4) Investigate whether the luxS/AI-2 system controls motility of H. pylori via AI-2 
signals only, or also via luxS-required cysteine metabolism; 
5) Explore the mechanism underlying motility phenotypic changes upon luxSHp 
inactivation. 
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2 General Materials and Methods 
2.1 Materials 
2.1.1 Commercial materials and reagents 
All commercial media were purchased from Bacto, UK and Oxoid Ltd, UK, and 
prepared according to the manufacturers recommendations. Specialist media for 
individual methods are described in following chapters. All chemicals were 
purchased from Sigma Chemical Company, UK. All restriction digestion reagents 
and PCR reagents were purchased from New England Biolabs Inc., UK and Promega 
Ltd, UK. All chemicals used to make chemically defined media (CDM) were of high 
purity (cell culture tested), and obtained from Sigma-Aldrich Co.  
2.1.2 Strains, plasmids and growth culture conditions 
The strains and plasmids used in this study are listed in Table 2.1. E. coli strains 
DH5D and DS941 (Summers & Sherratt, 1988, Yanisch-Perron et al., 1985) were 
used in cloning/subcloning experiments. E. coli was routinely propagated in Luria-
Bertani (LB) broth or on LB-agar plates at 37
o
C, under normal atmospheric 
conditions. V. harveyi BB170 was utilised as a reporter strain in the bioluminescence 
bioassay. Vibrio harveyi was grown in either LB or AB medium (Greenberg et al., 
1979) at 30
o
C, also under normal atmospheric conditions. H. pylori strains were 
routinely subcultured on horse blood agar (Oxoid) every 2-3 days, and were grown in 
a MACS VA500 Microaerobic Workstation (Don Whitley Scientific) using a 
humidified atmosphere consisting of 6% O2, 3% H2, 5% CO2 and 86% N2. Antibiotic 
selection was carried out at 100µgml
-1
 with ampicillin (or carbenicillin), and 50µgml
-
1
 for kanamycin.  
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For H. pylori metabolic supplementation experiments, the complete chemically 
defined medium (cCDM) of Reynolds and Penn was formulated as previously 
described (Reynolds & Penn, 1994), with variations as indicated in the text (Chapter 
4.2.1). CDM batch culture comparative growth studies were carried out as described 
previously (Doherty et al., 2009). 
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Table 2.1 Strains and plasmids used in this study 
Strains/Plasmids Genotype/notes Source 
Strains   
Escherichia coli   
, ?ɲ endA1 recA1 gyrA96 thi-1 hsdR17(rk
-
 mk
+
) relA1 supE44 ȴ ?lacZYA-argF) U169 F- 
Ɍ ? ?ĚlacZȴM15 deoA phoA ʄ- 
(Yanisch-Perron et al., 
1985) 
   
DS941 
thr-1 leu-6 thi-1 lacY1 galK2 ara-14 xyl-5 mtl-1 proA2 his-4 argE3 str-31 tsx-33 
supE44 rec+ recF lacIq lacZ ȴM15 
(Summers & Sherratt, 
1988) 
   
Vibrio harveyi   
BB170 luxN : : Tn5 AI-1 sensor negative; AI-2 sensor positive (Surette & Bassler, 1998) 
   
Helicobacter pylori   
J99 (ATCC700824) tŝůĚ-type strain (Alm et al., 1999) 
: ? ?ȴluxS J99; ȴluxS : :Kmr dŚŝƐƐƚƵĚǇ 
J99ȴluxS-F : ? ?ĚĞƌŝǀĂƚŝǀĞ ?ȴluxS : : km-sacB; Kmr Sucs dŚŝƐƐƚƵĚǇ 
: ? ?ȴluxS+ J99ȴluxS-&ĚĞƌŝǀĂƚŝǀĞ ?ȴluxS : : km-sacB ƌĞƉůĂĐĞĚ dŚŝƐƐƚƵĚǇ 
with original luxS locus; Suc
r
 Km
s
  
: ? ?ȴmetB J99; ȴmetB: :Kmr dŚŝƐƐƚƵĚǇ 
: ? ?ȴcysK J99; ȴcysK: : Kmr dŚŝƐƐƚƵĚǇ 
: ? ?ȴflhB : ? ?ĚĞƌŝǀĂƚŝǀĞ ?A?HP0770 Lys13 to Glu347; Kmr; non-motile  ?tĂŶĚ et al., 2006) 
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NCTC 11637 (ATCC43504) tŝůĚ-type strain (Marshall et al., 1984) 
 ? ? ? ? ?ȴluxS  11637; ȴluxS : :Kmr dŚŝƐƐƚƵĚǇ 
 ? ? ? ? ?ȴmetB 11637; ȴmetB: :Kmr dŚŝƐƐƚƵĚǇ 
 ? ? ? ? ?ȴcysK 11637; ȴcysK : :Kmr dŚŝƐƐƚƵĚǇ 
CCUG 17874
 tŝůĚ-type strain  (Marshall et al., 1984) 
17874 A?flaA 17874 ĚĞƌŝǀĂƚŝǀĞ ?A?flaA : : cat; Cmr Paul OToole 
17874 A?flgE 17874 ĚĞƌŝǀĂƚŝǀĞ ?A?flgE : : km; Kmr (O'Toole et al., 1994) 
   
Plasmids   
pGEM-T Commercial TA cloning vector; Ap
r
 Promega ?DĂĚŝƐŽŶ ?t/ 
pMWA2 Source of apolar aphA3 cassette; Ap
r
 Km
r
  ?tĂŶĚet al., 2006) 
pLUXS pGEM-T::luxSHp::aphA3; Km
r
 Theo Verboom 
pMETB pGEM-T bearing the metBHp gene; Ap
r
 dŚŝƐƐƚƵĚǇ 
pCYSK pGEM-T bearing the cysKHp gene; Ap
r
 dŚŝƐƐƚƵĚǇ 
pGEMTluxSXN396 pGEM-dǁŝƚŚŝŶƐĞƌƚĞĚ ? ? ? ? ?luxS; (Loh et al., 2004) 
pMF1 ƉDdĚĞůĞƚŝŽŶ-ŝŶƐĞƌƚŝŽŶĚĞƌŝǀĂƚŝǀĞ ?Ɖr Kmr dŚŝƐƐƚƵĚǇ 
pCF2 Ɖz^<ĚĞůĞƚŝŽŶ-ŝŶƐĞƌƚŝŽŶĚĞƌŝǀĂƚŝǀĞ ?Ɖr Kmr dŚŝƐƐƚƵĚǇ 
pProEx-luxSEC pProEX HT containing the luxS gene of E. coli MG1655 (Winzer et al., 2002a) 
pProEx HT mtan pProEX HT containing the pfs gene of E. coli (Winzer et al., 2002a) 
  
                                                 
 CCUG 17874 is identical to the type strain NCTC 11637, isolated by B. J. Marshall at Royal Perth Hospital, May 1982.  Marshall, B. J., H. Royce, D. I. Annear, C. S. 
Goodwin, J. W. Pearman, J. R. Warren & J. A. Armstrong, (1984) Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Lett. 25: 83-88. 
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2.2 General Methods 
2.2.1 DNA preparation and DNA manipulation techniques 
2.2.1.1 General molecular biology methods 
Preparation of plasmid DNA, DNA ligation, gel electrophoresis and transformation 
of E. coli strains were performed in accordance with standard methods (Sambrook et 
al., 1989). All PCRs were performed with Taq DNA polymerase (Roche Diagnostics, 
Lewes, UK). TA cloning was carried out using the pGEM-T vector system (Promega, 
Madison, WI). DNA-sequencing reactions were performed on PCR purified 
fragments or plasmids by Geneservice (Cambridge, UK). Plasmid DNA was 
extracted using the QIAquick spin miniprep kit (QIAGEN, UK). DNA fragments 
were purified from agarose gel using a QIAquick gel extraction kit (QIAquick, UK) 
according to the manufacturers instruction. H. pylori genomic DNA was isolated as 
described previously (Letley et al., 2003). DNA sequencing was conducted using 
standard fluorescent dye terminator chemistries, and analysis performed using the 
Applied Biosystems 3730 DNA Analyser system (Geneservice, Cambridge, UK, 
Applied Biosystems Inc, Foster City, CA.). Results were analysed using the Bioedit 
software suite (Hall, 1999). 
2.2.1.2 Polymerase chain reaction (PCR) 
A 25µl reaction mixture was set up for each DNA template containing: 2.5µl 10 × 
PCR buffer (Promega, UK), 2.5µl dNTPs (Promega, UK), 0.1µl Taq DNA 
polymerase (Promega, UK), 0.1µl each primer, 0.2µl template DNA, and 19.7µl 
distilled water. PCR reaction mixture without template was used as the negative 
control. Amplification conditions were; 95°C for 30s, 54°C for 30s, and 72°C for 2 
min, for 30 cycles in total. Thermal cycling for amplification began with an initial 
denaturation for 5 min at 95°C and ended with a final elongation for 10 min at 72°C. 
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2.2.1.3 Restriction digestion 
Reaction mixtures contained buffer, restriction enzymes, template and distilled water. 
All digestion reactions were carried out by incubating reaction mixtures at 37°C for 1 
h. The percentage volume of enzymes in the reaction mixture was less than 10%.  
2.2.1.4 T4 DNA ligation 
Reactions were performed in a final volume of 10µl containing 1µl T4 ligase (or 
1/10 diluted T4 ligase), 1µl T4 buffer, vector (1 unit), PCR amplified DNA or 
digested DNA fragment (3 units) and dH2O. The mixture was incubated at 4°C 
overnight. Prior to use in transformation reactions, salt was removed by dialysis 
against water using 13mm, 0.025µm pore-size nitrocellulose filters for 40 min. 
2.2.1.5 Electrophoresis of DNA 
DNA fragments were separated by electrophoresis using 1% agarose gels prepared in 
1 × Tris-acetate-EDTA (TAE) buffer (40nM Tris-acetate, 2mM EDTA, pH8.5), 
stained with ethidium bromide (0.5µg/ml). Diluted 7.5µl 1kb DNA ladder (500ng/µl, 
Promega) or diluted 7.5µl 2-log DNA ladder (NEB, UK) were used as the size 
markers. Gels were run at 80V to 100V in 1 × TAE buffer. DNA bands were 
visualised and photographed under ultra-violet (UV) light (Uvidoc). 
2.2.1.6 Preparation of H. pylori chromosomal DNA 
H. pylori was harvested from blood agar, and resuspended into 1ml of phosphate 
buffered saline (PBS). The suspension was then centrifuged at 13000 rpm for 5 min. 
Cell pellets were resuspended in 100µl TE buffer (10mM Tris-HCl, 1mM EDTA, pH 
8.0). 500µl GES buffer (5M guanidine thiocyanate, 0.1M EDTA, 0.5% (w/v) 
sarkosyl) was added and the mixture was incubated at room temperature for 5 min, 
and then placed on ice. 250µl of ice cold ammonium acetate (7.5M) (Sigma, UK) 
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was added, gently mixed and chilled on ice for 5 min. 650µl of chloroform was then 
added and mixed gently. All the samples were then centrifuged at 13000 rpm for 5 
min. The aqueous top layer containing DNA was removed into a fresh 1.5ml 
Eppendorf using wide end tips, and another 650µl of chloroform was added and 
centrifuged as before. The aqueous top layer was transferred again to a fresh 1.5ml 
Eppendorf using wide end tips and 0.54 × volume of isopropanol was added for 
DNA precipitation from the aqueous phase. The mixture was centrifuged at 13000 
rpm for 5 min. The supernatant was discarded and the pellet was washed twice with 
70% 500µl ethanol. After air drying, the pellet was resuspended in 100µl-200µl 
nuclease free water. 
2.2.2 Transformation methods 
2.2.2.1 CaCl2 method 
This method was utilised to transform plasmid to E. coli '+Į. 5ml overnight 
FXOWXUHRI'+ĮZDVXVHGWRLQRFXODWHPOIUHVK/%PHGLXPDQd cultured at 37°C 
for 1-2 h till OD550 was 0.5 (+/-10%) The culture samples was divided into two 
aliquots and centrifuged at 4.5 × 1000 rpm for 10 min. The pellet from each aliquot 
was resuspended in 20ml 0.1M CaCl2, and placed on ice for 30 min. Each aliquot 
was centrifuged at the same speed for 10 min. The supernatant was discarded. The 
pellet was resuspended in 2ml 0.1M CaCl2 and chilled on ice for 10 min. 1-ȝO'1$
OLJDWLRQZDVDGGHG WRȝOof cells. Cells were placed on ice for 40 min and heat 
shocked at 42°C for 1 min, and then placed on ice for further 10 min. Cells were 
spread on selective LB agar (containing 80ȝM X-Gal and 500ȝM IPTG).  
2.2.2.2 Electroporation 
Electroporation was used to transform plasmids into E. coli DS941. 20ml DS941 was 
incubated in LB broth overnight at 37°C whilst shaking. The overnight culture was 
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diluted 1:100 in 2L LB broth at 37°C whilst shaking until the OD600nm reached 0.5 
(+/-10%). Cells were pelleted by centrifugation for 35 min at 4.0 × 1000 rpm at 4°C. 
Cells were resuspended in 1L sterile distilled ice-cold water (4 × 250ml), and 
pelleted as before. Cells were washed twice with ice-cold water, and then pelleted 
and resuspended in 10% glycerol (4 × 20ml and 4 × 1ml), and divided into ȝO
aliquots. Cells were frozen rapidly in liquid N2, and stored at -80°C for use in 
HOHFWURSRUDWLRQȝO'1$OLJDWLRQZDVSUHSDUHGE\GLDO\VLVDJDLQVWGLVWLOOHGZDWHUIRU
20-30 min XVLQJ ȝP SRUH VL]H QLWURFHOOXORVH ILOWHUV Electro-competent cells 
ZHUH WUDQVIRUPHGZLWKȝO'NA ligation reaction mix. Transformation was carried 
out in a chilled electroporation cuvette, using a BioRad Gene Pulser. Electroporation 
voltage was 1.8kV/cm (0.1cm electrode gap), at a setting of 200 DQG ȝ) 7KH
cuvette was placed into the sample chaPEHUDQGWKHSXOVHZDVDSSOLHG7KHQȝO
of LB broth was added into the cuvette immediately. The cells were then incubated 
for 60 min at 37°C. Cells (100-200ȝl) was plated on selective LB agar and incubated 
overnight at 37°C. 
2.2.2.3 Natural transformation of H. pylori strains 
The H. pylori strains (J99 and 11637) were grown for 24 h on blood agar plates and 
were passed onto fresh blood plates and grew for another 24 h. The cells were 
harvested and suspended in 1000ml isosensitest-FBS (90 % (w/v) isosensitest, 10% 
(v/v) FBS) then pelleted by centrifugation at 13,000 rpm for 5 min. The cells were 
resuspended in 30-50Pl fresh isosensitest-FBS and placed as a spot in the centre of a 
blood agar plate and incubated at 37qC for 6 h. 3-5Pl of plasmid DNA (heat sterilised 
at 85qC for 10 min and allowed to cool to room temperature) was added to the centre 
of the H. pylori growth and incubated overnight. The cell mass was spread out over 
the surface of the plate and incubated at 37qC for 1 day and then transferred onto a 
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blood plates containing antibiotics (kanamycin 30 Pg/ml, cloramphenicol ȝJPO, 
sucrose 5% [w/v]). Transformants were selected by their ability to survive in the 
presence of antibiotic. The allelic double-crossover event and the orientation of the 
resistant cassette were verified by nucleotide sequencing across the points of 
insertion using the same primers.    
2.2.3 Sodium dodecylsulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE)  
2.2.3.1 Protein samples preparation   
Bacterial cells were taken from agar plate into 1ml PBS by a swab (for broth culture, 
cells were normalised by resuspending in PBS to give a standard OD600nm of 1.0). 
Samples were sonicated for 5 to 10 sec three times and kept on ice. Samples were 
then centrifuged for 30 sec by a high speed.100µl supernatants were taken and added 
with 100µl 2 × PAGE sample buffer (20% [v/v] glycerol, 125mM Tris-HCL, pH 6.8, 
4% SDS, 0.01PJPOEURPRSKHQROEOXHȕ-mercaptoethanol) and then inactivated 
by 100°C boiling water.  
2.2.3.2 SDS-PAGE gel electrophoresis 
A 12.5% resolving gel (4.2ml Acrylamide/Bis, 1.25ml RGB, 100µl 10% SDS, 4ml 
dH2O, 5µl TEMED, and 75µl 10% Ammonium Persulphate) and the stacking gel 
(750µl Acrylamide/Bis, 1.5ml SGB, 60µl 10% SDS, 3ml dH2O, 6µl TEMED, and 
150µl 10% Ammonium Persulphate) was routinely used. The combs in stacking gel 
were removed and the wells were washed with dH2O. The protein-PAGE gel was 
placed in the gel tank (Invitrogen) and 900ml 1 × SDS-PAGE running buffer (14.4g 
Glycine, 3g Tris, 1g SDS in 1L dH2O). 10µl to 20µl of protein samples were gently 
loaded to each well. Pre-stained broad range protein marker (Biolabs) was utilised to 
eliminate the molecular weight of the protein tested. The gels were run at 180V for 
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40 min to 1 h till the dye comes out of the gels. The stacking gel was removed and 
the gels stained or proteins were transferred to nitrocellulose membrane by the 
methanol Tris-glycine system described by Towbin et al (1992).   
2.2.4 Cysteine and DPD complementation experiment  
Cysteine was Sigma products and dissolved according to the manufacturers 
recommendation. Synthetic DPD was purchased from Omm Scientific Inc. DPD 
activity was quantified with the bioluminescence bioassay and compared to wild-
type H. pylori
 
grown to OD600nm of 1.0, at which maximal AI-2 activity was obtained. 
To test for complementation of motility, DPD (150µM, after 10 h and once again 
after 18 h of incubation) and cysteine (1.0mM, at the beginning of incubation) were 
added individually to bacteria-AGS cells co-cultures. Bacterial motility and cell 
morphogenesis were observed and visualized
 
by the phase-contrast microscope and 
EM, respectively. For analyses of flagella biosynthesis and RNA expression, DPD 
and cysteine were added (in the same way) individually to cell cultures of different H. 
pylori genotypes. After 24 h, cell culture samples were analysed using protein 
electrophoresis and Western blotting, and RNA was extracted and the transcript 
levels of genes of interest were measured.  
2.2.5 Statistical methods used 
The statistical analysis methods used in this study included Students t distribution 
test and standard deviation. 
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3 Mutagenesis of luxS, cysK and metB on H. pylori 
cysK-metB-luxS gene cluster  
 
3.1 Introduction                                              
Helicobacter pylori is a Gram-negative bacterium which causes peptic ulceration, 
gastric adenocarcinoma, and gastric lymphoma (Atherton, 2006). All H. pylori 
strains possess a homologue of luxS, best known as a quorum sensing (QS) molecule 
synthase. luxS homologues have been found in many bacterial genomes sequenced 
(Sun et al., 2004, Tomb et al., 1997, Vendeville et al., 2005, Hardie & Heurlier, 
2008). Some of the molecules formed in the reaction catalysed by LuxS are 
collectively termed auto-inducer-2 (AI-2) and have been shown to act as signalling 
molecules. They have been described as mediating a variety of effects in different 
bacteria, including virulence. In H. pylori, disruption of luxS has been shown to 
increase biofilm formation (Cole et al., 2004) and to reduce in vivo fitness and 
infectivity (Lee et al., 2006, Osaki et al., 2006). Several motility-associated luxSHp 
phenotypes have also been reported, including loss of growth phase-dependent flaA 
regulation (Loh et al., 2004), reduced motility on soft agar plates, and reduced 
transcription of the flagellar regulator gene flhA (Osaki et al., 2006, Rader et al., 
2007). 
 
In most bacteria, the enzyme encoded by luxS has an alternative (possibly primary 
and sometimes sole) function: it is an essential metabolic component of the activated 
methyl cycle (AMC). LuxS in the AMC catalyses cleavage of S-ribosylhomocysteine 
(SRH) to yield homocysteine and a by-product, 4, 5-dihydroxy-2, 3-pentanedione 
(DPD) (Figure 1.6) (Schauder et al., 2001, Winzer et al., 2002a, Winzer et al., 2003, 
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Vendeville et al., 2005). DPD is the precursor of the family of related, 
interconverting molecules AI-2 (Camilli & Bassler, 2006, Vendeville et al., 2005). 
The AMC in H. pylori is incomplete as the bacterium lacks MetB and MetH 
homologues to re-generate methionine from homocysteine (see Chapter 4.1 for detail 
information of the AMC in H. pylori). 
 
In searching for a possible metabolic role for LuxSHp, a hypothesis was formed: it 
could be part of a de novo cysteine biosynthesis pathway that uses methionine as a 
reduced sulphur source. The reasoning for this was based on the observation that H. 
pylori has an absolute requirement for methionine (Nedenskov, 1994, Reynolds & 
Penn, 1994, Mendz & Hazell, 1995), in agreement with its lack of metE and metH. 
Also, all complete H. pylori genomes available to date (including 26695, J99, 
HPAG1, G27, B128, Shi470 and 98-10) contain homologues of two genes, annotated 
as cysK and metB, which in other bacteria (e.g. B. subtilis and M. tuberculosis) are 
involved in the generation of cysteine and interconversion of cysteine and 
methionine, respectively (BLAST).  
 
In all sequenced H. pylori strains, cysK and metB are located immediately upstream 
of luxS, forming a cysKHp-metBHp-luxSHp gene cluster. According to the genome data 
of Genbank, H. pylori metB LVSUHGLFWHGWRHQFRGHDF\VWDWKLRQLQHȖ-synthase (CGS)-
like enzyme, while cysK is predicted to encode a cysteine-synthase or a cystathionine 
ȕ-synthase (CBS)-like enzyme. Recently, the metB gene from H. pylori strain SS1 
was purified and characterised and has been suggested to encode a functional CGS, 
but its physiological role was not established (Kong et al., 2008).  
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When pondering the fate of homocysteine, which is not converted to methionine in H. 
pylori due to a lack of MetE and MetH, coupled with the observation that the gene 
responsible for its production, luxS, is linked with two other genes predicted to be 
involved in methionine and cysteine metabolism, it was hypothesised that H. pylori 
is able to utilise homocysteine by converting it to cysteine via the reverse 
transsulphuration pathway (RTSP), involving the associated genes metB and cysK 
(also see Chapter 4.1 for more details).  
 
To define more specifically the primary metabolic roles of cysK, metB, and luxS 
homologues in the putative H. pylori RTSP, first of all, ǻluxS ǻmetB DQG ǻcysK 
mutants were constructed using an insertion-deletion strategy in two different H. 
pylori strtains J99 and NCTC11637 to avoid strain specific effects. As luxSHp 
comprises the last of the genes in the operon cysKHp-metBHp-luxSHp, to avoid polar 
effects of disrupting either cysKHp or metBHp, a variant of aphA3 which lacks both the 
promoter and terminator elements was used in producing mutants. Subsequently, the 
V. harveyi AI-2 assay (Bassler et al., 1997, Winzer et al., 2002a) was used to 
demonstrate that disruption of either cysKHp or metBHp does not block expression of 
downstream genes. 
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3.2 Materials and Methods 
3.2.1 Construction of mutations 
3.2.1.1 Construction of H. pylori ǻluxS strains  
(This work was done by Neil Doherty) 
All mutants were made following an insertion-deletion strategy. The H. pylori ǻluxS 
mutant strains were made by transforming J99 and NCTC11637 with 
pGEMT::luxS::aphA3 (a generous gift from Leo Smeets and Theo Verboom). 
3.2.1.2 Construction of H. pylori ǻmetB strains 
A 2.1kb region of the genome of metB was amplified from H. pylori J99 genomic 
DNA using the primer pair metB-F/metB-R (forward, 5>CTT GAT AAT CCC GCA 
GCC TAC TA<3; reverse, 5>ACC CCC ACT TCA GAC CAC TCA G<3). 
Amplified product included full metB along with approximately 500bp of upstream 
and downstream flanking sequence. The fragment was cloned into the pGEM-T [TA] 
vector system (Promega) to produce the plasmid pMETB. A deletion of metB was 
generated by inverse PCR with the primer pair metB-IF/metB-IR (forward, 
5>CGT GAA TTC CGG CTA AAC CAG<3, EcoRI site is underlined; reverse, 
5>TGA ACA GGA TCC GTT AGA AGA TT<3, BamHI site is underlined) using 
pMETB as template. An 860bp fragment cut from pMWA2 encoding kanamycin 
resistant cassette aphA3 (Wand et al., 2006) that contains the corresponding 
restriction site of EcoRI or BamHI on each end was cloned into pMETB inverse PCR 
product to form the plasmid pMF1. pMF1 was transformed into recipient wild-type 
H. pylori strains J99 and 11637. Putative double-crossover strains were selected, and 
the presence of the kanamycin resistant gene was verified by amplifying the mutated 
fragments on H. pylori chromosomal DNA using primers metB-F/metB-R and DNA 
sequencing.   
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3.2.1.3 Construction of H. pylori ǻcysK strains 
Primers cysK-F/cysK-R (forward, 5>CAC CAT TGA CA AAT CCT TCC<3; 
reverse, 5>TTT GGT GTT GGG CTT GAT AG<3) were designed to amplify a 
1.7kb cysK fragment with approximate 500bp of upstream and downstream flanking 
sequence; the product was cloned into vector pGEM-T to generate a new plasmid 
pCYSK. A mutation of cysK was produced by inverse PCR mutagenesis using 
pCYSK as template with the primer pair cysK-IF/cysK-IR (forward, 5>GCT GTT 
TTT CTG TGC TGA ATT CTT<3, EcoRI site is underlined; reverse, 5>GTG GAT 
CC
3.2.2 AI-2 in vitro biosynthesis 
G AGG GTT CTA TTT TGA<3, BamHI site is underlined). The apolar aphA3 
cassette were digested from pMWA2 and cloned into the inverse PCR product to 
produce a plasmid pCF2. pCF2 was purified and utilised to disrupt the cysK locus in 
H. pylori wild-type strain J99 and 11637 by natural transformation and selection of 
kanamycin resistant colonies. The resulting cysK :: km ǻcysK) strains were verified 
by PCR and a sequence of the genomic locus. 
3.2.2.1 Purification of the proteins LuxS and Pfs  
2ml of LB cultures of DH5Į/X[6 DQG'+Į3IV (with 2ȝl carbenicillin, 50mg/ml) 
ZHUHJURZQRYHUQLJKWPORIWKHRYHUQLJKWFXOWXUHVRI'+Į/X[6 DQG'+Į3IV 
were respectively used to inoculate 50ml fresh LB containing 50ȝl carbenicillin 
solution, grown at 37qC and 200 rpm for 2 h. 100ȝl of 0.5M IPTG added and 
incubation continued for another 3 h. Cell pellets were obtained by centrifugation 
and resuspended in 2ml bugbuster (Novagen), with 2ȝl benzonase (Novagen) added. 
Suspension was shaken gently for 20 min at room temperature and then centrifuged 
at 10,000g for 20 min at 4qC. Clear lysate was decanted off and collected ready for 
protein purification. For each protein preparation, approximately 2ml of the NI-NTA 
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His bind resin was loaded into small disposable chromatography column, and 
allowed to settle. Resin was washed with 5 × 1.5ml of bind buffer. Lysate was added 
to resin then washed with 5 × 3ml bind buffer followed by 5×3ml wash buffer. The 
column was then eluted with 5 × 1ml portions of the elute buffer, collecting 
individual 1ml fractions. Purified protein usually elutes in the 2
nd
 or 3
rd
 fraction, 
which is then stored at -80qC with the addition of 100ȝl 50% glycerol solution. 
Protein solutions could be used directly in following steps. 
3.2.2.2 Staining and drying of protein gels  
Gels (containing LuxS and Pfs protein bands, respectively) were stained with 
Coomassie blue staining solution (0.25g Coomassie brilliant blue, 45 % (v/v) 
methanol, 10 % (v/v) glacial acetic acid) for 20 min and destained in Coomassie blue 
destaining solution (20% [v/v] methanol, 7% [v/v] glacial acetic acid). After staining, 
gels were rinsed in dH2O and placed in gel-drying solution (Novex) with two 
DryEase
TM 
Mini-Cellophane sheets (Novex) for 10 min. The gel was sandwiched 
between the Mini-Cellophane sheets and air dried.  
3.2.2.3 In vitro synthesis of AI-2  
Sodium phosphate buffer (10mM, pH=7.7) was deoxygenated by sparging with 
helium (or nitrogen) for approximate 10 min. 1.7ml buffer was added to 3.08mg 
dehydrate SAH with 100ȝl of purified Pfs solution and incubated at 37qC for 2 h. 
900ȝl of the incubated solution was added to 1ml fresh buffer containing 100ȝl of 
LuxS solution, and incubated for another 2 h. 1.1ml buffer was added to the 
remaining 900ȝl as a negative control.  
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3.2.3 Bacterial growth curves and V. harveyi bioluminescence assay  
Bacterial broth cultures were started from a blood agar plate culture, diluted to an 
OD600nm of 0.05 in fresh BB medium, and grown at 37qC in a VAIN-cabinet with 
shaking. OD600nm measurements were taken at the 6 h, 24 h, 48 h and 72 h time 
points, and at the same time cell suspensions were harvested and filtered through a 
ȝPSRUHVL]HILOWHU7KH$,-2 activity in cell free supernatants (CFS) was tested as 
previously described using the V. harveyi reporter strain BB170 (Winzer et al., 2003, 
DeKeersmaecker & Vanderleyden, 2003). Briefly, an overnight V. harveyi culture 
was diluted 1:2500 in fresh AB medium (Greenberg et al., 1979). Cell free 
supernatant (CFS) samples were diluted 1:10 in the AB medium containing BB170 
into the 96 well bioluminescence plates to give D ILQDO YROXPH RI ȝO DQG were 
incubated at 30qC. The bioluminescence and optical density were determined at 30 
min intervals for at least 8 h using a luminometer (Anthos Labtech LUCY 1.0). AI-2 
activity alterations in bioluminescence were expressed as induction (n-fold) over the 
negative control.  
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3.3 Results  
3.3.1 The mutagenesis of MetBHp and CysKHp  
Genome sequence analysis of H. pylori (strains J99 and 26696) revealed putative 
genes luxS, metB and cysK (Alm et al., 1999, Tomb et al., 1997). luxSHp is located 
immediately downstream of metBHp and cysKHp. A Shine-Dalgarno sequence 
AGGAGA is generally located 10 basepairs upstream of the start codon ATG 
(methionine codon) of the putative operon cysKHp-metBHp-luxSHp, and such sequence 
is not found between each two genes of the three on the putative operon 
(http://genolist.pasteur.fr/PyloriGene/). Thus, co-transcription within the cysKHp-
metBHp-luxSHp genes cluster is predicted. The putative promoter includes putative -35 
(TTAACG) and -10 (TAAAAT) boxes located upstream of cysKHp 
(http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=
gfindb). The transcriptional start site is predicted to locate 74 basepairs upstream of 
the start codon of the putative operon. The size of transcripts could be assessed by 
northern blot and actual transcription start site(s) by primer extension analysis. The 
encoded proteins are predicted to comprise 308 (CysK), 380 (MetB) and 145 (LuxS) 
amino acids, respectively.  
 
To characterise the function of each of these genes, luxS, metB and cysK mutations 
were constructed in two H. pylori strains (J99 and 11637). Each mutant was created 
using a deletion/insertion approach, using the aphA3 cassette (kanamycin resistance) 
as a selectable marker (Wand et al., 2006). The general approach to this mutagenesis 
strategy is shown in Figure 3.1 (the diagram of cysKHp mutagenesis is not shown), 
and details are described in Chapter 3.2 Materials and Methods. Briefly, the metBHp 
and cysKHp PCR products were respectively cloned into vector pGEM-T to generate 
the new plasmids pMETB and pCYSK. Using pMETB and pCYSK as templates, 
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mutations of metBHp and cysKHp were produced by inverse PCR with primer pairs 
metB-IF/metB-IR and cysK-IF/cysK-IR, respectively. The mutagenesis of metBHp and 
cysKHp were confirmed by PCR (metB-F/metB-R and cysK-F/cysK-R) and DNA 
sequencing. To avoid polar effects of disrupting either cysKHp or metBHp, the apolar 
kanamycin cassette aphA3 which lacks both promoter and terminator sequences was 
used. The cassette ensures that transcription of the disrupted gene is initiated and 
terminated by the native promoter and terminator, respectively (see Chapter 3.3.2 for 
details). PCR products of each step for both metBHp and cysKHp mutangenesis are 
shown in Figure 3.2-3.8.  
 CHAPTER 3. RESULTS 
 
 69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Flow diagram of metBHp mutagenesis 
For details described in text, see Chapter 3.2 Materials and Method. MCS=multiple cloning 
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Figure 3.2 The metBHp and cysKHp PCR product 
The gels show the products generated in figure 3.1 Step A. The PCR products metBHp and 
cysKHp were amplified from J99 wild-type genomic DNA. The size of the original metBHp 
and cysKHp were 1140bp and 918bp, respectively. 500bp of additional DNA sequence was 
included at both ends of the original metBHp (and also cysKHp) sequence to make a final 
fragment containing the entire metBHp (and cysKHp) gene plus flanking sequences. Primers 
metBHp-F/metBHp-R and cysKHp-F/cysKHp-R were used in the amplification. The size of the 
metBHp PCR product was 2.1kb, and the size of the cysKHp product was 1.9kb. Marker: 
Promega 1kb DNA ladder. 
 
 
 
Figure 3.3 Digested products of plasmids pMETB and pCYSK 
The gels confirm the products generated in figure 3.1 Step B. Plasmids pMETB and pCYSK 
were generated by cloning metBHp and cysKHp into the vector pGEM-T. Both plasmids were 
digested by the enzyme HindIII (Promega, UK). The size of the digest products of pMETB 
and pCYSK are 5.1kb and 4.9kb, respectively. This step was to confirm the successful 
cloning of metBHp and cysKHp into pGEM-T. Marker: Promega 1kb DNA ladder. 
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Figure 3.4 Inverse PCR products generated from plasmids pMETB and pCYSK 
The gels show the inverse PCR products generated in figure 3.1 Step C. Mutations of 
metBHp and cysKHp were produced by inverse PCR mutagenesis using pMETB and pCYSK 
as templates with the primer pairs metB-IF/metB-IR and cysK-IF/cysK-IR, respectively. 
860bp metBHp sequence was deleted from the plasmid pMETB, and 227bp cysKHp was 
deleted from the plasmid pCYSK. By inverse PCR, restriction sites of EcoRI and BamHI 
were produced respectively on each end of each inverse PCR product. The pMETB inverse 
PCR product is 4.3kb. The pCYSK inverse PCR product is 4.6kb. Marker: Promega 1kb 
DNA ladder. Marker: Promega 1kb DNA ladder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Digested product of the plasmid pMWA2 and gel purified aphA3 
The two gels show the generation of the apolar cassette aphA3 (figure 3.1 D). The apolar 
kanamycin resistance gene aphA3 containing the corresponding restriction site of EcoRI or 
BamHI on each end was cut by restriction digestion from the plasmid pMWA2 (Wand et al., 
2006) (the gel shown on the left). The apolar aphA3 product was purified from the 
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electrophoresis gel. The gel-purified aphA3 product (860kb) was confirmed by 
electrophoresis (gel on the right). Marker: Promega 1kb DNA ladder. 
 
 
 
 
 
Figure 3.6 Digested products of pMF1 and pCF2  
The two gels confirm the generation of pMF1 and pCF2 (figure 3.1 E).The plasmids pMF1 
and pCF2 were generated by ligating aphA3 with the pMETB and pCYSK inverse PCR 
products. The size of pMF1 and pCF2 are 5.1kb and 5.7kb, respectively. Putative pMF1 
and pCF2 were digested by the enzyme HindIII (Promega, UK), and the size was 
confirmed by electrophoresis gel. Marker: Promega 1kb DNA ladder. 
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Figure 3.7 Confirmation of successful metBHp mutangenesis in H. pylori J99 and 
11637 strains 
Mutagenesis of metBHp was carried out in two H. pylori backgrounds, J99 and 11637. The 
mutated metBHp was amplified with the original metBHp-F/metBHp-R primers using the 
chromosomal DNA of J99 ƩmetBHp (1) and 11637 ƩmetBHp (2) as templates (gel on the 
left). The size of the disrupted metBHp is 2.1kb, which is almost the same as the wild-type 
metBHp. Therefore, restriction digestion was performed with enzymes EcoRI and BamHI 
using mutated J99 metBHp (1) and mutated 11637 metBHp (2) as templates (gel shown on 
the right). Band D was aphA3 (860bp). Band ǃ (740bp) and Ǆ (540bp) were the 5 and 
3 parts of metBHp respectively. C: metBHp PCR product amplified from 11637 wild-type 
genomic DNA was used as the sample control. Marker: Promega 1kb DNA ladder. 
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Figure 3.8 Confirmation of cysKHp mutagenesis in H. pylori J99 and 11637 strains 
ƩcysKHp mutants were constructed in H. pylori J99 (1) and 11637 (2) strains. The 
mutated cysKHp (2.3kb) was amplified with the original cysKHp-F/cysKHp-R primers using 
the chromosomal DNA of J99 ƩcysKHp and 11637 ƩcysKHp as templates. C: cysKHp PCR 
product amplified from 11637 wild-type genomic DNA was used as the sample control 
(1.8kb). Marker: Promega 1kb DNA ladder. 
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3.3.2 Apolar disruption of metBHp and cysKHp did not affect expression 
of the downstream gene luxSHp 
3.3.2.1 Auto-inducer-2 (AI-2) in vitro synthesis 
The in vitro synthesised AI-2 product is used widely in this study. For instance, it 
was utilised as a positive control in the AI-2 activity bioassay and as a supplemented 
chemical in the complementation experiment of the plate motility assay (see Chapter 
5). AI-2 was synthesised in the laboratory using the method reported previously, 
which exploits the two-step pathway catalysed by enzymes Pfs and LuxS (Figure 
3.9B) (Winzer et al., 2002a). As already described in Matherials and Methods, 
proteins Pfs and LuxS were produced by purifying from the overnight cultures of 
'+ĮPfs and DH5ĮLuxS (Figure 3.9A). The dehydrated SAH was then added in 
sodium phosphate buffer as the substrate. After 2 h of incubation, the purified Pfs 
converted SAH to SRH, the substrate in the LuxS catalysed reation. The newly added 
LuxS solution subsequently converted SRH to homocysteine and the precursor of AI-
2, DPD, after incubated at 37qC for another 2 h. The product of the synthetic 
pathway, AI-2 (or DPD) was examined using the V. harveyi BB170 bioluminescence 
assay. 
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Figure 3.9 Purified enzymes Pfs and LuxS and the Pfs-LuxS catalysed AI-2 in 
vitro synthetic pathway 
(A) The Coomassie blue stained SDS-PAGE gels of the purified Pfs and LuxS proteins, 
respectively. Both proteins were purified from the whole cell lysate. During the step of 
elution, columns containing resin were eluted with 5×1ml portions of the elute buffer, 
collecting individual 1ml fractions. Purified Pfs and LuxS products usually elute in the 2nd 
fraction. (B) The pathway of AI-2 synthesis was catalysed by Pfs-LuxS using SAH as the 
substrate. SAH, S-adenosylhomocysteine; SRH, S-ribosylhomocysteine; HC, 
homocysteine; Pfs, 5'-methylthioadenosine nucleosidase/S-adenosylhomocysteine 
nucleosidase; LuxS, S-ribosylhomocysteinase/auto-inducer-2 synthase; DPD, 4,5-
dihydroxy-2,3-pentanedione, the precursor of AI-2.   
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3.3.2.2 Bioluminescence assay for auto-inducer-2 activities in H. pylori wild-
types and mutants 
luxSHp, metBHp and cysKHp lie on the same operon. The integrity of downstream 
genes after mutagenesis of an upstream gene is essential to identify the function of 
each gene on the operon (Figure 3.10A). Therefore, the normal function of the 
downstream gene luxSHp was tested in all mutants using the V. harveyi AI-2 detection 
assay described previously (Bassler et al., 1997, Winzer et al., 2002a). Before testing, 
H. pylori wild-type strains J99 and 11637 and all mutant strains were grown in 
Brucella broth containing serum (10% v/v). This study shows that H. pylori wild-
type strains produce AI-2 in a growth dependent manner, in which AI-2 accumulated 
during late log phase, reaching maximum levels in early stationary phase (being 
reported in Chapter 5.3.2, Figure 5.4). Consequently, AI-2 activity in culture 
supernatants after 24 h of incubation was measured. Data presented here show that 
ǻmetBHp DQG ǻcysKHp mutants exhibited AI-2 activity, suggesting that insertion of 
aphA3 into metBHp and cysKHp did not affect expression of the downstream gene 
luxSHp $V H[SHFWHG WKH ǻluxSHp mutants, unlike the wild-type and the other two 
mutants, yielded significantly (p<0.001) reduced levels of bioluminescence, 
indicating that insertion of aphA3 into the luxSHp gene abrogated AI-2 production 
completely (Figure 3.10B). 
 C
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Figure 3.10 Disruption of metB and cysK has no polar effect on luxS function 
(A) Schematic representation of the operon cysK-metB-luxS and gene regions of ¨ luxS, ¨metB and ¨cysK mutants. The promoter of this operon is 
located upstream of cysK. The mutant strains are J99/11637 ¨ luxS::km (a), J99/11637 ¨ metB::km (b), J99/11637 ¨ cysK::km (c). Arrows with a gray 
pattern indicate the kanamycin resistance gene, aphA3. The restriction sites are labelled on each end of aphA3. (B) Cell free supernatants of J99 and 
11637 wild-type (WT) and mutants after 24 h incubation were examined for the ability to induce bioluminescence in the V. harveyi reporter strain BB170. 
AI-2 activity is shown as a ratio of bioluminescence (corrected by OD600nm of H. pylori growth) in the presence of H. pylori cell free culture supernatants 
(1/10 diluted) over the negative control (NC). A diluted in vitro synthesised AI-2 sample was utilised as a qualitative positive control (PC). 
Bioluminescence induced by :7ƩmetBHpDQGƩcysKHp VWUDLQVZDVVLJQLILFDQWO\JUHDWHU WKDQ WKDW LQGXFHGE\ WKHƩluxSHp mutant, as determined by 
paired Students t-test (p<0.001). Error bars indicate the standard deviation within triplicate samples. 
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3.4 Discussion 
H. pylori presents an interesting case: although lacking homologues for the identified 
AI-2 receptors, the bacterium is known to respond to exogenously added, synthetic 
AI-2 (Rader et al., 2007), pointing toward a role of LuxS in cell-cell signalling. On 
the other hand, Lee and coworkers (2006) proposed that the reduced in vivo fitness 
observed for an H. pylori SS1 ǻluxS mutant was caused by metabolic disturbances, 
possibly by a disruption of the metabolic flux through the AMC or other LuxS-
dependent pathways (Lee et al., 2006). Interestingly, previous physiological work 
(Mendz & Hazell, 1995, Nedenskov, 1994, Reynolds & Penn, 1994) and genome 
analyses have revealed that the AMC in H. pylori is incomplete, since the  organism 
is a methionine auxotroph that lacks the genes required for methylation of 
homocysteine (metE or metH) (Doig et al., 1999, Old et al., 1988, Thanbichler et al., 
1999). This made us question whether LuxS in H. pylori had any metabolic roles 
apart from generating AI-2 and if so, what these roles could be.  
 
Intriguingly, in all currently sequenced H. pylori strains, luxS is part of a three-gene 
cluster that in addition to luxS contains two other genes with putative functions in 
methionine and cysteine metabolism (Figure 3.10A). These genes, currently 
annotated as metB and cysK, until now have been proposed to encode cystathionine 
ȕ-synthase and cysteine synthase, respectively (Doig et al., 1999). The gene cluster 
(cysK, metB, and luxS) is not only conserved among H. pylori strains and H. 
acinonychis but also is present in several Gram-positive bacteria (Winzer et al., 
2003), suggesting that metB and cysK are not evolutionary relics of now inactive 
metabolic pathways but still fulfil a metabolic function linked to that of luxS. 
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The hypothesis that the cysKHp-metBHp-luxSHp gene cluster is responsible for cysteine 
formation was based on several considerations. First, all H. pylori strains studied by 
Reynolds and Penn (1994) and the vast majority of strains characterised by 
Nedenskov (1994) were able to grow without cysteine (Nedenskov, 1994, Reynolds 
& Penn, 1994). Since the organism is not capable of using sulphate as a sulphur 
source (Doig et al., 1999), a hitherto-unidentified pathway must exist that makes use 
of the reduced sulphur present in methionine to generate cysteine. Second, the 
metabolic fate of the homocysteine generated in the LuxS reaction is unclear. High 
concentrations of homocysteine are toxic in some organisms (Roe et al., 2002, Tuite 
et al., 2005). Third, only two enzymatic steps are required to convert homocysteine 
to cysteine in the so-called reverse transsulphuration pathway (RTSP) present in 
some bacteria (for example, in B. subtilis and P. putida), where part of the AMC, 
including LuxS, is known to contribute to methionine-to-cysteine conversion by 
generating the required homocysteine (Hullo et al., 2007, Vermeij & Kertesz, 1999).  
 
To determine the functions of the putative homologues of cysK, metB, and luxS in H. 
pylori (which appear to lie in a single operon), firstly a panel of mutant strains 
deficient in each one of these gene products were constructed in two different H. 
pylori strain backgrounds (J99 and 11637). The use of two different srtains is 
designed to avoid strain specific effects. To ensure that polar effects were not 
LQFXUUHGZLWKWKHǻmetBHp DQGǻcysKHp mutants, a variant of aphA3 lacking both the 
promoter and terminator elements which has been used successfully in previous 
studies (Wand et al., 2006) was inserted into the target genes. 
 
Several previous analyses already established the Gram-positive origin of luxS, but 
did not consider the remaining genes of the cysK-metB-luxS cluster (Lerat & Moran, 
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2004). Interestingly, similar clusters exist in a number of Gram-positive species 
(Winzer et al., 2003), for instance Oceanobacillus iheyensis, Clostridium perfringens, 
and Clostridium botulinum. Intriguingly, in some Bacillus species, notably B. subtilis, 
Bacillus cereus, and Bacillus anthracis, similar clusters contain the pfs gene instead 
of luxS. More significantly, the genes in the B. subtilis cluster that show similarity to 
cysKHp and metBHp KDYHUHFHQWO\EHHQVKRZQWRHQFRGHIXQFWLRQDOF\VWDWKLRQLQHȕ-
synthase (CBS) DQG F\VWDWKLRQLQH Ȗ-lyase (CGL), respectively, and have therefore 
been renamed mccA and mccB (methionine-to-cysteine-conversion genes) (Hullo et 
al., 2007). Indeed, MccA and MccB bear closer resemblance to these gene products 
than to other putative CysK and MetB homologues found in B. subtilis. These 
findings lend further support to the suggestion that these gene clusters form 
functional units that contribute to the generation of cysteine via reverse 
transsulphuration. It thus appears that during the course of evolution, the common 
ancestor of H. pylori and H. acinonychis has lost its native luxS gene and instead 
acquired a Gram-positive homologue together with the ability to generate cysteine.  
 
To unequivocally establish the nature of the reactions that link homocysteine with 
cysteine in H. pylori will require purification and detailed characterization of CysKHp 
and MetBHp. The latter enzyme has already been studied, but not with respect to its 
physiological function. Kong et al. (2008) cloned the respective gene from H. pylori 
SS1 and purified the recombinant protein. However, the enzymatic activity of 
MetBHp was measured only using an unphysiological side reaction that is observed 
for some enzymes in vitro in the presence of O-acetylserine and in the absence of 
other substrates (Kong et al., 2008). Thus, the true physiological role of MetBHp 
remained unclear. With regard to CysKHp, a similar enzyme from Lactobacillus casei, 
also annotated CysK, has recently been proposed to act as a cystathionine ȕ-synthase, 
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converting homocysteine to cystathionine (Irmler et al., 2008). However, to date, 
CysKHp has been thought to be a cysteine synthase that generates cysteine using 
sulphide (Doig et al., 1999). To define the true physiological role role of the cysKHp-
metBHp-luxSHp gene cluster, and to clarify more accurately the metabolic function of 
each gene on this three-gene cluster of H. pylori, metabolic complementaion using 
chemically defined media was performed and the results were confirmed using a 
metabolomic approach. Details of these works are reported in the following chapter. 
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CHAPTER 4.  
H. PYLORI LuxS, CysK AND MetB ARE 
KEY ENZYMES IN CYSTEINE 
BIOSYNTHESIS THROUGH A PROCESS 
OF REVERSE TRANSSULPHURATION 
 
 
 
 
 
 
 
 
 
The work in this chapter has been published in the Journal of Bacteriology. 
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4 H. pylori LuxS, CysK and MetB are key enzymes in 
cysteine biosynthesis through a process of reverse 
transsulphuration 
 
4.1 Introduction  
As stated previously, luxS homologues have been found in around half of all 
bacterial genomes sequenced (Sun et al., 2004, Tomb et al., 1997, Vendeville et al., 
2005). The enzyme encoded by luxS is now generally suggested to be involved in 
two processes: LuxS functions as an integral metabolic component of the AMC, a 
pathway that generates methyl groups with a higher transfer potential (Winzer et al., 
2002a, Winzer et al., 2003). Its alternative function is in the production of the 
quorum sensing (QS) molecule auto-inducer 2 (AI-2), a by-product of the LuxS 
catalysed reaction (Winzer et al., 2002a, Winzer et al., 2003).   
 
The AMC is a key metabolic pathway involving the interconversion of the amino 
acids methionine and homocysteine, generating S-adenosylmethionine (SAM) as an 
intermediate product (the full cycle is shown in Figure 4.1). SAM bears a methyl 
group with a relatively high transfer potential, and is used by numerous 
methyltransferases to carry out various cellular processes ranging from DNA 
methylation to detoxification of reactive metabolites. The product of the 
methyltransferase reaction is the toxic S-adenosyl-homocysteine (SAH). In the 
complete AMC, methionine is re-generated from SAH via homocysteine, ready for 
another round of methylation/transmethylation. SAH is metabolised in one of two 
ways; many bacteria, including H. pylori, generate homocysteine from SAH in a two 
step manner; a nucleosidase, Pfs, converts SAH to S-ribosylhomocysteine (SRH), 
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then LuxS converts this to homocysteine and DPD, the precursor of the molecule AI-
2. The alternative route is slightly different, with homocysteine formed directly from 
SAH in a one step reaction requiring SAH hydrolase (Figure 1.4) (Duerre & Walker, 
1977, Winzer et al., 2003, Winzer et al., 2002a). Therefore, no DPD is produced. 
 
 
 
Figure 4.1 Bacterial cysteine provision pathway 
Enzymes with previously described homologues in H. pylori are shown in red. Enzymes 
that do not have homologues in H. pylori are shown in black (MetE/MetH). The reverse 
transsulphuration pathway which is a major focus of this chapter is shown in blue. Data 
presented in this chapter show that CysKHp is the candidate CBS and MetBHp the candidate 
CGL in the reverse transsulphuration pathway. The two genes, cysKHp and metBHp are 
recommended to be renamed mccAHp (methionine-to-cysteine-conversion gene A) and 
mccBHp, respectively. &%6&\VWDWKLRQLQHǃ-V\QWKDVH&*/&\VWDWKLRQLQH Ǆ-lyase, DPD; 
4,5-dihydroxy-2,3-pentanedione, LuxS; S-ribosylhomocysteinase/auto-inducer-2 
synthase, MetE/MetH; Methionine synthase, MetK; S-adenosylmethionine synthase, Pfs; 
5'-methylthioadenosine nucleosidase/S-adenosylhomocysteine nucleosidase, SAM; S-
adenosylmethionine, SAH; S-adenosylhomocysteine, SRH; S-ribosylhomocysteine.  
 
 
Though H. pylori has a luxS homologue and possesses a functional homocysteine and 
DPD biosynthesis pathway (Forsyth & Cover, 2000, Joyce et al., 2000), it is not 
predicted to have a complete AMC due to its lack of a gene homologous to the genes 
encoding methyltransferase MetE or MetH required for the final step in the classical 
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AMC, the conversion of homocysteine to methionine (Tomb et al., 1997, Doig et al., 
1999). This suggests that H. pylori is unable to carry out de novo biosynthesis of 
methionine (Figure 4.1). This is supported by the observation that all H. pylori 
strains tested are auxotrophic for methionine (Nedenskov, 1994, Mendz & Hazell, 
1995). Interestingly, it has also been shown that many H. pylori strains do not require 
cysteine for growth, indicating that H. pylori possesses a cysteine provision pathway 
itself (Nedenskov, 1994, Mendz & Hazell, 1995). This presents a paradox, as 
genomic studies show that homologues to the genes which encode the components 
required for uptake of sulphate and conversion to sulphide are absent, suggesting that 
the classic route of the sulphate assimilatory cysteine biosynthetic pathway 
(SACBP)

 
 is not present in H. pylori (Tomb et al., 1997, Doig et al., 1999). 
The above facts lead to a hypothesis that the H. pylori luxS gene is part of a de novo 
cysteine biosynthesis pathway that uses methionine as a reduced sulphur source. The 
reasons are as follows: the organism has an absolute requirement for methionine, but 
can synthesise cysteine without utilising oxidised sulphur compounds such as 
sulphate (Doig et al., 1999). Also, in the incomplete AMC, homocysteine 
presumably accumulates with each successive series of methylation from SAM. 
Consequently it must possess a pathway to consume homocysteine. The gene 
responsible for the production of homocysteine, luxS, is linked to other genes which 
are predicted to be involved in methionine and cysteine metabolism. Therefore, it 
was hypothesised that H. pylori is able to utilise homocysteine by converting it to 
cysteine via the reverse transsulphuration pathway (RTSP), involving the conserved 
genes metBHp and cysKHp. In the classic route of the RTSP, the presence of the 
                                                 
 The route of the sulphate assimilatory cysteine biosynthetic pathway (SACBP) is shown in figure 
1.7. 
 CHAPTER 4. RESULTS 
 
 87 
enzymes cystathionine ȕ-synthase (CBS) and cystathionine Ȗ-lyase (CGL), assisted 
with their coenzyme pyridoxal 5'-phosphate (PLP), are required for the conversion of 
homocysteine to yield cysteine, in which CBS generates the intermediate 
cystathionine from homocysteine, and CGL in turn cleaves cystathionine to cysteine 
(Figure 4.1) (Cooper, 1983, Chang & Vining, 2002, Hullo et al., 2007). It was 
hypothesised that cysKHp and metBHp may encode enzymes possessing CBS and CGL 
activities.   
 
To test these hypotheses, nutritional requirements of H. pylori wild-types and 
mutants defective in genes luxS, metB and cysK were analysed. The metabolic roles 
of the three genes were established by growing all strains in chemically defined 
media (CDM) containing different combinations of sulphur-containing amino acids. 
The results were confirmed by analysing metabolite pools of cells of each strain. 
Data in this chapter confirm the role of LuxSHp in generation of homocysteine and 
DPD; and show that CysKHp and MetBHp are required for its subsequent conversion 
to cysteine (¨ luxSHp, ¨ metBHp and ¨ cysKHp mutants all becoming auxotrophic for 
cysteine), suggesting a primary metabolic role of LuxSHp, MetBHp and CysKHp in the 
RTSP. 
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4.2 Materials and Methods 
4.2.1    Development of chemically defined media (CDM) 
To study the growth of H. pylori strains under nutrient (sulphur) restricted conditions, 
formulated media based on Reynolds and Penns previous report were utilised 
(Reynolds & Penn, 1994). Different medium formulations were generated by varying 
amino acid content and other chemical components. As absolute nutritional 
requirements vary in different strains, a medium formulation containing the 17 non-
sulphur containing amino acids at non-limiting concentrations was produced. The 
chemically defined media (CDM) produced in this study comprised 0.5% (w/v) BSA, 
ȝ0 DGHQLQH ȝJPO OLSRLF DFLG P0 JOXFRVH P0 1D+&2 ȝ0
)H624.+22 ȝ0 &D12)2.+22 P0 .&O ȝ0 0J624.+22 P0
1D&OP01D2+324, 1% (v/v) 100 × vitamin solution and 50% (v/v) 2 × amino 
acids solution. The 100 × vitamin solution consisted of 82ȝ0ELRWLQP0FKROLQH
FKORULGH ȝ0 IROLF DFLG P0 myo-LQRVLWRO ȝ0 QLDFLQDPLGH P0 p-
DPLQREHQ]RLFDFLGȝ0FDOFLXPSDQWRWKHQDWHȝ0S\ULGR[LQHK\GURFKORULGH
ȝ0 ULERIODYLQ ȝ0 WKLDPLQH K\GURFKORULGH DQG Q0 F\DQRFREDODPLQH
(vitamin B12). Each amino acid solution was made individually at 10mg/ml first, 
WKHQPL[HG WRD ILQDOYROXPHRIPOV WRJLYHDîVROXWLRQFRUUHVSRQGLQJ WR WKH
following concentrations: 1.0mM gO\FLQH P0 DODQLQH P0 VHULQH ȝ0
tryptophan, 1.0mM proline, 1.05mM aspartic acid, 1.01mM glutamic acidP0
asparagine, 1.01mM methionine, 1.08mM histidine, 2.2mM phenylalanine, 4.0mM 
valine, 4.0mM threonine, 4.12mM leucine, 4.10mM glutamine, 4.88mM isoleucine, 
P0 O\VLQHP0DUJLQLQH*OXFRVHZDVDGGHGDVDFDUERQDQGHQHUJ\VRXUFH
Methionine is the unique sulphur source of the primary CDM. Complete CDM 
(cCDM) was generated by adding cysteine at a non-limiting concentration of 1.0mM. 
To produce different sulphur-containing conditions for metabolic complementation 
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experiments, 3 other variants of this medium were also made: CDM-Cys lacks 
cysteine (Cys), CDM+HC lacks cysteine, but contains homocysteine (HC) and 
CDM+CTT lacks cysteine, but contains cystathionine (CTT). Homocysteine (HC) 
and cystathionine (CTT) were added individually at the same molar concentrations as 
cysteine (1.0mM). All chemicals were highly purified Sigma products and were 
dissolved according to the manufacturers recommendation. All solutions were filter 
sterilised before use. The pH of the final media was adjusted to 7.4-7.6 with [1M] 
HCl / [1M] NaOH. All strains were pre-cultured for 24 h and inoculated to each 
CDM with OD600nm adjusted to 0.05.  
4.2.2 Metabolic complementation using CDM 
Four different fresh CDM were prepared as described in Chapter 4.2.1 (Doherty et al, 
2010) on the day of doing the experiments. Metabolic complementation was 
performed using a 25cm
2
 tissue culture flask containing 5ml of each CDM. H. pylori 
11637 and J99 wild-types and all mutants were grown on blood agar plates for 24 h 
before the experiment. To make the concentrated stock for each strain, bacterial cells 
of each strain were removed from each blood agar plate using a swab and suspended 
in CDM-Cys medium. The concentrated strain stocks were used to inoculate each 
flask containing CDM (in triplicate for each strain). The initial OD600nm of each 
culture sample was 0.05. All inoculated flasks were incubated (with lids opened 
partially) on shakers with a speed of 450 rpm in a MACS VA500 Microaerobic 
Workstation (Don Whitley Scientific) using a humidified atmosphere consisting of 
6% O2, 3% H2, 5% CO2 and 86% N2. OD600nm of each sample was measured at the 6 
h, 24 h, 48 h and 72 h time points. 
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4.2.3 Sample preparation and relative quantification of candidate 
metabolites 
(In this experiment, sample preparation was completed by the author and 
quantification of metabolites was done by Mr Nigel Halliday, School of Molecular 
Medical Sciences, University of Nottingham) 
To make cell pellets for metabolimic analysis, bacteria were grown in complete 
CDM (cCDM) for 24 h using the same protocol shown in Chapter 4.2.2. All 
subsequent manipulations were performed on ice or in chilled equipment, and all 
plastic ware was pre-chilled prior to use. 3ml of culture at an OD600nm at 1.0 was 
taken as a standard sampling volume (variances from this OD were corrected for by 
using larger or smaller volumes). The required volume of cultures was quenched in 
5ml ice-cold PBS in a 15ml Falcon tube. Samples were centrifuged at 2000 rpm for 
10 min. The supernatants were discarded and cell pellets were washed in another 5ml 
ice-cold PBS. After the same spin stage was repeated, the supernatants were 
carefully removed and the tubes were spun briefly once more to bring the remaining 
liquid off the sides of the tubes. The residual liquid was removed and the dry cell 
pellets were stored at -80qC. At stage of quantification of metabolites, Methionine, S-
adenosyl methionine (SAM), S-adenosyl homocysteine (SAH), S-ribosyl 
homocysteine (SRH), homocysteine (HC), cystathionine (CTT) and cysteine in cell 
pellets were analysed by quantitative liquid chromatography tandem electrospray 
ionization mass spectrometry (LC-MS-MS) ( Singh et al., 2006, Heurlier et al., 
2009). Briefly, 90µl water containing two internal standards (13CD3-Methionine and 
B-Hleu) was added to the freeze-dried sample of extracted metabolites. This was 
followed by the addition of 40µl iso-butanol/pyridine mixture (3:1 v/v), 10µl iso-
butylchloroformate and 200µl dichloromethane/tert-butylmethyl-ether (1:2 v/v) with 
mixing at each stage. 150µl of upper organic phase was removed, and evaporated to 
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dryness under a stream of nitrogen gas. The derivatised metabolites were then 
redissolved in 100µl LC mobile phase (80% v/v methanol in 10mM ammonium 
formate) prior to LC-MS-MS analysis. LC separation was done on an Agilent 1100 
system (Agilent, Waldbron, Germany) using a mobile phase (80% v/v methanol in 
10 mM ammonium formate) at a flow rate of 200µl/min using a LUNA ODS C18(2) 
column (150 × 2.0 mm, 5µm particle size) (Phenomenex, Macclesfield, UK), 
maintained at 30°C. The MS system was a Waters Micromass Quattro Ultima triple 
quadrupole (Waters, Manchester, UK), used in positive ion multiple reaction 
monitoring scan mode to monitor specific precursor/product ions for each metabolite. 
The concentrations of individual metabolites were calculated from calibration lines 
using the peak area ratio to internal standard. Integrated values for each peak were 
normalized by dividing by the area of the corresponding internal standard peak in 
order to express the concentrations of metabolites in arbitrary units (Singh et al., 
2006, Heurlier et al., 2009).  
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4.3 Results 
4.3.1 LuxSHp, CysKHp and MetBHp are required for de novo cysteine 
biosynthesis in H. pylori 
In order to determine the effects of mutagenesis of cysKHp, metBHp and luxSHp, 
various chemically defined media (CDM) were composed based on the complete 
CDM (cCDM) of Reynolds and Penn (Reynolds & Penn, 1994). This is a versatile 
system which allows precise control of the composition of the medium. cCDM 
contained both of the sulphur containing amino acids, methionine and cysteine. 4 
variants of this medium were also produced, all of which lacked cysteine. One had 
no additional source of sulphur (hereafter referred to CDM), the others contained 
either homocysteine (CDM+HC), or cystathionine (CDM+CTT) (see Chapter 4.2 
Materials and Methods for concentrations). Using these media, all strains (the wild-
type and ¨ cysKHp, ¨metBHp and ¨luxSHp mutants of both H. pylori strain 11637 and 
J99) were found to grow well in cCDM (Figure 4.2 for 11637 and J99). Upon 
omission of cysteine (CDM), the wild-type strains still grew, although less well than 
in the complete medium (Figure 4.2 A-a and B-a). In contrast, all three mutants were 
auxotrophic for cysteine, with no growth detected (Figure 4.2 A-bcd and B-bcd). 
These observations confirmed that wild-type H. pylori is able to grow in the absence 
of cysteine, and so possesses a cysteine de novo biosynthesis pathway. They also 
revealed that cysKHp, metBHp and luxSHp are all part of this pathway. 
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4.3.2 Metabolic complementation of growth defects demonstrates the 
steps in the cysteine biosnthesis pathway catalysed by LuxSHp, CysKHp 
and MetBHp 
Next, all steps in the proposed H. pylori reverse transsulphuration pathway (RTSP) 
(Figure 4.1) catalysed by LuxSHp, CysKHp and MetBHp were examined. These 
experiments gave the same results for mutants constructed in the 11637 and J99 
background; results are presented in Figure 4.2 A-bcd and B-bcd. 
 
For ¨ luxSHp mutants, adding homocysteine to the CDM lacking cysteine improved 
growth of the ¨luxSHp strain, and cystathionine (CTT) restored growth to levels seen 
with cCDM (CDM with cysteine) (Figure 4.2 A-b and B-b). This implies that, as 
expected, LuxSHp is required for the conversion of S-ribosylhomocysteine (SRH) to 
homocysteine. 
 
¨cysKHp mutants could grow in cCDM (CDM containing cysteine) and in CDM 
lacking cysteine but containing cystathionine (CDM+CTT), but not in CDM lacking 
cysteine (CDM) or CDM lacking cysteine but containing homocysteine (CDM+HC) 
(Figure 4.2 A-c and B-c), suggesting that CysKHp catalyses the conversion of 
homocysteine to cystathionine.  
 
Finally, ¨ metBHp mutants could only grow in cCDM, indicating an absolute 
requirement for cysteine (Figure 4.2 A-d and B-d). This would be consistent with 
MetBHp catalysing the final step from cystathionine to cysteine, although further 
experimentation is needed to confirm this (see Chapter 4.3.3 metabolomic analysis). 
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In contrast to results for the wild-type, none of the mutants could grow in CDM 
lacking cysteine but containing potassium sulphide (CDM+S) (data not shown). Thus, 
it seems that CysKHp is not acting like CysK homologues in other bacteria (which 
use sulphide to generate cysteine), in agreement with the reported absence of the 
assimilatory sulphate reduction pathway in H. pylori (Doig et al., 1999). 
 
Taking these observations together, the hypothesis formulated was that H. pylori 
generates cysteine from methionine via components of the AMC, followed by 
reverse transsulphuration, with LuxSHp converting SRH to homocysteine, and 
CysKHp converting homocysteine to cystathionine which is finally converted to 
cysteine by MetBHp. 
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 CHAPTER 4. RESULTS 
 
 
95 
 C
 CHAPTER 4. RESULTS 
 
 
96 
  
  CHAPTER 4. RESULTS 
 
 
97 
Figure 4.2 Growth of H. pylori 11637 and J99 strains in chemically defined media 
(CDM) 
Methionine is present in each CDM as a sulphur source. OD600nm were measured at the 
indicated time intervals in cultures. The mean OD600nm values of triplicate culture samples 
are shown on each growth curve; error bars indicate standard deviation. Growth of H. 
pylori strains 11637 and J99 wild-type (a ƩluxS (b ƩmetB (c DQG ƩcysK (d) in 
complete CDM (cCDM, circles), CDM lacking cysteine (CDM, squares), CDM lacking 
cysteine but containing homocysteine (CDM+HC, triangles) and CDM lacking cysteine but 
containing cystathionine (CDM+CTT, diamonds). The mean OD600nm values of triplicate 
culture samples are shown. Error bars indicate standard deviations from the means. 
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4.3.3 Analysis of key metabolite pools confirms the proposed pathway 
of cysteine biosynthesis and specifically identifies reaction substrates  
(In this experiment, sample preparation was completed by the author and 
quantification of metabolites was done by Mr Nigel Halliday, School of Molecular 
Medical Sciences, University of Nottingham) 
In metabolic complementation experiments, both wild-type strains were tested but no 
mutant strains were able to grow without cysteine, indicating that disruption of any 
gene on the operon cysKHp-metBHp-luxSHp, as expected, disrupted the cysteine 
biosynthesis pathway in H. pylori. Accordingly, further experiments were designed 
both to investigate cysteine provision in more detail and to obtain more lines of 
evidence to clarify the role of luxS, metB and cysK in H. pylori metabolism. 
Metabolomic analysis was used to measure pool sizes of relevant metabolites to 
provide further evidence for the uptake and consumption of all components through 
the predicted cysteine biosynthesis pathway in H. pylori.  
 
Cell extracts of H. pylori wild-type and all mutants were grown in cCDM for 24 h 
and then analysed. In accordance with known data, metabolites through the proposed 
RTSP in H. pylori include methionine, SAM, SAH, SRH, homocysteine (HC), 
cystathionine (CTT) and finally cysteine (Cys). In most cases, the levels of 
individual metabolites found were corrected for those found in the wild-type, and 
expressed as fold changes relative to this (Figure 4.3).  
 
As expected, significantly (p<0.01) increased SRH level was detected in the ǻluxSHp 
mutant. However, SRH was only detected in the luxS strain, and was below the 
detection threshold in the wild-type, ¨ cysKHp and ¨ metBHp strains. Therefore, the 
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relative SRH level was expressed as 1 in the ¨luxS strain, and as 0 in all other strains. 
The other main differences between the metabolite profiles of the ǻluxSHp mutant 
relative to the wild-type were that HC and CTT were virtually undetectable in the 
mutant. 
 
When analysing the metabolites present in the ǻcysKHp mutant, approximately 2 fold 
more SAH (p<0.01) was found in the mutant compared with the wild-type. Most 
strikingly, the level of HC were 11 to 12 fold greater than in the wild-type, 
suggesting that this metabolite was accumulating in this strain. Like the ǻluxSHp 
mutant, the ǻcysKHp mutant seemed to produce minimal levels of CTT. 
 
Finally, in the ¨ metBHp strain, around 2 fold more SAH (p<0.01), and 2-3 fold more 
HC (p<0.01) was found compared with the wild-type. Most importantly, CTT was 
present in around a 5 fold excess relative to the wild-type, indicating that this 
metabolite was accumulating in this strain.  
 
These results are consistent with data obtained from the metabolic complementation 
experiments, in which it was demonstrated that LuxSHp converts SRH to HC; 
CysKHp cleaves HC to CTT; and MetBHp acts in the conversion of CTT to Cys, the 
final step in the cysteine biosynthesis pathway.  
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Figure 4.3 Metabolomic assays for all metabolites through the proposed reverse 
transsulphuration pathway in H. pylori 
Cell extracts of H. pylori 11637 wild-type and mutant strains grown in complete CDM in 
triplicate were taken after 24 h of incubation. All metabolites involved in the conversion of 
methionine to cysteine via the RTSP were quantified individually. The Y axis shows the 
fold change of each metabolite normalised to the level of the wild-type (WT). Levels of 
metabolites that were below the detection threshold were expressed as 0. SRH, was only 
detected in the ¨ luxSHp strain, and was below the detection threshold in the wild-type, 
¨cysKHp and ¨metBHp strains. Therefore, the relative SRH level was expressed as 1 in the 
¨luxSHp strain, and as 0 in all other strains. Values are mean activities of triplicate cell 
extract samples of each H. pylori strain. Error bars indicate standard deviation.  
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4.3.4 CysKHp and MetBHp, could be enzymes with cystathionine ȕ-
synthase DQGF\VWDWKLRQLQHȖ-lyase activities 
The conversion of homocysteine to cysteine through the RTSP in H. pylori is 
performed via the intermediate cystathionine, followed by its subsequent cleavage to 
cysteine. Sufficient evidence has been provided to show that this reaction in H. pylori 
requires CysK and MetB. According to genome data of Genbank, H. pylori cysK is 
annotated to be a cysteine-synthase, while metB is annotated to be a CGS. The role of 
H. pylori metB to encode a CSG was also reported in a structural study (Kong et al., 
2008). However, data presented in this chapter strongly suggest that CysKHp 
produces cystathionine in the conversion of homocysteine to cysteine, which is 
supposed to be an enzyme with CBS activity, while MetBHp cleaves cystathionine to 
cysteine and has CGL activity. 
 
Protein sequences of H. pylori CysK (CBS) and MetB (CGL) were compared with 
those of enzymes similarly annotated from other microorganisms (Figure 4.4). In 
BLAST searches of Genbank, H. pylori CysK shares 56% identity with CBS from 
Leuconostoc mesenteroides and Lactobacillus reuteri, 55% identity with CBS from 
Oenococcus oeni and 54% identity with CBSs encoded by yrhA homologues from 
Bacillus amyloliquefaciens and B. subtilis (Figure 4.4A) (Liu et al., 2008). H. pylori 
MetB shows 59% identity with CGL (encoded by yhrB) from B. subtilis, 57% 
identity with CGL from Lactobacillus reuteri and 55% identity with CGL from 
Clostridium botulinum (Figure 4.4B) (Liu et al., 2008). The sequence of pyridoxal 
phosphate binding motif of H. pylori CysK is over 75% identical to the motifs of 
CBSs from other microoganisms, while the same motif of H. pylori MetB is over 
85% identical to the motifs of CGLs from other microorganisms.    
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Figure 4.4 Comparison of aligments of H. pylori CysK and MetB with Genbank 
CBS and CGL 
(A) Alignment of H. pylori J99 CysK and Genbank sequences of CBS from different 
microorganisms. (B) Alignment of H. pylori J99 MetB and Genbank sequences of CGL from 
some other microorganisms. The sequences with dark background represent identical 
amino acids in all enzymes analysed. The sequences with yellow background show the 
pyridoxal phosphate binding motifs in CBS and CGL from each microorganism. 
 CHAPTER 4. RESULTS 
 
 104 
4.4 Discussion 
LuxS is now generally understood to carry out at least two functions, one in 
metabolism and one in cell-cell signalling (Bassler et al., 1997, Winzer et al., 2002b, 
Vendeville et al., 2005, Rezzonico & Duffy, 2008). Bacterial signalling systems 
based on LuxS-generated AI-2 are known to regulate gene expression in several 
members of Enterobacteriaceae (Li et al., 2007, Xavier et al., 2007) and notably 
Vibrio species. In this chapter, metabolic functions of cysKHp, metBHp and luxSHp in 
the cysteine biosynthetic pathway have been newly discovered and identified by 
analysing growth of different H. pylori genotypes in chemically defined media and 
quantifying metabolite pools in cell pellets, by which we confirm the primary 
metabolic role of LuxSHp in the imcomplete AMC and in cysteine provision. 
 
The results of this chapter are straightforward and in full agreement with the 
hypothesis (described in both chapters 3.1 and 4.1). First, it demonstrates that all 
genes of the cysK-metB-luxS gene cluster in H. pylori (in both 11637 and J99, to 
avoid strain specific effects) are required for cysteine prototrophy: mutation of any 
one of these genes (¨luxSHp, ¨ metBHp and ¨ cysKHp) rendered the respective strain 
auxotrophic for cysteine (Figure 4.2A-b and B-b). Chemical complementation 
restored the growth of all mutants and also indicated a sequential order for the 
involved enzymatic activities, which is LuxSHp-CysKHp-MetBHp. The results 
suggested that the true physiological function of the cysKHp gene product lies in the 
conversion of homocysteine to cystathionine; the latter is then used by MetBHp to 
generate cysteine. This interpretation was further corroborated and extended by 
metabolite profiling. In full agreement with the proposed metabolic functions, the 
metabolite pools of ǻluxSHp mutants showed accumulation of SRH and depletion of 
both homocysteine and cystathionine, whereas ǻcysKHp mutants accumulated 
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homocysteine and were depleted for cystathionine. Interestingly, SAH were elevated 
2 fold compared to the wild-type, which may indicate a weak feedback inhibition 
effect of homocysteine on Pfs, an enzyme catalysing the reaction immediately prior 
to the LuxS reaction in the AMC. ǻmetBHp mutants were the only strains that 
accumulated cystathionine. Again, an increase in the levels of SAH was seen, 
suggesting that either higher levels of homocysteine can inhibit pfs, or that both 
homocysteine and cystathionine may lead to its inhibition. All of these data provide 
the evidence that an RTSP is operational in H. pylori. 
 
Data presented in this chapter indicate that compared with the bacteria which have 
mutiple pathways for metabolism of cystiene and methionine, H. pylori possesses a 
simpler route for degradation of methionine and biosynthesis of cysteine, which is 
the RTSP only. This is consistent with the analysis of the numerous H. pylori 
genomes available to date (e.g. KEGG http://www.genome.jp/kegg/ and 
PyloriGene http://genolist.pasteur.fr/PyloriGene/). Unlike H. pylori, many other 
organisms (e.g. S. Typhimurium, E. coli, Lactococcus lactis, Azospirillum brasilense, 
plants and fungi) utilise an alternative sulphate assimilatory cysteine biosynthesis 
pathway (SACBP) to synthesise cysteine, which involoves transport and reduction of 
inorganic sulphate to sulphide in one branch and the synthesis of O-acetyl-serine 
(OAS) in the other (Droux, 2004, Kredich & Tomkins, 1966, Sperandio et al., 2005, 
Ramirez et al., 2006). The SACBP cannot exist in H. pylori due to its lack of the 
enzyme needed to produce sulphide from sulphate (Hullo et al., 2007). Moreover, the 
TSP cannot be a principal supply route since there is no machinery to provide the 
second substrate, O-succinyl- (or O-acetyl-) homoserine (OAH / OSH) for the 
formation of cystathionine from cysteine in H. pylori (Tomb et al., 1997, Cooper, 
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1983). Consistently, all H. pylori strains tested are auxotrophic for methionine, but 
none are auxotrophic for cysteine (Nedenskov, 1994, Mendz & Hazell, 1995).  
 
As mentioned in the last chapter, the enzyme MetBHp has already been studied, but 
not with respect to its physiological function (Kong et al., 2008). Thus, the true 
physiological role of MetBHp remained unclear until the presence of the experimental 
data here, by which MetBHp appears to be an enzyme with cystathionine Ȗ-lyase 
(CGL) activity. To date, CysKHp has been thought to act as a cysteine synthase that 
uses sulphide to generate cysteine (Doig et al., 1999). However, the finding that 
sulphide cannot support growth of H. pylori in the absence of cysteine, at least under 
conditions in the experiments presented here, suggests that CysKHp is solely 
dedicated to homocysteine conversion. Thus, CysKHp is proposed to be an enzyme 
with cystathionine ȕ-synthase (CBS) activity. 
 
CBS and CGL both belong to the superfamily of pyridoxal-5-phosphate (PLP) 
dependent enzymes. CBS lies in the E family (tryptophan synthase class) of PLP 
dependent enzymes, and CGL is in the J-subdivision of the D family (aspartate 
aminotransferse class). Interestingly, similarity searches (BLAST) of the metBHp and 
cysKHp gene products (sequentially located upstream of luxSHp) reveals that these 
gene products also fall within the PLP dependent enzyme superfamily. MetBHp falls 
into the J-subdivision of the D family, and is annotated as a CGL. CysKHp belongs to 
the E family, and is annotated as either a CBS or an O-acetyl-serine sulfhydrylase 
(OAS-sulfhydrylase).  
 
The multiple sequence alignments of CBSs and CGLs have shown identities and 
similarities between the sequences of cysKHp and metBHp products and sequences of 
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enzymes with the same activities in some other bacteria including L. mesenteroides, 
L. reuteri, O. oeni, C. botulinum, B. amyloliquefaciens and B. subtilis (Figure 4.4). 
As stated previously (in Chapter 3.4), the genes cluster in B. subtilis that show 
similarity to cysKHp and metBHp have recently been shown to encode functional CBS 
and CGL, respectively, and have therefore been renamed MccA and MccB 
(methionine-to-cysteine-conversion genes) (Hullo et al., 2007). Accordingly, here in 
this study, cysKHp is recommended to be renamed mccAHp (methionine-to-cysteine-
conversion gene A) and metBHp is recommended to be renamed mccBHp.  
 
The third gene on the operon cysKHp-metBHp-luxSHp, luxS, has been the subject of 
much recent controversy in the bacterial literature. A range of microorganisms and 
pathogens including H. pylori have been shown to possess luxS homologues, and to 
produce AI-2, but appear to lack an AI-2 sensory apparatus (i.e. the LuxP/Q and the 
Lsr system) (Rezzonico & Duffy, 2008), in agreement with suggestions that in most 
species luxS probably fulfils a primarily metabolic role in the AMC (Rezzonico & 
Duffy, 2008, Winzer et al., 2002a, Winzer et al., 2002b, Winzer et al., 2003). The 
relevance of the established cysteine biosynthesis pathway for the lifestyle, fitness, 
and virulence of H. pylori is not clear. The reduced in vivo fitness observed for the H. 
pylori SS1 ǻluxS mutant (Lee et al., 2006) may indeed be linked to its inability to 
convert methionine to cysteine, although a role of AI-2 cannot be excluded.  
 
H. pylori and other members of this genus have lost the ability to reduce sulphate 
(Doherty et al., 2010, Doig et al., 1999). However, it can be assumed that they are 
well adapted to their specific habitats, which therefore must provide sufficient 
reduced sulphur sources for these organisms to thrive. Presumably, the conversion of 
homocysteine to cysteine removes a potentially toxic metabolite and at the same time 
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reduces the (energetically costly) need for cysteine uptake. On the other hand, a 
similar effect would have been achieved if the organism had maintained a functional 
AMC. In the absence of exogenous cysteine, growth of H. pylori will be limited by 
its capacity to generate this compound from homocysteine. Homocysteine 
availability, in turn, is determined by the number of methylation reactions carried out 
by the cells (i.e., the number of SAM molecules that can be converted to SAH, and 
then further to homocysteine via the action of Pfs and LuxS, see Figure 4.1). Under 
these conditions, generation of the quorum sensing products comprising AI-2, at least 
in theory, is directly proportional to growth of the population and the resulting AI-2 
concentration should thus provide a very accurate measure of population density. It is 
now important to determine whether the other phenotypes associated with luxS 
mutagenesis in H. pylori are dependent on the metabolic role of LuxS, or its role as 
the AI-2 synthase. Related work is reported and discussed in following chapters. 
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CHAPTER 5.  
H.PYLORI LuxS IS REQUIRED FOR 
MOTILITY, AND THIS IS DEPENDENT 
ON AUTO-INDUCER-2 PRODUCTION 
RATHER THAN METABOLIC EFFECTS 
 
 
 
 
 
 
 
 
The work presented this chapter has been published in BMC Microbiology. 
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5 H.pylori LuxS is required for motility, and this is 
dependent on auto-inducer-2 production rather than 
metabolic effects 
 
5.1 Introduction 
Many bacteria are known to release extra-cellular signalling molecules (auto-
inducers) to communicate cell to cell. It is generally assumed that auto-inducers 
(including auto-inducer-2) are employed to regulate aspects of bacterial behaviour, 
including modulation of cell population density, response to changes of cellular 
phenotypes, interaction with hosts and expression of genes crucial for bacterial 
survival or virulence - a process termed quorum sensing (QS) (Sperandio et al., 
2003, Camilli & Bassler, 2006, Vendeville et al., 2005).  
 
As stated in previous chapters, LuxS catalyses one of the steps in the activated 
methyl cycle (AMC), a pathway that generates methyl groups with a higher transfer 
potential (Winzer et al., 2003). The precursor of auto-inducer-2 (AI-2), 4, 5-
dihydroxy-2, 3-pentanedione (DPD) is generated as a by-product in the conversion of 
SRH to homocysteine. Through a process of dehydration and spontaneous cyclisation, 
some or all of the DPD is rearranged into a cocktail of chemically related molecules 
known as AI-2 including 4-hydroxŷ5-methyl-3 (2H) furanone, (2R, 4S) -2-methyl-2, 
3, 3, 4-tetrahydroxy-tetrahydrofuran and furanosyl borate diester. These have been 
shown to function as signals of communication between bacteria (Winzer et al., 2003, 
Vendeville et al., 2005). In some organisms, the AMC is different. For example, in P. 
aeruginosa, LuxS and Pfs are replaced by a single enzyme (SAH hydrolase) which 
converts SAH to homocysteine in a one step reaction without the concomitant 
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production of DPD (or AI-2) (Duerre & Walker, 1977). As described in Chapter 1. 
Introduction, AI-2 has been extensively studied in V. harveyi, in which it regulates 
bioluminescence and other traits (Camilli & Bassler, 2006, Lerat & Moran, 2004, 
Bassler et al., 1997). Use of a V. harveyi reporter strain that expresses 
bioluminescence in response to addition of AI-2 has become the standard method for 
detecting AI-2 production by other bacterial species (Bassler et al., 1997). 
 
H. pylori, a Gram-negative bacterium which causes peptic ulceration, gastric cancer 
and gastric mucosa-associated lymphoid tissue (MALT) lymphoma, contains a luxS 
homologue and possesses an integral homocysteine and DPD (or AI-2) biosynthesis 
pathway (Atherton, 2006, Forsyth & Cover, 2000, Joyce et al., 2000). luxSHp 
(HP010526695; JHP0097J99) is next to housekeeping genes mccAHp (HP010726695; 
JHP0099J99) and mccBHp (HP010626695; JHP0098J99) (Tomb et al., 1997, Doig et al., 
1999, Doherty et al., 2010). Data from a related study (Doherty et al., 2010) have 
demonstrated that the AMC of H. pylori is incomplete, and that LuxSHp, MccAHp and 
MccBHp constitute the sole cysteine biosynthetic pathway in this bacterium via a 
reverse transsulphuration pathway (RTSP). This consequently makes the true role of 
LuxSHp in bacterial signalling unclear. 
 
To date, information on phenotypic changes exhibited as a result of luxSHp 
inactivation remains limited. Two ¨ luxSHp mutants were reported to form biofilms 
more efficiently than the parent strain, indicating a possible but counterintuitive role 
of luxSHp in biofilm reduction (Cole et al., 2004). Studies of two independent groups 
looked at fitness of ¨ luxSHp mutants in vivo using mouse and gerbil models, 
respectively (Lee et al., 2006, Osaki et al., 2006). They showed that mutated luxSHp 
strains SS1 and TK1402 exhibited diminished motility and reduced fitness in co-
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infection experiments. In both cases, restoration of luxSHp by genetic 
complementation partially restored these phenotypes (Lee et al., 2006, Osaki et al., 
2006). Lee and coworkers argued that the decreased fitness in the ¨luxSHp mutant of 
strain SS1 was most likely due to the disruption of the cycle of SRH consumption 
and homocysteine synthesis and that AI-2 seemed unlikely to be a QS signal 
molecule (Lee et al., 2006).  
 
In this study, the role of LuxSHp in AI-2 production was confirmed by a V. harveyi 
bioluminescence assay. Experiments were set up to distinguish between the 
mechanisms underlying the alteration in motility of ¨luxSHp mutants, and to clarify 
whether this originated from a disruption of cysteine metabolism or production of the 
signalling molecule AI-2. The lack of motility in mutants disrupted in components of 
the reverse transsulphuration pathway other than LuxS, coupled to the inability of 
cysteine to complement the motility defect of the ǻluxSHp mutant, shows that 
disruption of cysteine biosynthesis is not able to reduce motility in H. pylori. 
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5.2 Materials and Methods 
5.2.1 Construction of the complemented ǻluxS+ strain 
H. pylori J99 wild-type was transformed with the plasmid pGEMTluxSXN396 
containing sacB-km construct encoding kanamycin resistance (Km
r
)
 
and (5%) 
sucrose sensitivity (Suc
s
) (Loh et al., 2004). Disruption of the chromosomal luxSHp 
gene was accomplished by natural transformation,
 
allelic exchange, and screening for 
kanamycin-resistance
 
as previously described (Doherty et al., 2010), resulting in the 
J99 ǻluxS mutant strain. The presence of the sacB-km cassette was verified by 
amplifying fragments on H. pylori chromosomal DNA using primers luxS-F/luxS-R 
(forward, 5>GTG GCT TTA GCG GGA TGT TTT<3; reverse, 5>GCGA ACA 
AAT CCC CGC TG<3) and DNA sequencing. The J99 ǻluxS was then transformed 
with plasmid pGEMTluxS (encoding wild-type luxS), and transformants in which 
sacB-km had been replaced with the introduced original luxS locus were selected on 
(5%) sucrose resistance (Suc
r
) and kanamycin sensitivity (Km
s
). The presence of the 
original luxS gene was verified by amplifying fragments on H. pylori chromosomal 
DNA using primers luxS-F/luxS-R and DNA sequencing.   
5.2.2 Motility bioassays 
5.2.2.1 Plate motility assay 
Plate motility assay of H. pylori was performed in Brucella broth medium (BD 
Biosciences), supplemented with 7% (v/v) fetal bovine serum (Gibco), 0.35%-0.45% 
ZY DJDU QR 2[RLG DQG LQGLFDWRU ȝJPO 7HWUD]ROLXP &KORULGH 6LJPD 
Tetrazolium chloride is a redox dye which may be reduced to a pink compound, a 
fluorescent formazan derivative (Kaprelyants & Kell, 1993). Plates were seeded with 
ȝOH. pylori liquid culture (forming a circle with 3mm diameter) standardised to an 
OD600nm of 1.0 and were incubated at 37qC for up to 7 days under the condition 
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described before. The motility halos were recorded using a digital camera and the 
area of each halo was measured using GS-800 Calibrated Densitometer (Biorad). 
When measuring, the entire colour of each halo (increase in diameter) was quantified, 
including faint colour at the edges of the colonies. 
5.2.2.2 Plate motility assay using chemically defined media 
The liquid chemically defined media were prepared as previously described 
(Reynolds & Penn, 1994, Doherty et al., 2010). 60ml of sterile chemically defined 
media were added to 40ml of molten 1% Oxoid No. 1 agar base to make 0.4% semi-
solid chemically defined agar. Cysteine supplemented plates (CSP) were made by 
adding cysteine to the molten agar. The final concentration of cysteine was 1.0mM, 
which was non-limiting for H. pylori growth. The centre of each plate was seeded 
with one-day incubated H. pylori cells and was incubated for 5 days under the 
conditions described above. The motility halos were recorded using a digital camera 
and the area of each halo was measured using a GS-800 Calibrated Densitometer 
(Biorad).  
5.2.2.3 Motility assay with AI-2 complementation  
AI-2 was synthesised enzymatically as described previously (Winzer et al., 2002a) 
using purified proteins LuxSE. coli and PfsE. coli. For FRPSOHPHQWDWLRQRI WKHǻluxSHp 
motility phenotype, soft motility agar plates (0.4% w/v) were made as previously 
described. Bioluminescence activity of the AI-2 product was quantified using the V. 
harveyi bioassay and compared to the cell from supernatant (CFS) from H. pylori 
wild-type broth culture standardised to an OD600nm of 1.0 at the time point in the 
growth curve that maximal AI-2 activity was measured. The AI-2 supplemented 
plate (ASP) was prepared using the 0.4% soft agar containing in vitro synthesised 
AI-2 (0.25% v/v). The buffer control plate (BCP) was produced using 0.4% soft agar 
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into which was added the buffer control solution (0.25% v/v) produced in parallel to 
in vitro AI-2 synthesis (only buffer containing no AI-2). 24 h H. pylori cultures were 
seeded individually onto the centre of each motility plate and incubated for 5 days. 
The area of outward migration was recorded with a digital camera and measured 
using GS-800 Calibrated Densitometer (Biorad). 
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5.3 Results 
5.3.1 The construction of the complemented ǻluxSHp+ strain 
To facilitate construction of the complemented ¨ luxS+ mutant, a two-step 
mutagenesis strategy was used, allowing gene replacement without introducing new 
selectable markers into the final strain. The method uses a two-gene cassette 
containing both a selectable marker km and a counterselectable marker sacB. The 
km-sacB cassette was cloned into the gene luxS (yielded the plasmid 
pGEMTluxSXN396) (Loh et al., 2004) and used to replace the J99 wild-type luxS 
gene on the chromosome by allelic exchange. The transformant obtained from the 
first mutagenesis step was the J99ǻluxS-F, a strain with kanamycin resistance (kmr) 
and 5% sucrose sensitivity (Suc
s
). A second transformation replaces the mutated luxS 
containing the km-sacB cassette with an engineered plasmid, pGEMTluxS, containing 
the original luxS gene. The resulting transformant was the complemented ¨ luxS+ 
mutant, with the phenotype of (5%) sucrose resistance (Suc
r
) and 5% kanamycin 
sensitivity (km
s
) (Figure 5.1). 
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Figure 5.1 Flow diagram of construction of the complemented ¨luxSHp+ mutant 
In the process of constructing this mutant, steps labelled by white arrows went first, and 
were then followed by the steps labelled with blue arrows. For details in text see Materials 
and Method. MCS=multiple cloning site 
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Figure 5.2 PCR product of luxSHp 
The gel shows the product generated in figure 5.1 Step A. The PCR product of luxSHp was 
amplified from J99 wild-type genomic DNA. The size of the original luxSHp was 456bp. Around 
350bp of additional DNA sequence was included at both ends of the original luxSHp sequence 
to make a final fragment containing the entire luxSHp plus flanking sequences. Primers luxSHp-
F/luxSHp-R were used in the amplification. The size of the whole luxSHp PCR product was 
1.15kb. Marker: Promega 1kb DNA ladder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Digested plasmid pGEMTluxS 
The gel confirms the product generated in figure 5.1 Step B.The plasmid pGEMTluxS 
(4.15kb) was produced by insertion of the luxSHp PCR product into the vector pGEM-T. 
This was confirmed by restriction digestion with the enzyme NotI and the size of the 
digested product was checked on an electrophoresis gel. Marker: Promega 1kb DNA 
ladder.  
1.0kb 
3.0kb 
3.0kb 
4.0kb 
luxS 
pGEMTluxS 
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5.3.2 The H. pylori ǻluxS mutant lost the ability to produce AI-2 while 
the wild-W\SHǻmccAHp DQGǻmccBHp mutants did not 
The ability of each mutant to produce AI-2 was assayed using the V. harveyi AI-2 
detection system described by Surette and Bassler (Bassler et al., 1997, Winzer et al., 
2002a). H. pylori wild-type J99 and all mutant strains (ǻluxS, ǻmccA and ǻmccB) 
were grown in Brucella broth containing serum (10% v/v). AI-2 activity in the CFS 
was detected from the log phase. The wild-type produced AI-2 in a growth 
dependent manner, in which AI-2 accumulated during the late log phase and onward, 
reaching maximum levels in the stationary phase. During stationary phase, AI-2 
levels decreased and were almost undetectable by 72 h during the death phase. 
6LPLODU GDWD ZHUH REWDLQHG ZLWK ǻmccBHp DQG ǻmccAHp mutants. After the peak, 
bioluminescence activity decreased to an undetectable level by 72 h. On the other 
KDQG WKH ǻluxSHp mutant, unlike the wild-type and the other two mutant strains, 
yielded significantly (p<0.001) reduced levels of bioluminescence at each time point, 
indicating that the production of AI-2 is luxSHp-dependent and that insertion of 
kanamycin cassette (aphA3) into mccAHp and mccBHp does not affect expression of 
the downstream gene luxSHp (Figure 5.4).  
   ?Ǥ
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Figure 5.4 AI-2 production in H. pylori is luxS dependent 
AI-2 production in J99 wild-type (black column), ¨luxSHp (red column), ¨mccBHp (blue 
column) and ¨mccAHp (white column) mutants was measured. Strains were grown in 
Brucella broth, and aliquots were removed at 24h, 30h, 48h and 72h to assess the 
optical density (wild-type, square; ¨luxSHp, diamond; ¨mccBHp, circle; ¨mccAHp, triangle) 
and the amount of AI-2 in the filtered culture supernatant using the V. harveyi bioassay. 
AI-2 activity is shown as a relative bioluminescence (corrected by OD600nm of H. pylori) 
in the presence of 1/10 diluted H. pylori culture supernatants over the negative control 
(NC, Brucella broth alone). A diluted in vitro synthesised AI-2 sample was utilised as a 
qualitative positive control (PC) (Winzer et al., 2002a). Bioluminescence induced by 
wild-type, ƩmccBHp, and ƩmccAHp strains was significantly greater than that induced by 
the ƩluxSHp mutant, as determined by paired Students t-test (p<0.001). The lines 
represent the growth (OD, righthand axis) and the bars represent the AI-2 activity 
(bioluminescence, lefthand axis). Error bars indicate the standard deviation of triplicate 
samples for the bioluminescence and OD600nm measurements, respectively.  
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5.3.3 Deletion of luxSHp DEROLVKHV PRWLOLW\ ZKLOH WKH ǻmccAHp and 
ǻmccBHp mutants remained motile 
To investigate whether motility of H. pylori was affected by cysteine biosynthesis, 
firstly, motility was compared between wild-type, ǻluxSHpǻmccAHp DQGǻmccBHp 
mutants. To do this, the 24 h liquid culture of each strain was spotted onto each 
quarter of a semi-solid agar plate and incubated for up to 7 days. The resulting 
swarming halo areas were quantified after 3, 5 and 7 days of incubation. As stated in 
Materials and Methods, tetrazolium chloride was utilised as an indicator. The 
mechanism of the tetrazolium staining is that when the colourless chemical 
tetrazolium chloride diffuses into actively respiring tissues it accepts electrons from 
the mitochondrial electron transport chain, reducing it to a pink compound, formazan. 
The accumulation of formazan stains the tissues red, and the intensity of the red 
colour is proportional to the rate of respiration in those tissues (Kaprelyants & Kell, 
1993).  
 
Halo areas that surrounded the wild-W\SH ǻmccAHp DQG ǻmccBHp strains kept 
increasing during continuous incubation, although the latter was slightly delayed in 
FRPSDULVRQ WR WKH RWKHUV $IWHU  GD\V RI FXOWXUH WKH ǻluxSHp mutant remained 
almost non-motile and produced a significantly (p<0.001) reduced swarm halo 
compared to wild-W\SH ǻmccAHp DQG ǻmccBHp strains in 3 independent repeat 
experiments (Figure 5.5A). After 7 days, the wild-W\SH ǻmccAHp DQG ǻmccBHp 
mutants produced halos of (mean ± SD) 8.5 ± 0.6 mm, n=4; 5.6 ± 0.9 mm, n=4; and 
7.8 ± 0.6 mm, n=4 increases in diameter, respectively (Figure 5.5B). These results
 
revealed that the reduction in motility was likely a result peculiar to luxSHp mutation 
rather than due to disruption of cysteine biosynthesis. 
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Figure 5.5 Motility bioassay of H. pylori strains on the normal soft plate 
ǋO RI liquid growth (24h) of wild-type, ¨ luxSHp, ƩmccBHp DQG ƩmccAHp mutants were 
seeded on each quarter of a soft agar plate. After 3, 5 and 7 days of incubation, the 
swarming halo of each strain was (A) recorded using a digital camera and (B) the area of 
each halo (wild-type, square; ¨luxSHp, diamond; ¨mccBHp, circle; ¨ mccAHp, triangle) was 
measured using a GS-800 Calibrated Densitometer (Biorad). Error bars indicate the 
standard deviation of halo sizes of quadruple measurements in one experiment. 
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5.3.4 Exogenous AI-2 or genetic complementation can restore the 
PRWLOLW\GHIHFWRIWKHǻluxSHp mutant, but exogenous cysteine addition 
can not 
To rule out the possibility that second site mutations in WKH ǻluxSHp mutant were 
inhibiting motility, genetic complementation was performed to create WKH ǻluxSHp+ 
strain (see Chapter 5.2 Materials and Methods). The non-motile ¨flhB mutant was 
used as a negative control (Wand et al., 2006). 24 h culture of wild-W\SHǻluxSHp, 
ǻluxSHp+ and ¨flhBHp strains grown in Brucella broth were individually spotted onto 
normal motility plates. After 5 days of incubation, the mean halo diameter of the 
ǻluxSHp+ strain was (6.9 ± 0.2 mm, n=4), which was slightly larger than that of wild-
type (4.7 ± 0.7 mm, n=4). The ǻluxSHp and ¨flhBHp mutants showed very similar 
non-motile phenotypes (Figure 5.6A).  
 
To examine whether AI-2 can influence motility of H. pylori, motility of the wild-
W\SHǻluxSHp and ¨flhB mutants was assessed using AI-2 supplemented plates (ASP). 
The ASP was prepared using 0.4% soft agar containing in vitro synthesised AI-2 
(0.25% v/v). The buffer control plate (BCP) was also produced using 0.4% soft agar 
into which was added the buffer control solution (0.25% v/v) produced in parallel to 
in vitro AI-2 synthesis (only buffer containing no AI-2). After 5 days of incubation, 
the halo size of the wild-type on ASP increased by 11.2 ± 0.7 mm, n=4,  compared 
with a 5.4 ± 0.2 mm, n=4 increase on the non-supplemented plate (compare Figure 
5.6A or the right panel of Figure 5.6B with the left panel of Figure 5.6B). Whilst the 
ǻluxSHp mutant was non motile on the BCP, the halo increased by 4.6 ± 0.4 mm, n=4 
on ASP (Figure 5.6B). The control ¨flhBHp mutant remained non-motile on the ASP 
(Figure 5.6B).  
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Having established an influence on motility for one of the chemicals reliant on 
LuxSHp function (AI-2), we sought to establish whether another (cysteine) could 
behave similarly. Data shown in previous chapters have revealed that exogenous 
cysteine rescues growth defects of mutants (ǻluxSHp, ǻmccAHp and ǻmccBHp) unable 
to complete cysteine biosynthesis via the RTSP of H. pylori in chemically defined 
broth (see Chapter 4.2.1). Chemical complementation of motility was thus performed 
using chemically defined plates supplemented with 1.0mM cysteine. Methionine was 
added to the plates as the sulphur source since all H. pylori strains are methionine 
auxotrophs. After 5 days of incubation, wild-type H. pylori and ǻmccAHp and 
ǻmccBHp mutants formed swarming halos of (4.9 ± 0.3 mm, n=4), (3.6 ± 0.6 mm, 
n=4) and (4.3 ± 0.9 mm, n=4) increases in diameter, respectively 7K H ǻluxSHp 
mutant remained non-motile (Figure 5.6C).  
 
Taken together, data presented here indicate that the motiOLW\GHIHFWRI WKHǻluxSHp 
mutant was restored either genetically or chemically with AI-2, but not with 
exogenous cysteine. This suggests that luxS/AI-2 play a role in enhancing bacterial 
motility, rather than an intact cysteine biosynthesis pathway, implying a likely role of 
luxSHp in signalling.  
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Figure 5.6 AI-2, but not cysteine rescues the motility defect of the LuxSHp 
mutant.  
(A) Wild-type, ¨luxSHp, and ¨ luxSHp+ bacteria were seeded onto soft plates composed of 
normal medium. The non-motile ¨ flhB mutant served as the the negative control. (B) 
Wild-type, ¨ luxSHp and ¨flhB bacteria were seeded onto motility plates supplemented 
with in vitro synthsised AI-2. Wild-type and ¨ luxSHp were also seeded on motility plates 
containing buffer control solution used for in vitro AI-2 synthesis. (C) Wild-type, ¨ luxSHp 
ƩmccAHp DQG ƩmccBHp strains were seeded onto chemically defined motility plates 
supplemeneted with cysteine. After 5 days of incubation, the swarming halo of each strain 
on each plate was recorded using a digital camera and the area of each halo was 
measured using GS-800 Calibrated Densitometer (Biorad). 
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5.4 Discussion 
The function of luxSHp is controversial due to putative roles both in signalling and 
metabolism. Earlier publications have suggested that AI-2 may not act as a signal in 
some bacteria but instead may simply be a by-product of the important AMC 
pathway (Winzer et al., 2003). In support of this, in some bacteria, production of AI-
2 does appear to be associated with metabolic rather than regulatory phenomena 
(Doherty et al., 2006). In H. pylori, it has been shown that, rather than functioning in 
recycling methionine as in most bacteria, LuxS (along with newly-characterised 
MccA and MccB), synthesises cysteine via a process of reverse transsulphuration. 
This makes the mechanism underlying phenotypic changes upon luxS inactivation 
unclear, in particular, whether the phenotypic alterations are due to the disrupted 
cysteine provision pathway, or due to loss of the signalling molecule AI-2. This work 
shows that AI-2 signalling but not cysteine provision is necessary for normal levels 
of motility in H. pylori strain J99, suggesting a likely role of H. pylori AI-2 in 
signalling. 
 
First of all, the role of LuxSHp in AI-2 formation was confirmed by doing the V. 
harveyi bioluminescence assay. Experimental data showed that AI-2 activity peaked 
in the stationary phase and then significantly fell. Previously, Forsyth et al. and Loh 
et al. individually reported that maximal AI-2 activity appears in early log phase (5 h 
~ 10 h) rather than stationary phase (Loh et al., 2004, Forsyth & Cover, 2000). 
However, similar to our study, Rader et al. (2007) found maximum AI-2 activity in 
stationary phase. Interestingly, they found a very strong luminescence peak in late 
stationary phase (at 40 h) (Rader et al., 2007).  
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Also, ǻmccBHp DQG ǻmccAHp strains were shown producing AI-2 in a growth-
dependent-manner. AI-2 activity of these two mutants consistently peaked at an 
earlier stage compared to the wild-type. This suggests two possibilities: firstly, 
disruption of upstream mccB or mccA in H. pylori could be affecting the transcription 
of luxS, making LuxS accumulate at an earlier time point. Alternatively, inhibition of 
cysteine biosynthesis by disrupting mccBHp or mccAHp somehow could be stimulating 
the conversion of SRH to AI-2/homocysteine at an earlier growth phase, 
consequently causing earlier appearance of higher quantities of AI-2. Moreover, it 
appeared that colour changes of the mutants on motility plates were slightly different 
from the wild-type (Figure 5.5A and 5.6). This may be due to the fact that respiratory 
activity of the bacteria is involved in the colour change of the tetrazolium staining, 
and hence the changes in altering capability of mutants might affect the degree of 
colour change compared with wild-type. As tetrazolium chloride is a redox dye, the 
fact that cysteine is a redox active molecule might thus be an additional factor to 
cause the issue.  
 
Previous studies have shown that mutations of luxSHp in H. pylori diminished 
motility on soft agar. The altered motility phenotype was restored completely by 
genetic complementation with luxSHp or significantly restored by metabolic 
complementation with wild-type CFS (Rader et al., 2007, Osaki et al., 2006, Lee et 
al., 2006). In contrast to our study, in Osaki et al. and Rader et al.s studies 
complementation of luxSHp was performed by placing luxSHp at a second site in the 
chromosome rather than at the original locus (Osaki et al., 2006, Rader et al., 2007). 
/LNHWKHVHSUHYLRXVUHSRUWVRXUVWXG\VKRZVWKDWDEROLVKHGPRWLOLW\RI-ǻluxSHp 
mutation was restored entirely by complementation with the luxSHp gene and 
significantly by in vitro synthesised AI-2. The previous studies, with complete 
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complementation of motility with luxSHp through insertion at a new chromosomal 
locus, argue against polar effects of luxSHp mutagenesis on other genes which 
influence motility. Our study, with complementation with luxSHp through creating a 
revertant results in similar levels of LuxSHp to wild-type and thus better shows that 
the phenotypes attributed to the mutant were not due to secondary mutations 
elsewhere in the chromosome. 
 
Having demonstrated that MccAHp and MccBHp function consecutively to convert the 
product of LuxSHp (homocysteine) into cysteine as part of the RTSP (Doherty et al., 
2010), it was reasoned that inactivation of any of these three enzymes would have a 
similar influence upon cysteine biosynthesis, whilst only the ¨ luxSHp mutant would 
be devoid of AI-2. Thus, if the reduced motility of the ¨ luxSHp mutant derived from 
disrupted cysteine biosynthesis, mutants in mccAHp and mccBHp would have a similar 
motility defect. Therefore, an experiment was performed to exclude the possibility 
that the effect on motility was due to non-specific secondary metabolic effects of 
LuxSHp. To do this, wild-type, ǻluxSHp, ǻmccAHp and ǻmccBHp strains were 
inoculated on the same motility plate, allowing the production of AI-2 and the 
biosynthesis of cysteine to be isolated from each other. As expected, disruption of 
cysteine biosynthesis by independent mutations that had no influence on AI-2 
SURGXFWLRQGLGQRWDOWHUPRWLOLW\,QFRQWUDVWWKHPRWLOLW\GHIHFWRIDǻluxSHp mutant 
of H. pylori was genetically complemented by luxSHp, or chemically complemented 
by the addition of exogenous AI-2 but not by exogenous cysteine. This, for the first 
time suggests that motility of H. pylori can be blocked by the loss of luxSHp itself, but 
cannot be affected by disrupting the cysteine provision pathway.  
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Furthermore, on both normal motility plates and the cysteine supplemented plates, 
the ǻmccAHp mutant appeared to be less motile than the wild-W\SHDQGWKHǻmccBHp 
PXWDQW KRZHYHU LWV VZDUPLQJ KDOR ZDV VWLOO VLJQLILFDQWO\ ODUJHU WKDQ WKH ǻluxSHp 
mutant). This may be because inactivation of mccAHp directly disrupted the 
conversion of homocysteine to cystathionine, allowing homocysteine to accumulate 
in cells. We speculate that this could potentially signal the cells to stop the 
production of homocysteine; consequently, as a by-product in the production of 
homocysteine, the synthesis of AI-2 could also be affected.   
 
Motility is an absolute requirement for H. pylori colonization in several animal 
models (Ottemann & Lowenthal, 2002, Eaton et al., 1992, Lee et al., 2006, Osaki et 
al., 2006) and is thus considered an important virulence trait of this pathogen. The 
LuxS associated motility control exists in some other bacteria, for example, in E. coli 
O157: H7, the expression of more than 30 genes related to motility and flagella 
assembly was down-regulated in the ǻluxS mutant, and the mutant had less motility 
than the wild-type (Sperandio et al., 2001). In Gram-negative C. jejuni and V. 
alginolyticus, removal of the gene luxS altered flallelar gene transcription and 
bacterial motility (He et al., 2008, Tian et al., 2008). In Proteus mirabilis, however, 
deletion of luxS did not change its motility phenotype, probably because this 
bacterium has an intrinsic hierarchical system to control its motility (Schneider et al., 
2002). All of these altherations led to an assumption that motility of H. pylori is 
likely to be regulated by LuxS via modulating transcription of genes correlated to 
motility or flagella synthesis. 
 
H. pylori may use AI-2, which has been shown to be produced in a cell density 
dependent manner, in conjunction with other environmental cues, to regulate motility 
 CHAPTER 5. RESULTS 
 
 130 
as a survival strategy within the human stomach. Patterns of H. pylori dispersal 
within the gastric environment are correlated with disease outcome, with ulcers 
associated with higher bacterial density in the distal stomach and gastric cancer 
arising from infections in which the bacteria are distributed throughout the stomach 
(Blaser & Kirschner, 1999). Consequently the prediction was that, at reasonably high 
cell densities and when AI-2 concentration researches up to a critical level, it may be 
beneficial for H. pylori to increase flagella production or enhance some flagellar 
function as a strategy to promote motility and dispersal throughout the stomach. To 
test this hypothesis, more experimental data are exhibited following this chapter to 
give compelling evidence on the mechanism of LuxS/AI-2 signalling on regulation 
of motility in H. pylori.  
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CHAPTER 6.  
LuxS-SYNTHESISED AUTO-INDUCER-2 
REGULATES MOTILITY BY 
MODULATING GENE TRANSCRIPTION 
AND FLAGELLAR SYNTHESIS 
 
 
 
 
 
 
 
 
 
 
 
The work presented in this chapter has been published in BMC Microbiology. 
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6 H. pylori LuxS-synthesised auto-inducer-2 
regulates motility by modulating gene transcription 
and flagellar synthesis 
 
6.1 Introduction 
Auto-inducer-2 (AI-2) production is widespread among bacterial species; its 
formation is catalysed by the enzyme LuxS (Vendeville et al., 2005). It is widely 
utilised by both Gram-positive and Gram-negative bacteria. So far, known AI-2 
dependent processes in bacteria include bioluminescence, biofilm formation, motility, 
and regulation of virulence factors (Vendeville et al., 2005).  Good examples include 
Vibrio harveyi and Vibrio cholerae, where AI-2 regulates density-dependent 
bioluminescence and virulence production, respectively (Bassler et al., 1997, Camara 
et al., 2002). Although AI-2 production is common among bacterial species, it 
remains controversial as to how many of these bacteria utilise AI-2 as a signalling 
molecule, as opposed to producing it as a metabolic byproduct of the SAM pathway.  
 
One such controversial case is Helicobacter pylori. Previous chapters have clarified 
the role of LuxSHp in cysteine metabolism and the role of AI-2 in bacterial motility. 
It is now important to elucidate the mechanism underlying the motility defect of H. 
pylori induced by LuxS inactivation. There are several possible ways whereby a 
motility defect could be associated with loss of luxSHp. Firstly, reduced flagellar 
structural gene transcription and related protein synthesis would lead to loss of 
flagella. Secondly, normal flagella structures may be synthesised in the ¨ luxS mutant 
but a lack of a functional motor may prevent rotation. Thirdly, both motor and 
flagellum may be functional, but unable to respond to incoming signals.  
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In terms of gene transcription related to LuxSHp/AI-2, a previous study has 
demonstrated that a ¨luxSHp mutant lost growth-phase-dependent regulation of 
expression of the major flagellin, FlaA, and that cell culture supernatants containing 
AI-2 could increase flaA transcription (Loh et al., 2004). More recently, Rader et al. 
have shown that luxSHp mutations affect flagellar morphology in strains that also lack 
one of the transcriptional regulators (ı28, flgS or flgM), and that this can be 
complemented upon the addition of DPD. They reported that loss of luxSHp caused 
decreased transcription of the flagellar regulator flhA, and that expression of flhA was 
induced by DPD (Rader et al., 2007). This complementation through the addition of 
exogenous DPD re-established the possibility that in H. pylori there could be a LuxS-
dependent signalling network. 
 
In order to clarify the mecKDQLVPXQGHUO\LQJDOWHUDWLRQVRIPRWLOLW\ LQ WKHǻluxSHp 
mutant, electron microscopy (EM) was employed to examine flagella assembly and 
the levels of individual components of flagella were assessed at a transcriptional and 
translational level. By examining motility, flagellar morphogenesis, flagellar gene 
transcription and protein expression in H. pylori wild-type and mutant cells, the 
demonstration here that exogenously added AI-2 (or DPD) influences motility via 
regulating flagellar gene transcription (and thus the number and length of flagella) 
supports the existence of an additional role for LuxS in H. pylori as a signalling 
molecule synthase. Moreover, the inability of cysteine to complement the motility 
DQG IODJHOODU JHQH WUDQVFULSWLRQ LQ WKH ǻluxSHp mutant, confirms that disruption of 
cysteine biosynthesis is not the mechanism underlying the reduction in motility. 
  
 CHAPTER 6. RESULTS 
 
 134 
6.2 Materials and Methods 
6.2.1 Motility assay by microscopy 
Motility analysis was also carried out by direct observation under phase-contrast 
microscopy using a Nikon Eclipse E600 after cells were grown in co-culture 
conditions. Briefly, co-cultures of H. pylori-AGS cells were prepared (described 
below). After 24 hȝOFXOWXUHZDVSODFHGRQWRDPLFURVFRSHVOLGHDQGFRYHUHGZLWK
a coverslip and free-swimming H. pylori cells were examined under the microscope.  
6.2.2 Tissue culture and bacterial co-culture 
6.2.2.1 AGS cells culture 
All chemicals were Gibco, UK products. Human gastric adenocasinoma (AGS) cells 
were grown in culture medium (Hams F-12 supplemented with L-glutamine 
(200mM) and FBS [10% v/v]) in a 37qC incubator containing 5% CO2. After cells 
have grown to confluency, the flask was washed twice by the sterile Phosphate 
Buffered Saline (PBS) and filtered trypsin was then added. Cells with trypsin were 
incubated for 2-3 min. After all cells were suspended in trypsin, they were poured 
into a 20ml universal tube. The universal tube containing cells was topped up with 
the culture medium and centrifuged for 3 min at 1500 rpm. The supernatant was 
poured off into a waste bottle. The universal tube was flicked to resuspend cell pellet 
and refilled with 20ml medium. The wash step was then repeated once more. Cell 
pellets were resuspened in 5ml or 8ml of culture medium. The 1 in 5 or 1 in 8 
dilution was then added to a 75cm
2
 flask containing fresh media mix and incubated 
at the same condition as before to allow cells to re-grow to confluency.  
6.2.2.2 AGS cells-bacteria coculture 
AGS cells were counted using the trypan (0.35% v/v) blue dye method. Cells were 
seeded at a density of 1 × 10
5
 cells/ml into 6 well plates and grown to 80% 
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confluency. The cells media mix was removed and replaced with 2ml fresh F-12 
media. Plates were inoculated with 24 h H. pylori liquid cultures standardised to an 
OD600nm of 0.1 and incubated for one day in a microaerophilic environment. Bacterial 
cells were then analysed using a phase-contrast Nikon Eclipse E600 microscope and 
electron microscopy.  
6.2.3 Electron microscopy (EM) 
H. pylori cells were pre-grown as described for motility analysis. 15ȝl of culture was 
allowed to settle on a carbon formvar grid (Agar Scientific) for 1min. The suspension 
was removed and the grid washed by addition of 15ul of PBS for an additional 
minute. This was removed and the cells stained with 0.5% Phospho-tungstic acid 
(PTA) pH7.0 for one minute. Grids were examined and pictures taken using a JEOL 
JEM1010 Transmission Electron Microscope. Three groups of H. pylori cell samples 
prepared on different dates were examined. Each group of samples contained wild-
W\SHǻluxS DQGǻluxS+ cells treated and not treated with DPD. For each group, 100 
H. pylori cells from each culture sample were examined. 
6.2.4 Western blotting 
24 h liquid (Brucella broth) culture of each H. pylori strain was adjusted to OD600nm 
RI$ȝO cell sample of each strain was then centrifuged at 5500 rpm for 1 min. 
Culture supernatants were removed and cell pellets were fully resuspended in 1ml 
sterile PBS. ȝO SURWHLQ VDPSOH ZDV FROOHFWHG The same volume of 2 × sample 
buffer was added and boiled for 10 min. SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) was carried out as described in General Materials and Methods 
(Chapter 2.2.3). For immunoblotting, proteins were transferred from SDS-PAGE gels 
to nitrocellulose paper by the methanol Tris-glycine system described by Towbin et 
al. (Towbin et al., 1992). Briefly, it was run by the electrophoretic method in 
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Western buffer (14.4g Glycine and 3.03g Tris in 1L dH2O) at 150mA for 1 h. 
Transfer of proteins was verified by staining the membrane with Ponceau S for 1 min. 
The stain was then removed with PBS. The membrane was immersed in blocking 
buffer (3% skimmed milk in PBS), shaking at room temperature for 20 min. The 
blots were incubated with rabbit polyclonal antibodies against H. pylori flagellin and 
hook protein
§§
Table 6.1
 (diluted 1/1,000--1/10,000) (Ryan et al., 2005) in blocking buffer 
overnight at 4°C (or 1-2 h at room temperature) on a shaker. The blot was then rinsed 
3 times using PBS-Tween (0.2%). Bound antibodies were detected using secondary 
anti-rabbit IgG alkaline phosphatase conjugate antibody (diluted 1/5,000 in 3% 
skimmed milk) (Sigma, UK). The blot was rinsed three times in PBS-Tween (0.2%) 
and developed using the BCIP/NBT substrate system (Dako, UK). The quantitative 
scan of the protein bands was performed using a GS-800 Calibrated Densitometer 
(Biorad). The reflective density (RD) of each protein band was measured using the 
Quantity One 4.6.5 software (Biorad). The primary and secondary antibodies used 
and rinse conditions are shown . 
 
Table 6.1 Primary and secondary antibodies and rinse conditions 
 
 
 
GAR: goat anti rabbit; AP: alkaline phosphatase conjugate antibody 
 
                                                 
§§ The antibody is a generous gift from Paul OToole. 
Name 
Mono/ 
PBS-tween 
Secondary 
Polyclonal antibody 
Anti-flagellin 
Polyclonal 0.2% 3×5 mins GAR-AP 
and hook protein 
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6.2.5 Detection and quantitative analysis of RNA expression  
6.2.5.1 RNA isolation 
RNA for transcriptional test was isolated from H. pylori cells after 24 h of incubation 
in Brucella broth. Culture collects were treated with RNA protection reagent 
(QIAGEN, UK) and RNA was extracted using RNeasy mini kit (QIAGEN, UK). 
Contaminating genomic DNA was removed using DNA free kit (Ambion).  
6.2.5.2 cDNA synthesis 
Synthesis of cDNA was performed using Ominiscript RT kit (QIAGEN, UK) and 
random hexamers (Roche, Germany). Firstly, template RNA was stored on ice. 
RNase inhibitor (Ambion) was diluted to a final concentration of 10U/µl in ice-cold 
1 × buffer RT (0.1µl 10 × buffer RT, 0.65µl dH2O and 0.25µl 40U/µl RNase 
inhibitor) and kept on the ice. 20µl reaction mixtures of cDNA positive samples 
contained 2µl 10 × buffer RT, 2µl dNTP mix, 2µl random hexamers, 1µl RNase 
inhibitor (10U/µl), 6µl H2O, 1µl omniscript and 6µl RNA. cDNA negative samples 
contained 1µl 10 × buffer RT, 1µl dNTP mix, 1µl random hexamers, 0.5µl RNase 
inhibitor (10U/µl), 3.5µl H2O and 3µl RNA. All reaction mixtures were incubated at 
37qC for 0.5 h-1 h.  
6.2.5.3 Quantitative analysis of transcription by RT-PCR 
Quantitation of transcripts of selected genes of interest was accomplished by 
quantitative reverse transcription-PCRs (qRT-PCRs) using Rotor-gene 3000. Primers 
utilised in RT-PCRs are listed in Table 6.2. All RT-PCR reaction mixtures contained 
12.5ȝORI6<%5*UHHQ0L[4,$*(18.ȝORIJHQHVSHFLILFSULPHUVȝOF'1$
template (cDNA was diluted 10-fold prior to adding into the RT-PCR reactions) and 
51DVHIUHHZDWHUWRDILQDOYROXPHRIȝO7KHDPSOLILFDWLRQSURJUDPZDVqC for 
15 min, followed by 35 cycles of 95qC for 15 sec, 56qC for 60 sec, and 72qC for 30 
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sec. All samples, including the controls (16S and no-template), were run in triplicate. 
Transcript level of each gene was normalised to the 16S rRNA in each sample.  
       
 
Table 6.2 Primers used for RT-PCR and efficiencies 
                                                                                                                                                                                        
Primer Sequence (5'-3') Efficiency 
16S_F CGA TGA AGC TTC TAG CTT GC 
1.81 
16S_R ATA GGA CAT AGG CTG ATC TC 
ı80F GTC AAA ACG ATG GAG ACC ACT TT 
2.07 ı80R GCA CTT GAG CGA TAA TGT CTT CT 
ı54F CGA AGT TTA TGA GAA AGT ACG CAA 
1.90 ı54R AAA ATC TTT AGA AAA TTC ATG GTG TT 
ı28F GTC AAT GGG GCA ATG TTA GAT 
2.05 ı28R AAT GCT CAT CGC TAG GCT CT 
flgRF ACG GAC GCT AAT GTC ATG CTA 
1.96 
flgRR ATG TTG ATC GCT ATA AAA GGG TG 
flgSF AAC AGC ATT CAG GGC AAG C 
1.95 
flgSR AAG AGA GAT AGA GCC TAC GG 
flgMF CGT GTGGAA AAG AAT GAA A 
1.87 
flgMR AGA AGT CTC ATG CAA GTT GAT 
flaAF CAG GTT CGT ATC GCT ACA GGC 
1.98 
flaAR ATC ACT TCT GCT AAC ACG CCG 
flaBF ACT GGG ATT GGG GCG TTA 
2.03 
flaBR TCA ACC TCC CGTCAG CGT C 
flgEF GCT CAG GCA CGA TCA CTC TAA 
2.01 
flgER AAC GCC ATG AAA GGT CTT AAT AC 
flhAF TCA TTG GAG GGT TTT TAG TGG 
2.06 
flhAR GGT GCG AGT GGC GAC AAT 
motAF TGA GTT TAG AGG GGC GAG TG 
1.93 
motAR CCA GTA ATG AGC GGC ACC 
motBF TTC AGG GAA AGA AGA AGA GCA A 
1.92 
motBR TCA AAC AGC AAA CTA GAG AAA A 
fliIF ACG AGC GAT GAT AGC CCT TTA 
2.04 
fliIR ACC GAT TTC TCT TTG AGC CAT 
ureAF GAT GAT GTG ATG GAT GGT GTG G 
1.95 
ureAR TAA GAA CAA CTC ACC AGG AAC C 
  
 CHAPTER 6. RESULTS 
 
 139 
6.2.5.4 Efficiency Calculation  
To calculate relative transcriptional levels of the genes of interest using the Pfaffl 
method (Pfaffl, 2001), the reaction efficiency of each PCR was calculated (Figure 
6.1). The PCR efficiencies were calculated by diluting the positive control cDNA 
(J99 wild-type in experiments presented here) and calculating the gradient from plots 
of dilution against CT value (cycle number at which the threshold was crossed). 
Examples of plots calculation are shown in Figure 6.2. 
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A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Efficiency runs for motA (A) and motB (B) RT-PCRs. 
The PCR efficiencies were calculated by diluting the positive control cDNA (J99 wild-type) 
and calculating the gradient from plots of dilution against CT value. The efficiency of 
motA reaction is 1.93 and the efficiency of motB reaction is 1.92. 
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Figure 6.2 Pfaffls equation and examples of melt and amplification curves 
produced by flaA RT-PCT rotor. 
(A) Pffafls equation; (B) melting temperature for flaA; (C) amplification for flaA.  
Degree: qC 
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6.3 Results 
6.3.1 ǻ/X[6Hp mutants have altered flagella morphology and 
swimming patterns  
(Microscopic analyses were collaboration with Laura Hobley and Liz Sockett, 
Institute of Genetics, University of Nottingham) 
Motility plates effectively indicate motility phenotypes of the population, but do not 
give any indication of the structure of the motility organelle (flagellum), or the 
swimming pattern of individual cells. To characterise the phenotypes underlying the 
GHFUHDVHGDELOLW\RIWKHǻluxSHp mutant to swarm in soft agar, we observed motility 
of individual bacterial cells using phase-contrast microscopy and also examined the 
flagellar morphology of the cells using electron microscopy (Figure 6.3). Cells tested 
included wild-type, ǻluxSHp, ǻluxSHp+ grown in the presence and absence of DPD 
and cysteine. All cells were grown in co-culture with human gastric adenocarcinoma 
(AGS) cells for 24 h before testing, as previous experiments in our laboratory have 
shown that this gives highly reproducible results in H. pylori motility experiments.  
 
For microscopic motility assay, bacteria on quite a few different areas of the slides 
were examined (>200 cells of each strain sample were examined). Phase-contrast 
microscopy revealed that 40-50% of wild-type cells and 75-ǻluxSHp+ cells were 
swimming; whereas fewer WKDQRIǻluxSHp cells could swim. When grown with 
exogenous DPD, swimming cells were 50% in wild-typeLQǻluxSHp and 70% 
LQ ǻluxSHp+. Cultures of ǻluxSHp grown with exogenous cysteine consistently 
contained less than 2% motile cells. To exclude the possibility that the restoration of 
PRWLOLW\RIǻluxSHp cells was due to an effect of DPD on AGS cells rather than H. 
pylori, a control sample was set up in which the wild-W\SHDQGǻluxSHp mutant were 
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co-cultured individually with AGS cells that had been treated with DPD overnight. 
DPD was washed off with the media before co-culturing. As expected, both wild-
W\SH DQG ǻluxSHp cells in these control cultures showed very similar motility 
phenotypes to those co-cultured with normal AGS cells, indicating that DPD is a 
functional signaling molecule to H. pylori cells rather than eukaryotic cells. 
0RUHRYHU WKHDSSUR[LPDWHVZLPPLQJVSHHGRI WKHǻluxSHp cells was visibly lower 
compared to the wild-W\SH ǻluxSHp+ and all cell samples plus DPD. Notably, the 
DPRXQWRIǻluxSHp cells in co-cultures was visibly less for the other strains; whereas, 
in rich media (e.g. Brucella broth), the ¨luxSHp mutant grew as fast as wild-type. 
 
For electron microscopy, three groups of H. pylori cell samples prepared on different 
dates were examined. Each group of samples contained wild-W\SHǻluxS DQGǻluxS+ 
cells treated and not treated with DPD. For each group, 100 H. pylori cells from each 
culture sample were examined. Electron microscopic images showed that all samples 
tested (wild-W\SHǻluxSHp DQGǻluxSHp+, grown in the presence or absence of DPD) 
produced a flagellar filament of some kind in the majority of bacterial cells, but those 
RIWKHǻluxSHp strain were consistently short and usually fewer in number. Changes 
were quantified, rounding to the nearest 5% and quoting means ± SD. In the 
experiments, nearly all of the wild-type cells (95% ± 3%, n=3) (n=3 means 3 
independent microscopic experiments) tested had flagella and most of these had 
multiple flagella, which were usually at one pole and typically 3-4 in number (90% ± 
3%, n=3) (Figure 6.3A,QFRQWUDVWIHZHUǻluxSHp cells tested had flagella (70% ± 
5%, n=3) and these were typically shorter and also fewer in number (30% ± 5%, n=3 
of cells had only one or two short flagella (Figure 6.3B). The complemented 
ǻluxSHp+ cells (Figure 6.3C) were similar to wild-type, with nearly all cells (95% ± 
3%, n=3) possessing 3-4 normal long flagella at least one pole. Addition of DPD to 
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ǻluxSHp cells (Figure 6.3E) also converted them to a wild-type morphology, with the 
vast majority (95% ± 3%, n=3) producing 3-4 wild-type length flagella usually 
present at a single pole. Addition of DPD to wild-type cells (Figure 6.3D) had little 
significant effect with nearly all remaining flagellate as before (95% ± 3%, n=3) 
although more cells were seen with a flagellum at both poles. Addition of DPD to the 
ǻluxSHp+ cells (Figure 6.3F) had a similar effect, with more cells with flagella at both 
poles. 
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Figure 6.3 luxS/DPD modulates flagellar morphogenesis 
H. pylori cells were co-cultured with AGS cells. Cells were stained with 0.5% PTA. Scale bars represent 2um. (A) wild-type, (B) 
ƩluxSHp & ƩluxSHp+, (D) wild-W\SH ZLWK '3' ( ƩluxSHp ZLWK '3' DQG ) ƩluxSHp+ with DPD. DPD was added after 10 h of 
incubation and once again after 18 h of incubation during the co-culture.  
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6.3.2 Mutation of luxSHp resulted in decreased production of flagellar 
proteins FlaA and FlgE  
7KH UHGXFHG QXPEHU DQG OHQJWK RI IODJHOOD LQ ǻluxSHp cells observed by electron 
microscopy could result from a number of different changes in the proteome. As 
previous work had suggested possible involvement of major flagella proteins, these 
were investigated by immunoblotting whole cell lysates with anti-flagellin (FlaA and 
FlaB) and anti-FlgE (hook protein) antiserum (Figure 6.4). To exclude global 
differences in protein production between strains, the loading was corrected for 
numbers of bacteria rather than for total protein levels. However, in practice, FlaB 
levels were very similar between all wild-type and mutant strains and were not 
shown to vary in the subsequent transcription analysis, so these acted as a reasonable 
loading control. Because we were interested in the ratio of flagella proteins within 
each wild-type or mutant strain, results were expressed relative to FlaB levels within 
each strain. In these experiments, H. pylori wild-type 17874, and derived mutants 
(¨flaA and ¨flgE) were used as positive and negative controls, respectively. H. pylori 
wild-W\SHLWVǻluxSHp PXWDQWWKHFRPSOHPHQWHGǻluxSHp+ mutant and controls were 
grown in Brucella Broth at 37qC for up to 24 h, at which point high levels of AI-2 
activity were detected. In the experiments, four repetitions were included, when the 
reflective density (RD) of each protein band was measured using Quantity One 4.6.5 
software (Biorad).  
 
All strains tested were found to produce FlaB at approximately the same level 
(Figure 6.4). The reflective density of the FlaB bands of the wild-W\SH ǻluxSHp 
PXWDQWDQGWKHFRPSOHPHQWHGǻluxSHp+ mutant were (means ± SD) 0.210 ± 2.0E-03 
RD, n=4; 0.204 ± 5.8E-04 RD, n=4; and 0.207 ± 5.8E-04 RD, n=4, respectively. All 
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other results (FlaA and FlgE) were expressed relative to FlaB in each strain. 
Mutagenesis of LuxSHp reduced the expression of FlaA relative to FlaB (from mean 
1.60 in the wild-W\SH WR LQ WKHǻluxSHp mutant, p<0.01), and complementation 
increased the ratio back to wild-type levels (mean 1.70 in WKH ǻluxSHp+ mutant, 
p FRPSDUHG ZLWK WKH ǻluxSHp mutant). Next, FlgE expression was examined, 
and a similar trend was found (wild-type FlgE:FlaB ratio mean 0.74; ǻluxSHp mutant 
0.51; complemented ǻluxSHp+ mutant 0.77; pIRUGLIIHUHQFHVEHWZHHQǻluxSHp 
mutant and wild-type and complemented stains). These data show that FlaA and 
FlgE syntheses were reduced relative to FlaB in the ¨ luxSHp mutant and these 
changes were restored by genetical complementation.  
 
 
 C
 CHAPTER 6. RESULTS 
 
 
148 
 
 
 
 
 
Figure 6.4 Mutation of luxS causes altered flagellin and hook protein production 
Cell lysates of the strains indicated were subjected to immunoblotting with anti-flagellin (FlaA and FlaB) and anti-hook protein (FlgE) 
together. The proteins were measured in wild-type, ƩluxSHp, ¨luxSHp+ cells grown in Brucella broth at 37qC for 24h. H. pylori strain 17874 
wild-type served as the positive control. Mutants in flaA (a kind gift from Paul OToole) and flgE (O'Toole et al., 1994) derived from this 
strain (17874¨flaA and 17874¨flgE) served as negative controls for identifying FlaA and FlgE, respectively. 
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6.3.3 AI-2 regulates the transcription of flagellar genes 
Previous reports have provided evidence that luxSHp-dependent QS may modulate 
motility via transcriptional regulation of flaA or flhA (Rader et al., 2007). 
Quantitative RT-PCR (qRT-PCR) was utilised to screen for alterations in 
transcription of these and other genes involved in flagellar assembly. This may help 
to extend our understanding of the regulatory mechanisms that might be involved. 
The same cultures were analysed as in the previous section so that direct 
comparisons between transcriptional and translational effects could be made in the 
presence and absence of DPD. To exclude an effect of cysteine biosynthesis, 
exogenous addition of cysteine was also undertaken. RNA samples were obtained 
from the same liquid cultures utilised in protein production analysis (see previous 
section). The concentration of cysteine was non-limiting to H. pylori growth. 16S 
rRNA transcription was used for normalization and ureA served as a non-flagella 
linked gene control (Figure 6.5A). 
 
H. pylori wild-type LWV ǻluxS PXWDQW DQG WKH FRPSOHPHQWHG ǻluxS+ mutant were 
grown in Brucella broth at 37qC for up to 24 h, a condition in which a high level of 
AI-2 activity was detected (Figure 5.4). &XOWXUHV RI ZW  '3' DQG ǻluxS + DPD 
(DPD was added after 10 h of incubation and once again after 18 h of incubation) 
were also involved in this experiment. Interestingly, we did not find DPD of different 
FRQFHQWUDWLRQV ȝ0 ȝ0 DQG ȝ0 UHVXOWHG LQ VLJQLILFDQW YDULDWLRQ LQ
bioluminescence (Figure 6.5E). 16S RNA transcription was used for normalization. 
The gene ureA was used as a transcriptional gene control. 
 
 CHAPTER 6. RESULTS 
 
 150 
The flagellar genes tested included: three main sigma IDFWRUVı28 (intermediate class 
JHQH ı54 FODVV  JHQH DQG ı80; class 1 flagellar genes flhA (encodes flagellar 
regulator component), flgR (encodes response regulator protein), flgS (encodes 
histidine kinase), motA and motB (encode flagellar motor proteins); class 2 genes 
flaB (encodes minor flagellin) and flgE (enodes flagellar hook protein); and a class 3 
gene flaA (encodes major flagellin). The flagellar basal body gene fliI (encodes 
membrane-associated export ATPase), flhF (functionally equivalent to master 
regulators), and the anti-sigma factor flgM were also examined. 
 
ı80 showed a consistent pattern of 1.8-2 fold (p<0.001) reduced transcription in the 
ǻluxSHp mutant compared to the wild-W\SHZKLOHı54 DQGı28 LQWKHǻluxSHp mutant 
were transcribed at close to wild-type levels (Figure 6.5A). For class 1 genes tested, 
flhA, flgR and flgS were 1.75 fold, 1.5 fold and 1.7 fold (p<0.001) respectively down-
UHJXODWHGLQWKHǻluxSHp mutant. Both motA and motB were over 1.5 fold (p<0.001) 
down-UHJXODWHGLQWKHǻluxS mutant compared to the wild-type (Figure 6.5B). For the 
class 2 genes tested, flgE was approximately 1.4 fold (p<0.001) down-regulated in 
the mutant; while flaB did not exhibit any significant change. flaA was the only class 
3 gene tested in this study, and it was around 3.5-4 fold (p<0.001) down-regulated in 
WKHǻluxSHp mutant (Figure 6.5C). The intermediate class genes flhF and flgM were 
transcribed almost at the same level in both wild-type and the ǻluxSHp mutant. The 
transcription of fliI was also significantly (p<0.001) reduced LQ WKHǻluxSHp mutant 
(Figure 6.5D).  
 
The reduced transcription of ı80, flhA, flgR, flgS motA, motB, flgE, flaA and fliI was 
restored genetically by the complementation of the mutant with the wild type luxSHp 
gene. Also, 150µM DPD was sufficient to restore the transcription of these genes in 
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ǻluxSHp cells to at or near the level of the wild-type. In wild-type cells, addition of 
DPD markedly increased transcription of flhA, motA, motB and flaA, whilst ı80, flgR, 
flgS, flgE and fliI only showed a marginal increase. Exogenous addition of cysteine 
to the ǻluxSHp mutant did not significantly increase transcription of any of the genes 
studied; suggesting that addition of cysteine was not able to restore the transcription 
of flagellar genes (data not shown). Consistent with the analysis of protein levels, 
these RT-PCR data indicate that luxSHp disruption has a greater effect upon 
transcription of flaA than of flaB. Taken together, these data suggest that the effect of 
LuxS in cysteine metabolism does not regulate expression of flagellar genes, and that 
the effects on flagellar gene transcription are likely through AI-2 production. 
 
 
 
 
(A) The main flagellar regulator factors and ureA (non-flagellar gene control) 
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(B) Class 1 flagellar genes tested 
 
 
 
(C) Class 2 and 3 flagellar genes tested 
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(D) The intermediate class genes tested and the basal body gene fliI 
 
 
 
(E) AI-2 activity bioassay 
 
Figure 6.5 luxS/DPD modulates H. pylori flagellar gene transcription 
Transcript levels of (A) ı80, ı54, ı28, ureA; (B)  flhA, flgR, flgS, motA, motB; (C) flaB, flgE, 
flaA; (D) flgM, flhF, fliI were determined by qRT-PCR normalised to the levels of the 16S 
rRNA gene. Relative expression of ureA was utilised as a gene control. The Y axis shows 
the relative transcriptional level of each gene in each strain normalised to the level of the 
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same gene in the strain control (which is J99 wild-type in every case). Values are mean 
activities of triplicate RNA samples of each strain. Transcript levels were measured in 
wild-type and ƩluxSHp cultures grown with or without DPD and in ¨ luxSHp+ cultures grown 
without DPD (ǋ0). (E) AI-2 activity in DPD solution (at concentrations of  50, 150 or 
ǋ0 and in the cell free culture supernatants (24h) of H. pylori wild-type, ¨luxSHp and 
¨luxSHp+ strains grown in the Brucella broth (corrected by OD600nm). Negative control is 
Brucella broth alone. A diluted in vitro synthesised AI-2 sample was utilised as a 
qualitative positive control (Winzer et al., 2002a).  Error bars indicate standard deviation.  
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6.4 Discussion 
In WKLVFKDSWHU WKHSURFHVVHVXQGHUO\LQJ WKH ORVVRIPRWLOLW\RI WKHǻluxSHp mutant 
were manifested by fewer and shorter flagella that presumably derived from the 
altered flagella protein production and the modulated expression of a number of 
genes linked with flagella assembly and function.  
 
Firstly, microscopic assay showed sigQLILFDQWO\ UHGXFHG PRWLOLW\ LQ WKH ǻluxSHp 
mutant and this was completely restored by genetaically complementation and 
significantly restored by addition of DPD. EM pictures showed that deletion of 
luxSHp reduced flagellar number and length and that this could be complemented by 
the luxSHp gene and at least partially by DPD, but not by the provision of cysteine. 
Also it was noted that addition of DPD to the ¨ luxSHp+ complemented strains or 
wild-type promoted flagella formation at the second pole. In the experiments 
presented here, it was clear that the majority of ǻluxSHp mutant cells had flagella. 
Although not involved in this study, image analysis can be used, for example the 
Hobson BacTracker (Morehouse et al, 2005) or video imaging and analysis with the 
ImageJ package (Murray & Kazmierczak, 2006, Collins, 2007). These methods 
would help to get a more quantitative measure of motility, including not only rotary 
movement of cells but also translational movement by directed swimming. 
 
The smaller flagella observed in the mutant could result from the observed alteration 
of FlaA : FlaB ratio as previously described (Suerbaum et al., 1993, Josenhans et al., 
1995). However, proving this would require extensive immuno-EM analysis with 
anti-FlaA and anti-FlaB antisera, which was mot provided due to time constraint. As 
flaA has been confirmed to be essential for motility in H. pylori while flaB is a 
structural subunit of filament which increases motility (Josenhans et al., 1995, 
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Suerbaum et al., 1993), the change of the ratio between flagellins FlaA and FlaB may 
be one factor resulting in the abolished motility of the ǻluxS mutant. Also, 
LuxSHp/AI-2 appears to affect the position of flagella, suggesting that LuxSHp/AI-2 
may affect genes involved in the formation of flagella at the cell poles.  
 
Loh et al. also found that luxSHp regulates the growth-phase-dependent expression of 
flaA, but they did not find an obvious effect of AI-2 on flaA transcription (Loh et al., 
2004). They explained that this might be since H. pylori lacks specific regulatory 
proteins needed for AI-2 signalling (e.g. LuxP, LuxU, LuxO) (Loh et al., 2004). To 
find out the proposed effects of LuxSHp/AI-2 on signalling, the transcription of some 
flagellar genes in cells of wild-W\SHǻluxSǻluxS+ZW'3'DQGǻluxS + DPD was 
compared using RT-PCR.  
 
The transcriptional data of flaA, flaB and flgE are consistent with phenotypes of 
bacteria found by EM and immuno-blotting. This is in contrast to a previous report 
where truncated flagella were only reported in G27 strains that also lacked one of the 
transcriptional regulators (ı28, flgS or flgM) and where wild-type length flagella were 
reported for the ǻluxSHp mutant alone (Rader et al., 2007). However, surprisingly in 
that report, the addition of DPD to the double mutants lengthened the flagellar 
filaments. This was reminiscent of what was found in the single ǻluxSHp mutant of 
J99 where DPD addition or luxSHp complementation restored flagellar length to the 
wild-type level.  
 
The model of the flagellar regulon suggests that flagellar gene transcription of H. 
pylori is tightly regulated by three RNA polymerase sigma IDFWRUVı80ı54 DQGı28 
1LHKXVı80 controls the transcription of class 1 genes (early flagellar genes), 
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including  FlhA (flagellar basal body components), FlgR (response regulator protein),  
FlgS (histidine kinase), MotA and MotB (flagellar motor proteins) etc.; ı54 controls 
class 2 genes (middle flagellar structural genes), assisted by the histidine kinase FlgS 
and the response regulator FlgR. The minor flagellin FlaB and hook protein FlgE are 
inYROYHGLQWKLVFODVVı28 and FlgM regulate the transcription of class 3 genes (late 
flagellar structural genes) containing the major flagellin FlaA. Intermediate class 
JHQHVVWUXFWXUDODQGUHJXODWRU\JHQHVDUHJHQHUDOO\FRQWUROOHGE\DOORIı80ı54 and 
ı28. This class includes FlgM and FlhF (predicted to be flagellar basal body 
components). Both FlhA and FlhF (functionally equivalent to master regulators) are 
necessary for full transcription of classes 2, 3 and the intermediate class genes 
(Figure 6.6).  
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Figure 6.6 Current model of regulation in flagellar biosynthesis of H. pylori***
The different classes of flagellar genes are regulated by the housekeeping sigma factor 
ı80 (class 1) and the alternative ı54 (class 2) and ı28 (class 3). The intermediate genes 
controlled by more than one promoter are grouped in a separate category. The list of 
putative class 1 genes is not complete, because regulons have not been fully investigated. 
Transcription of class 2 genes is governed by ı54, assisted by FlgS (or FleS) and FlgR. 
FlhA and FlhF are both necessary for full transcription of flagellar classes 2 and 3 and the 
intermediate class. FlgM plays a role in the transcriptional blockade of class 2 and 3 genes 
 
                                                 
*** Figure 6.6 is from the paper Niehus et al., 2004. 
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in flhA mutants, but only in the feedback block of class 3 genes in flhF mutants (Niehus et 
al., 2004).  
 
As an upper tier regulator gene in the model of the H. pylori flagellar regulon, 
reduced transcription RIı80 in the ǻluxSHp mutant may be the factor leading to the 
lower expression of some of the class 1 genes including flhA, flgR, flgS, motA and 
motB. The reduced expression of flagellar motor genes (motA and motB) which 
control flagellar rotation could be one factor contributing to slower motility of the 
ǻluxSHp mutant although it could also be caused by the lower flagellar number 
requiring fewer motor units to encircle each flagellar base.  
 
Mutants defective in flhA were previously described as being defective in flagellar 
apparatus
 
assembly and in motility. This is despite FlhA being a membrane bound 
protein, shown to be present at the base of the flagellum in bacteria such as 
Salmonella (Minamino & Macnab, 1999). Recently Rust and coworkers (2009) 
reported that the anti-sigma factor for ı28, FlgM, interacts with FlhA at the base of 
the Helicobacter flagellum and this interaction modulates the expression of flagellar 
JHQHVE\ı28 (Rust et al., 2009). The decrease in flhA expression, seen in our ǻluxSHp 
mutant could explain the change in flagellar length but not via an FlgM-dependent 
pathway as seen by Rader, as Rust and coworkers report that FlgM levels were wild-
type in a ¨ flhA mutant in Helicobacter strains N6 and 88-3887 (Motile variant of 
26695) (Rust et al., 2009). Also, the data here showed that reduced transcription of 
flhA did not result in transcriptional reduction in ı28 and ı54. This could be because 
ı28 and ı54 are not only regulated by flhA but also by another regulator gene such as 
flhF which was not affected by loss of luxSHp in our experiments.  
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A previous study suggests that flhAı54, flgR and flhF were required for the presence 
of flagella, motility and the expression of the flagellar proteins (Niehus et al., 2004). 
The data in this chapter showed that only flhA and flgR of these four genes, were 
down-regulated when luxSHp was absent, and that although ı28 DQG ı54 were not 
affected by reduced expression of flhA, the class 2 gene flgE and the class 3 gene 
flaA were still significantly down-UHJXODWHGLQWKHǻluxSHp mutant. This might be due 
WR WKHHIIHFWRI)OJ5)OJ6 UHGXFHG LQ WKHǻluxSHp mutant) in co-UHJXODWLRQRIı54-
dependent class 2 and intermediate class genes; and also could be due to the role of 
FlgM in the transcriptional blockade of class 2 and 3 genes when flhA is expressed at 
lower level or mutated (Figure 6.6).  
 
Both Rust and coworkers (Rust et al., 2009) and Neihus and co-workers (Niehus et 
al., 2004) show that FlaB is not regulated by the same regulatory pathway as FlaA, 
and as FlaB levels in our ¨ luxSHp mutant concur with this (Niehus et al., 2004), the 
short flagella observed LQ WKH ǻluxSHp mutant are likely to be predominantly 
composed of FlaB (normally hook-proximal) flagellins. These may be extended, to 
give functional length propellers by synthesis and assembly of FlaA in wild-type 
filaments and in filaments from luxSHp-FRPSOHPHQWHGǻluxSHp+ bacteria or ¨ luxSHp 
bacteria+DPD which have longer flagella.  
 
FlaB and FlgE are part of the same regulon that is controlled by the FlgS/FlgR two 
component system and the sigma factor ı54 (RpoN) (Niehus et al., 2004). 
Interestingly, though no significant change in FlaB was found, FlgE production as 
well as its gene expression was affected by loss of LuxS/AI-2. This suggests that 
luxS inactivation might differentially affect transcription of flagella genes with the 
same class. One possibility is that the FlgR/FlgS-ı54 regulatory complex might have 
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different effects on the same class of genes when affected by loss of LuxS; another 
possibility is that there may be additional regulation from the other regulator genes, 
for example flhF. 
 
Flagellar assembly needs a type III secretion system which is dependent upon export 
chaperones that protect and transport structural subunits using the membrane-
associated export ATPase, FliI (Jenks et al., 1997, Lane et al., 2006). Therefore, the 
decreased transcription of fliI might be another factor in blocking motility via 
shortened filament length in the ǻluxSHp mutant, as Helicobacter ǻfliI mutants are 
non-motile and synthesise reduced amounts of flagellin (FlaA, FlaB) and hook 
protein (FlgE) subunits (Jenks et al., 1997).  
 
In conclusion, the significantly reduced transcription of flhA, flgR, flgS, motA, motB, 
flaA, flgE and fliI, together with decreased FlaA and FlgE synthesis are likely to 
H[SODLQ WKH PRWLOLW\ GHIHFW LQ WKH ǻluxSHp mutant which seems to be due to both 
fewer and shorter flagella. In the experiments here, the motility defect, down-
regulated flagellar gene expression and reduced synthesis of flagellar proteins in the 
ǻluxSHp mutant were due to loss of AI-2 only, and not to the metabolic effect of 
luxSHp on biosynthesis of cysteine. These results suggest that LuxS/AI-2 is likely to 
be a functional signalling system contributing to control motility in H. pylori. 
However, it is still uncertain whether AI-2 functions as a true QS signal in H. pylori, 
in part because there are no genes encoding proteins that can be confidently 
identified as components of an AI-2 sensory and regulatory apparatus in H. pylori 
(Tomb et al., 1997, Rezzonico & Duffy, 2008). Also, we cannot exclude the 
possibility that AI-2 acts through other undefined effects and not as a signalling 
molecule, although as it is known to have similar effects through signalling in other 
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bacteria, this appears unlikely. 
 
Previously, Lee et al. and Osaki et al ORRNHGDW ILWQHVVRIǻluxSHp mutants in vivo 
using mouse and gerbil models, respectively (Lee et al., 2006, Osaki et al., 2006). 
The authors did not favour a signalling explanation for the reduced fitness 
mechanisms but both speculated that it might be caused by metabolic disturbances 
upon loss of luxSHp (Lee et al., 2006, Osaki et al., 2006). However, it could 
potentially be explained by reduced signalling leading to reduced motility, and given 
the ecological niche of H. pylori there would be logic to a QS system increasing 
motility. For example, it is speculated that if a microcolony of H. pylori in a 
particular area of the stomach reached a critical size it would be potentially 
advantageous for flagellar biogenesis to be enhanced so that highly motile bacteria 
could disseminate to new regions of the stomach. If this hypothesis was confirmed, it 
would have important implications for H. pylori virulence and for the spread of 
infection within and between people.  
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7 General discussion 
 
7.1 Conclusion 
The evidence presented in this thesis suggests that the three-gene cluster cysKHp-
metBHp-luxSHp encodes the capacity to generate cysteine from products of the 
incomplete activated methyl cycle (AMC) of H. pylori in a process of reverse 
transsulphuration. In this pathway, S-ribosyl homocysteine (SRH) is converted by 
LuxSHp to homocysteine (as in the classic AMC), and thence by CysKHp to 
cystathionine and MetBHp to cysteine. The misnamed genes cysKHp and metBHp are 
recommended to be renamed as mccA (methionine-to-cysteine-conversion gene A) 
and mccB, respectively. 
 
As well as being a metabolic enzyme in the reverse transsulphuration pathway 
(RTSP), this work shows that the third gene of this gene cluster, LuxSHp, has an 
alternative role in regulation of motility by modulating flagellar transcripts and 
flagellar biosynthesis. This is through production of the signalling molecule AI-2, 
rather than the metabolic effect of LuxS in cysteine biosynthesis. These results 
provide preliminary evidence that AI-2 is also likely to be a functional signalling 
molecule in H. pylori. However, at this stage, data in this thesis have still not shown 
whether AI-2 is a true quorum sensing (QS) signal or whether LuxS/AI-2 is a real QS 
system employed by this bacterium. 
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7.2 Discussion 
7.2.1 Comparison of LuxS in cysteine synthesis in H. pylori with other 
bacteria 
Like H. pylori, several other bacterial species including P. aeruginosa, M. 
tuberculosis and B. subtilis are capable of cysteine biosynthesis through the reverse
 
transsulphuration pathway (RTSP). However, in these bacteria, in contrast to H. 
pylori, the sulphate assimilatory cysteine biosynthesis pathway (SACBP) is strongly 
favoured (Vermeij & Kertesz, 1999, Wheeler et al., 2005, Hullo et al., 2007). 
Usually, the enzymes S-ribosylhomocysteinase (which is LuxS in H. pylori), 
F\VWDWKLRQLQHȕ-V\QWKDVH&%6DQGF\VWDWKLRQLQHȖ-lyase (CGL) are responsible for 
the generation of the intermediates homocysteine and cystathionine, and the final 
product cysteine, respectively, through the process of the reverse transsulpuration 
(Hullo et al., 2007, Doherty et al., 2010). P. aeruginosa is slightly different because 
a single enzyme SAH hydrolase is present instead of the Pfs-LuxS combination, 
converting SAH to homocysteine in a one step reaction without the concomitant 
production of DPD (or AI-2) (Duerre & Walker, 1977). In other bacteria also, in the 
absence of LuxS and Pfs, the alternative enzyme, SAH hydrolase, is often present. 
Sometimes, both LuxS/Pfs and SAH hydrolase can be absent, but there is only one 
example (Bifidobacterium) in which all three proteins (LuxS, Pfs and SAH hydrolase) 
are present (Vendeville et al., 2005). However, the analysis of the numerous 
Bifidobacterium genomes available to date (e.g. KEGG http://www.genome.jp/kegg/) 
suggests that Bifidobacterium does not appear to possess a RTSP. In M. tuberculosis, 
MetB is a special case due to its dual function acting as CBS and CGL in both 
directions of the reaction between cystathionine and cysteine, resulting in its dual 
role in both directions of the TSP and the RTSP (Wheeler et al., 2005). Like the H. 
pylori RTSP, the pathway in B. subtilis is completed by its enzymes LuxS, MccA 
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and MccB. The difference is that B. sublitis MccB, is also able to convert 
homocysteine to sulphide directly. Sulphide can be incorporated into cysteine 
through the SACBP, a process which is not present in H. pylori (Hullo et al., 2007).  
7.2.2 Role of LuxS in metabolism and signalling between bacteria 
Whether generated as a by-product in the activated methyl cycle (AMC) or the RTSP 
pathway, the function of AI-2 and the physiological role of LuxS remain matters of 
debate. In S. aureus, AI-2 has been thought to be a pure metabolic product without a 
QS effect (Doherty et al., 2006). In the EHEC E. coli O157:H7 ǻluxS mutant, the 
type III secretion and motility defects were restored genetically by luxS but failed to 
be restored by addition of synthetic AI-2 (Sperandio et al., 2003). In S. Typhimurium, 
luxS affects biofilm formation (De Keersmaecker et al., 2005) and flagellar phase 
variation (Karavolos et al., 2008), again implying a metabolic but not a signaling role. 
However, similar to EHEC E. coli, the two phenotypic changes seen in S. 
Typhimurium upon loss of luxS can be restored genetically but not by addition of 
synthetic AI-2 (Choi et al., 2007, De Keersmaecker et al., 2005). These findings 
indicate that the contributions of luxS to type III secretion and motility in EHEC E. 
coli and to biofilm formation and flagellar phase variation in S. Typhimurium might 
not be signal- or QS- dependent, further implying that phenotypes dependent on the 
gene luxS and AI-2 in some bacteria may be secondary to metabolic changes rather 
than QS (Karavolos et al., 2008).   
 
Data presented in this thesis have suggested a likely function of AI-2 in a QS 
regulatory network in H. pylori. Nevertheless, no AI-2 sensory apparatus, for 
example, the LuxP/Q and the Lsr system has been identified in H. pylori (Rezzonico 
& Duffy, 2008). Therefore, like most species, luxSHp/AI-2 has a proven metabolic 
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role (Rezzonico & Duffy, 2008, Winzer et al., 2002a, Winzer et al., 2002b, Winzer 
et al., 2003). Although our work suggests it is likely to have a secondary role in QS 
signalling, this needs futher analyses as there is no definitive explanation for the 
mechanism to sense or respond to exogenous AI-2 in H. pylori cells. 
 
In contrast, in some bacteria LuxS/AI-2 has an undoubted signalling role. For 
example, in the marine bacterium V. harveyi, in addition to LuxCDABE, AI-1 and 
AI-2 jointly regulate genes encoding a variety of putative functions including a 
secreted metalloprotease, three putative type III secretion system components and a 
conserved hypothetical protein (Surette et al., 1999). In B. subtilis, LuxS activity is 
required for biofilm formation, swarming motility and social and
 
pluricellular 
behavior (Lombardia et al., 2006). In EHEC E. coli O157:H7, 404 genes were 
regulated by luxS at least 5 fold, which comprises approximately 10% of the array 
genes, mainly including genes involved in the type III secretion system, cell division, 
Stx expression, assembly of flagella, chemotaxis, motility and transport (Sperandio et 
al., 2001). In S. Typhimurium, the luxS gene is necessary for expression of genes in 
pathogenicity island 1 (Choi et al., 2007). To date, alterations in bacterial motility 
and biofilm formation seem to be the most commonly seen phenotypic changes upon 
inactivation of luxS or loss of AI-2. H. pylori appears similar. In addition, it is 
interesting and important to know if H. pylori AI-2 affects pathogenicity associated 
genes, for example, vacA, dupA and genes invoved in the cag-pathogenicity island. 
However, due to time constraints, work on putative AI-2 related effects on H. pylori 
pathogenicity was not pursued in this study. 
 
Although the non-cysteine metabolism associated phenotypic changes observed on 
deletion of luxSHp could be complemented genetically and also by addition of AI-2, 
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the exact mechanistic link between luxS mutation and altered phenotypes is still 
unclear. There are several possible explanations other than a signalling effect. One is 
the increased metabolic burden, which is caused by the inability of the strain to 
salvage SAH to homocysteine, allowing accumulation of the toxic intermediate SAH. 
The other possibility is that AI-2 may be used as a precursor for biosynthetic 
purposes not connected with signalling. In other systems, at least some of the 
observed changes are related to the metabolism of sulphur amino acids (Sperandio et 
al., 2005) and others as a response of the cell to the disruption of the AMC.  
 
To date, there is still no explanation for why a signalling molecule AI-2 should be 
generated in the AMC, or the RTSP. Could this be because QS is actually controlled 
by the metabolic AMC or RTSP? The provision of AI-2 would be guaranteed 
through the central AMC (or the incomplete AMC in H. pylori) or RTSP as the 
pathway is significantly meaningful for bacterial survival and normal growth. The 
linkage of luxS to other genes (like mccA and mccB in H. pylori) involved in the 
AMC and cysteine synthesis suggests that LuxS has an original role in central 
metabolism, and further clues that relate to the function of AI-2 will probably be 
obtained from establishing the signal transduction/uptake pathways present in 
different bacteria.  
7.2.3 Role of LuxS in Biology of H. pylori and other bacteria 
QS systems mediated by AHL (AI-1) signalling molecules are typically species 
specific (Williams, 2007). In contrast, the LuxS/AI-2 systems of EHEC E. coli, 
EHPC E. coli, S. Typhimurium, and H. pylori do not appear to be species specific. 
For instance, AI-2 of these species is able to induce bioluminescence in V. harveyi 
(Surette et al., 1999, Loh et al., 2004). One possible role for such a nonspecific 
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bacterial QS system could be to detect total viable bacterial biomass as an indication 
of competition for nutritional resources. Alternatively, a bacterial signalling molecule 
may not regulate the gene expression of the same bacterium, but may act on other 
bacterial species. For example, some S. aureus strains produce signalling molecules 
that interfere with QS networks in other S. aureus strains (Ji et al., 1997). S. aureus 
may also produce a signalling molecule identical to that produced by Enterococcus 
faecalis (Firth et al., 1994, Muscholl-Silberhorn et al., 1997). For H. pylori, up to 
now there is no evidence for the regulatory function of H. pylori AI-2 on other 
bacterial species (except for V. harveyi). However, cells of the gastric system itself 
may be an alternative target for signalling molecules of H. pylori. If gastric epithelial 
cells were responsive to H. pylori AI-2, this might represent a bacterial strategy for 
altering the gastric environment to allow persistent H. pylori colonization (Blaser & 
Kirschner, 1999, Williams et al., 2000, Williams, 2007).  
 
H. pylori is special in terms of its colonizing place within the gastrointestinal 
ecosystem. Almost the entire length of the gastrointestinal tract has plentiful and 
diverse microbial flora, while H. pylori is often the only species colonizing the 
gastric mucosa (Cover & Blaser, 2009). A number of bacteria are able to pass 
through the stomach, and many of them can colonize other regions of the alimentary 
channel. However, it is remarkable that H. pylori is almost the only species that 
successfully colonizes the gastric niche, although many other bacteria have robust 
acid tolerance mechanisms. This might help H. pylori to enter the gastric mucus layer 
and escape from the very acidic pH of the gastric environment (McGowan et al., 
1996). In addition, H. pylori produces chemicals that may prevent other bacterial 
species from colonizing (Freeman, 1999). It is thus tempting to speculate that the 
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capacity of H. pylori to produce and detect AI-2 may be an important factor for 
preventing competing bacterial growth in the gastric mucosa. 
7.2.4 LuxS/AI-2 as a therapeutic target 
A major goal of bacterial QS studies is the development of potential anti-QS agents, 
allowing the development of novel anti-microbial strategies. H. pylori treatment is 
complex and antibiotic resistance is necessary, so effective new strategies for H. 
pylori treatment are badly needed. Potential strategies include the use of molecules 
with a similar structure to auto-inducers which interfere with signalling (QS 
molecular antagonists or QS blockers), and development of auto-inducer degradation 
pathways. Due to its widespread distribution, AI-2 potentially offers the possibility to 
develop effective wide-ranging antimicrobials. Amazingly, both synthetic and 
natural molecules, as well as mechanisms to take up and degrade AI-2 have been 
reported to interfere with AI-2 signalling (Manefield et al., 1999, Manefield et al., 
2001, Rasmussen et al., 2000, Givskov et al., 1996, Novak & Fratamico, 2004, Kim 
et al., 2008).  
 
7.3 Future work 
7.3.1 In vitro study on the H. pylori cysteine biosynthetic pathway  
Experiments presented here have identified an H. pylori cysteine biosynthesis 
pathway through a process of reverse transsulphuration. The metabolic functions of 
the enzymes LuxSHp, MccAHp and MccBHp were identified based on a group of 
bioassays. To further analyse the activities of the key enzymes of this pathway would 
need replication of the H. pylori cysteine biosynthetic pathway in vitro. To do this, 
the enzymes LuxSHp, MccAHp and MccBHp should be cloned and expressed in an E. 
coli system. Similar to the experiment of in vitro AI-2 synthesis, the SAH product 
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could be used as the substrate in the putative in vitro RTSP. The appropriate quantity 
of MccAHp and MccBHp would be added in each step respectively to complete the 
cysteine in vitro synthesis. 
7.3.2 Look carefully at the ratio of FlaA: FlaB 
Osaki and co-workers have reported that low level infection by ¨ luxS mutants is due 
to poorer colonization. In their study, virulence factors and adhesion appeared 
normal but flagella were inactive (Osaki et al., 2006). This could be due to the 
change of the ratio FlaA: FlaB. The levels of FlaA and FlgE in our experiments are 
reduced in the ¨ luxS mutant based on the Western blot (Figure 6.4). With a 
quantitative scan of the bands, it is difficult to tell accurately if there is a difference 
in the ratio of FlaA to FlaB in the ¨ luxS mutant compared to wild-type. More 
convincing experimental data could be obtained by purifying and analysing flagella 
that have been sheared from the cells. This would also distinguish between flagellar 
proteins that are exported and assembled into the flagellum versus subunits that are 
within the cytoplasm.  
7.3.3 Can exogenous AI-2 addition induce transcriptional changes?  
It seems that addition of AI-2 to the ¨luxS mutant gives a slightly different zone of 
motility than the wild-type has. The reason for this could be that the cells are simply 
growing differently; they might be stressed by the AI-2 molecule in some way (e.g. 
through an oxidative stress response). It is clear that the motility defect is not merely 
a straightforward lack of flagella. Whether it is in part due to motor dysfunction, 
different subunit assembly, or some sort of start-rotating signal loss is unclear. 
Microarray, may give clues to homologues involved in other bacteria, but precise 
experiment using a candidate approach will likely be needed. Also, this project could 
be extended to check protein levels of all up-regulated and down-regulated genes. 
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7.3.4 If AI-2 is available during initial adhesion, can the ¨ luxS mutant 
then cause a normal infection?  
H. pylori possesses numerous adhesion molecules, which are important
 
for 
colonization in animal models. Osaki
 
et al (2006) in their study using Mongolian 
gerbils indicate that the decreased infectivity of the ǻluxS mutant strain was not due 
to decreased adhesion activity, but was due to lower motility (Osaki et al., 2006). 
Also, in gerbil stomachs, some of numerous other types of bacteria
 
may possess the 
luxS/AI-2 system.
 
Osaki
 
and co-workers speculated that AI-2 produced by other 
bacteria affected
 
the H. pylori ǻluxS mutant strain, thus allowing the mutant to 
survive
 
in the gerbil stomach (Osaki et al., 2006). The question is, if AI-2 is available 
during initial adhesion, would the ¨luxSHp mutant lead to a normal infection? This 
could be investigated by in vivo co-infection of wild-type and the ¨ luxSHp mutant. 
This work could be done by co-innoculating the ¨luxSHp mutant with wild-type, 
killing wild-type with antibiotics (as the ¨ luxSHp mutant contains an antibiotic 
resistance cassette) and seeing if the mutant can maintain infection at the same 
density.  
 
7.4 Problems with experimental approaches in this thesis 
Most of the key problems with experiments have been discussed in each chapter. 
However, there are still some specific problems as well as general problems with 
experimental approaches that have not been considered fully. These are now 
discussed below.   
 
In Chapter 5, the flagella morphology and swimming patterns were examined using 
electron and phase-contrast microscopy. Previous studies have reported that the 
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number and length of flagella in the ǻluxSHp mutant was no different compared to the 
wild-type (Rader et al., 2007, Osaki et al., 2006); whereas data presented here 
suggested that both the length of flagella filaments was shortened and the number of 
flagella was less in the ǻluxSHp mutant. The contradictory results between this study 
and other studies may be due to the different strain used, so it would have been better 
if additional strains had been examined, as H. pylori is very genetically variable.   
 
The regulatory role of LuxS on flagellar genes has been demonstrated in Chapter 6, 
and some flagellar genes have been analysed at the RNA level (Figure 6.5). Now 
more data are needed at the protein level, but this would be difficult or impossible to 
achieve at the moment as levels of proteins concerned would be too low to visualise 
without specific antisera, and these antisera are not currently available to us. Also in 
Chapter 6, data suggest the possible signalling function of AI-2, but it is difficult to 
entirely exclude the possibility that AI-2 is acting through a different mechanism 
affecting flagella synthesis (although the low concentrations used make it unlikely 
that this would be through acting as an energy source). As stated in Chapter 6, the 
machinery (if any) for sensing or importing AI-2 into H. pylori is unknown and it is 
hard to predict the abundance of protein families with low homology to LuxP/Q or 
Lsr of Vibrio and Enterococcus (Taga et al., 2001, Xavier & Bassler, 2005, Xavier et 
al., 2007). Therefore, currently it is not possible to clarify the mechanism whereby 
AI-2 affects flagella synthesis, or to tell if AI-2 acts on a central regulator of flagella 
synthesis. 
 
Throughout this study, experiments of AI-2 (DPD) complementation were performed 
in several assays including plate motility bioassays, microscopic analyses and 
transcriptional tests. In these experiments, ȝ0 '3' was used because this 
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concentration was found to induce the same level of bioluminescence as the 24 h 
wild-type cell free supernatants (CFS) in the V. harveyi bioluminescence bioassay. 
However, although the concentration of DPD (ȝ0) has been assumed to be 
biological because it is appropriate to the Vibrio system, in truth we do not (and 
cannot) know whether it is truly relevant to the H. pylori system. Data presented 
suggest that it is the physiologically relevant concentration at least during in vitro 
growth of H. pylori. Determining in vivo AI-2 concentrations would be complicated 
by the many resident microbes that produce it. 
 
Also in this study, a mutagenesis approach rather than the approach of looking at 
actual enzyme activity was used to investigate the physiological function of the 
three-gene cluster mccAHp-mccBHp-luxSHp. It may be worth further confirming the 
function of each of the enzymes MccAHp, MccBHp and LuxSHp by constructing the 
RTSP in vitro (also see Chapter 7.3.1). 
 
Finally, due to time constraints, no in vivo study using animal models was performed 
in this work. Although the primary metabolic function of the three-gene cluster 
mccAHp-mccBHp-luxSHp and the possible secondary role of LuxSHp in contributing to 
control motility by signalling have been investigated, it is still not clear how the two 
effects (metabolic and signalling) of LuxSHp would affect each other, and how the 
three-gene cluster of H. pylori would function in the host. This could be investigated 
using Mongolian gerbils by in vivo infection of each strain individually, or by in vivo 
co-infection of wild-type and each of the mutants (the wild-type could then be 
eliminated using antibiotics). Once the initial colonization of each strain was 
established, the role of related H. pylori genes in the host could be studied. 
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In many bacteria, LuxS functions as a quorum-sensing molecule synthase. However, it also has a second,
more central metabolic function in the activated methyl cycle (AMC), which generates the S-adenosylmethi-
onine required by methyltransferases and recycles the product via methionine. Helicobacter pylori lacks an
enzyme catalyzing homocysteine-to-methionine conversion, rendering the AMC incomplete and thus making
any metabolic role of H. pylori LuxS (LuxSHp) unclear. Interestingly, luxSHp is located next to genes annotated
as cysKHp and metBHp, involved in other bacteria in cysteine and methionine metabolism. We showed that
isogenic strains carrying mutations in luxSHp, cysKHp, and metBHp could not grow without added cysteine
(whereas the wild type could), suggesting roles in cysteine synthesis. Growth of the luxSHp mutant was
restored by homocysteine or cystathionine and growth of the cysKHp mutant by cystathionine only. The
metBHp mutant had an absolute requirement for cysteine. Metabolite analyses showed that S-ribosylhomo-
cysteine accumulated in the luxSHp mutant, homocysteine in the cysKHp mutant, and cystathionine in the
metBHp mutant. This suggests that S-ribosylhomocysteine is converted by LuxSHp to homocysteine (as in the
classic AMC) and thence by CysKHp to cystathionine and by MetBHp to cysteine. In silico analysis suggested
that cysK-metB-luxS were acquired by H. pylori from a Gram-positive source. We conclude that cysK-metB-luxS
encode the capacity to generate cysteine from products of the incomplete AMC of H. pylori in a process of
reverse transsulfuration. We recommend that the misnamed genes cysKHp and metBHp be renamed mccA
(methionine-to-cysteine-conversion gene A) and mccB, respectively.
Helicobacter pylori is a Gram-negative bacterium which
causes peptic ulceration, gastric adenocarcinoma, and gastric
lymphoma (2). All H. pylori strains possess a homologue of
luxS, best known as a quorum-sensing molecule synthase. luxS
homologues have been found in around half of all bacterial
genomes sequenced to date (38, 42, 44). Some of the molecules
formed in the reaction catalyzed by LuxS are collectively
termed autoinducer 2 (AI-2) and have been shown to act as
signaling molecules. They have been described as mediating a
variety of effects in different bacteria, including on virulence. In
H. pylori, disruption of luxS has been shown to increase biofilm
formation (6) and to reduce in vivo fitness and infectivity (20,
29). Several motility-associated luxSHp phenotypes have also
been reported, including loss of growth phase-dependent flaA
regulation (24), reduced motility on soft agar plates, and re-
duced transcription of the flagellar regulator flhA (29, 30).
In most bacteria, the enzyme encoded by luxS has another
(possibly primary and sometimes sole) function: it is an inte-
gral metabolic component of the activated methyl cycle
(AMC). The AMC is a key metabolic pathway that generates
S-adenosylmethionine (SAM) as an intermediate product (the
full cycle is shown in Fig. 1). SAM bears a methyl group with
a relatively high transfer potential and is used by numerous
methyltransferases to carry out cellular processes, including
nucleic acid and protein methylation and detoxification of re-
active metabolites (11). The product of the methyltransferase
reaction is S-adenosylhomocysteine (SAH), and in the com-
plete AMC, SAM is regenerated from SAH via homocysteine
and methionine, ready for another round of methylation/
transmethylation (35, 44, 47, 49). The role of LuxS in the AMC
is to catalyze cleavage of S-ribosylhomocysteine (SRH) to yield
homocysteine and a by-product, 4,5-dihydroxy-2,3-pentanedi-
one (DPD) (Fig. 1) (35, 44, 47, 49). DPD is the precursor of
the family of related, interconverting molecules collectively
termed “AI-2” (5, 44).
H. pylori is unusual among bacteria in not having a complete
AMC. The final step in the classical AMC, the conversion of
homocysteine to methionine can be carried out by either of two
N5-methyltetrahydrofolate-dependent methyltransferases, MetE
or MetH. However, all H. pylori genomes studied to date lack
metE and metH homologues (4). This raises the question of
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whether the only function of LuxS in H. pylori is as a quorum-
sensing molecule synthase or whether LuxS in H. pylori has an-
other, as yet undescribed, metabolic role.
In searching for a possible metabolic role for LuxSHp, we
formed the hypothesis that it is part of a de novo cysteine
biosynthesis pathway that uses methionine as a reduced sulfur
source. Our reasoning for this was based on three observations.
First,H. pylori has an absolute requirement for methionine (26,
27, 31), in agreement with its lack of metE and metH. Second,
H. pylori can synthesize cysteine without apparently making use
of oxidized sulfur compounds, such as sulfate: genomic studies
show that homologues to the genes which encode the compo-
nents required for uptake of sulfate and conversion to sulfide
are absent (10). Third, all completeH. pylori genomes available
to date contain homologues of two genes, annotated as cysK
and metB, located immediately upstream of luxS. In other
bacteria, these are involved in the generation of cysteine and
interconversion of cysteine and methionine, respectively. Re-
cently themetB gene from H. pylori strain SS1 was purified and
characterized, but its physiological role was not established
(18).
When we pondered the fate of homocysteine, which is not
converted to methionine in H. pylori due to a lack of MetE and
MetH, coupled with the observation that the gene responsible
for its production, luxS, is linked with two other genes pre-
dicted to be involved in methionine and cysteine metabolism,
we hypothesized that H. pylori is able to utilize homocysteine
by converting it to cysteine via the reverse transsulfuration
pathway (RTSP), involving the associated genes metB and
cysK. We thus set out to address this hypothesis and more
specifically to define the roles of the cysK, metB, and luxS
homologues in the putative H. pylori RTSP.
MATERIALS AND METHODS
Strains, plasmids, and media. The strains and plasmids used in this study are
shown in Table 1. Escherichia coli strains DH5 and DS941 (37, 51) were used
in cloning/subcloning experiments. E. coli was routinely propagated in Luria-
Bertani (LB) broth or on LB agar plates at 37°C under normal atmospheric
conditions. Vibrio harveyi was grown in either LB or AB medium (12) at 30°C,
also under normal atmospheric conditions. H. pylori strains were routinely pas-
saged on horse blood agar (Oxoid) every 2 to 3 days and were grown in a MACS
VA500 microaerobic workstation (Don Whitley Scientific) using a humidified
atmosphere consisting of 6% O2, 3% H2, 5% CO2, and 86% N2. Antibiotic
selection was carried out at 100 g ml1 with ampicillin (or carbenicillin) and 50
g ml1 for kanamycin.
ForH. pylorimetabolic supplementation experiments, the complete chemically
defined medium (cCDM) of Reynolds and Penn was formulated as previously
described (31), with variations as indicated in the text. The concentrations of
methionine and cysteine used were 505 M and 1.0 mM, respectively. For the
variations of CDM lacking cysteine (see Results for description of use), different
chemicals were added: homocysteine (at 1.0 mM), cystathionine (at 1.0 mM), or
potassium sulfide (a range of concentrations up to 1.0 mM were utilized). All
chemicals were of high purity (cell culture tested) and were obtained from
Sigma-Aldrich Co. CDM batch culture comparative growth studies were carried
out as described previously (9).
Measurement of AI-2 activity. AI-2 measurements were performed as de-
scribed previously (3, 47). Twenty-four-hour culture supernatant samples, cor-
responding to mid-late log phase, were tested. AI-2 activity was expressed as fold
change in induced bioluminescence from the reporter strain compared with that
for the negative control. Negative control samples consisted of media which had
not been inoculated but otherwise were treated as test cultures. Positive
controls were carried out using in vitro-synthesized AI-2, prepared as de-
scribed previously (8).
DNA manipulation. Recombinant DNA techniques were carried out using
standard methods (34). PCR amplifications were performed using either stan-
dard DNA polymerase (GoTaq; Promega, Madison, WI) or proofreading DNA
polymerase (Novagen KOD; Merck Chemicals Ltd., United Kingdom). Restric-
tion digests were performed in accordance with the manufacturer’s recommen-
dations (Promega, Madison, WI). E. coli genomic and plasmid DNA was isolated
using the Qiagen range of preparatory kits (Qiagen, United Kingdom). H. pylori
genomic DNA was purified as described previously (22). DNA sequencing was
conducted using standard fluorescent dye terminator chemistries, and analysis
was performed using the Applied Biosystems 3730 DNA analyzer system (Gen-
eservice, Cambridge, United Kingdom, and Applied Biosystems Inc., Foster City,
CA.). Results were analyzed using the BioEdit software suite (13).
Mutagenesis of luxSHp, metBHp, and cysKHp. All mutants were made following
an insertion-deletion strategy. The H. pylori luxS mutant strains were made by
FIG. 1. Bacterial methionine and cysteine interconversion path-
ways. The activated methyl cycle (AMC) regenerates the active methyl
donor, SAM, from the toxic methyl transferase product, SAH. SAH is
metabolized in one of two ways. Many bacteria, including H. pylori,
generate homocysteine from SAH in a two-step manner: a nucleosi-
dase, Pfs, converts SAH to SRH, and then LuxS converts this to
homocysteine and DPD. The alternative route produces homocysteine
directly from SAH in a one-step reaction requiring SAH hydrolase (11,
47). Many bacteria synthesize cysteine through the sulfate assimilatory
cysteine biosynthetic pathway, which uses inorganic sulfur as a sub-
strate (pathway bounded by a dashed triangle). Enzymes with previ-
ously described homologues in H. pylori are shown in red. Enzymes
that do not have homologues in H. pylori are shown in black. The
reactions of the transsulfuration and reverse transsulfuration path-
ways, which are a major focus of this paper, are shown in green and
blue, respectively. We show in this paper that CysKHp is the candidate
cystathionine -synthase and MetBHp the candidate cystathionine
-lyase in the reverse transsulfuration pathway. We suggest that these
genes be renamed mccA (methionine-to-cysteine-conversion gene A)
and mccB, respectively. CBL, cystathionine -lyase; CBS, cystathionine
-synthase; CGL, cystathionine -lyase; CGS, cystathionine -synthase;
DPD, 4,5-dihydroxy-2,3-pentanedione; LuxS, S-ribosylhomocysteinase/
autoinducer 2 synthase; MetE/MetH, methionine synthase; MetK,
S-adenosylmethionine synthase; Pfs, 5-methylthioadenosine nucleo-
sidase/S-adenosylhomocysteine nucleosidase; SAM, S-adenosylmethi-
onine; SAH, S-adenosylhomocysteine; SRH, S-ribosylhomocysteine.
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transforming J99 and NCTC11637 with pGEMT::luxS::aphA3 (a generous gift
from Leo Smeets and Theo Verboom).
The cysK and metB loci were mutagenized as follows. Fragments containing
the open reading frames (ORFs) and approximately 400 to 500 bp on either side
were amplified from J99 genomic DNA using the following primer pairs: cysK
(forward, 5-CACCATTGACAAATCCTTCC-3; reverse, 5-TTTGGTGTTGG
GCTTGATAG-3) and metB (forward, 5-CCTGATAATCCCGCAGCCTACT
A-3; reverse, 5-ACCCCCACTTCAGACCACTCAG-3). These products were
then cloned into pGEM-T Easy (Promega, Madison, WI). Inverse PCR (iPCR)
products were generated from these using the following primer pairs, which were
designed so that resulting clones would contain a deletion of a large part of the
open reading frame of each target gene, preventing gain of function recombina-
tion/excision events: metB (5 iPCR, 5-CGTGAATTCCGGCTAAACCAG-3
[EcoRI site underlined]; 3 iPCR, 5-TGAACAGGATCCGTTAGAAGATT-3
[BamHI site underlined]) and cysK (5iPCR, 5-GCTGTTTTTCTGTGCTGAA
TTCTT-3 [EcoRI site underlined]; 3iPCR, 5-GTGGATCCGAGGGTTCTA
TTTTGA-3 [BamHI site underlined]). These were prepared for cloning by
restriction digestion and purified. The apolar aphA3 cassette, conferring kana-
mycin resistance, was isolated from pMWA2 (46) by restriction digestion with
EcoRI/BamHI and ligated into the prepared iPCR products. Positive clones
were selected on the basis of kanamycin resistance and confirmed by PCR and
DNA sequencing. The resultant vector constructs are nonreplicative in H. pylori
and were used as suicide vectors to transform J99 and NCTC11637.
Bacterial transformations. E. coli was transformed with plasmid DNA by
electroporation using a Bio-Rad Gene Pulser with pulse controller at a voltage
of 1.8 kV, with a resistance of 200  at 25-F capacitance. H. pylori was
transformed by natural transformation using established protocols (22). Recom-
binant H. pylori strains were recovered by selection on Columbia agar base
containing kanamycin, egg yolk emulsion (5% [vol/vol]), and triphenyl tetrazo-
lium chloride at a working concentration of 40 g ml1. Inclusion of this indi-
cator made it easier to see the small recombinant colonies.
Sample preparation and relative quantification of candidate metabolites. The
following protocol was developed for sampling H. pylori cultures prior to metab-
olite analysis. Strains were grown in complete CDM for 24 h. All subsequent
manipulations were performed on ice or in chilled equipment, and all plastic
ware was prechilled prior to use. Three ml of culture at an optical density (OD)
at 600 nm (OD600) of 1.0 was taken as a standard sampling volume (variances
from this OD were corrected for by using larger or smaller volumes). This was
quenched in 5 ml ice-cold phosphate-buffered saline (PBS). Cells were recovered
by centrifugation and washed with a further 5 ml ice-cold PBS. The cells were
again recovered by centrifugation, and cell pellets were stored at 80°C.
Metabolite analysis was performed as described previously (15, 36).
Phylogenetic analyses. Primary amino acid sequences were aligned using the
ClustalW algorithm using BioEdit (13). Accession numbers of individual protein
sequences used are as follows: H. pylori, LuxS, NP222818; MetB, NP222819;
CysK, NP222820; RecA, NP222862; Helicobacter acinonychis, LuxS, YP665186;
MetB, YP665187; CysK, YP665188; RecA, YP664174; Helicobacter hepaticus,
LuxS, NP859707; MetB, NP859593; CysK, NP860380; RecA, NP860164; Helico-
bacter bilis, LuxS, ZP04580164; MetB, ZP04581342; CysK, ZP04581369; RecA,
ZP04580683; Helicobacter canadensis, LuxS, ZP03656033; MetB, ZP03656080;
CysK, ZP03656337; RecA, ZP03655680; Helicobacter pullorum, LuxS,
ZP04808703; MetB, ZP03661228; CysK, ZP03660206; RecA, ZP04808545;
Helicobacter winghamensis, LuxS, ZP04583537; MetB, ZP04583291; CysK,
ZP04582871; RecA, ZP04583642; Helicobacter cinadei, LuxS, ZP03657497;
MetB, ZP03658434; CysK, ZP03658433;RecA, ZP03659220; Wolinella succino-
genes, LuxS, NP908224; MetB, NP907217; CysK, NP907372; RecA, NP907645;
Campylobacter jejuni, LuxS, YP002344589; MetB, ZP01699839; CysK,
YP002344310; RecA, YP179815; Enterococcus faecium, LuxS, ZP00604876;
MetB, ZP00604875; CysK, ZP00604874; RecA, ZP00603401; Staphylococcus au-
reus, LuxS, BAB43220; MetB, NP370984; CysK, BAB56621; RecA, NP371809;
E. coli, LuxS, NP417172; MetB, NP418374; CysK, NP416909; RecA, YP853918;
and Bacillus subtilis, LuxS, NP390945; MccB, NP390603; MccA, NP390604; and
RecA, ZP03591416.
These alignments were used to derive phylogenies based on neighbor-joining
methods using the Mega4 suite of programs (40). Bootstrap values were gener-
ated based on 1.000 replicates of each calculation (consensus bootstrap trees had
identical topologies).
RESULTS
Nonpolar mutation of metBHp, cysKHp, and luxSHp. To de-
termine the functions of the putative homologues of MetB,
CysK, and LuxS in H. pylori (MetBHp, CysKHp, and LuxSHp),
we first constructed a panel of mutant strains deficient in each
TABLE 1. Bacterial strains and plasmids used in this study
Strain/plasmid Genotype/notes Source/reference
Strains
Escherichia coli
DH5 endA1 recA1 gyrA96 thi-1 hsdR17(rk
 mk
	) relA1 supE44 (lacZYA-argF)
U169 F 
80dlacZM15 deoA phoA 
51
DS941 thr-1 leu-6 thi-1 lacY1 galK2 ara-14 xyl-5 mtl-1 proA2 his-4 argE3 str-31
tsx-33 supE44 rec	 recF lacIq lacZ M15
37
Vibrio harveyi
BB170 luxN::Tn5; AI-1 sensor negative; AI-2 sensor positive 39
Helicobacter pylori
J99 (ATCC 700824) Wild-type strain 1
J99luxS J99; luxS::Kmr This study
J99metB J99; metB::Kmr This study
J99cysK J99; cysK::Kmr This study
NCTC 11637 (ATCC 43504) Wild-type strain 25
11637luxS 11637; luxS::Kmr This study
11637metB 11637; metB::Kmr This study
11637cysK 11637; cysK::Kmr This study
Plasmids
pGEM-T Commercial TA cloning vector; Apr Promega, Madison, WI
pMWA2 Source of apolar aphA3 cassette; Apr Kmr 46
pLUXS pGEM-T::luxS::aphA3; Kmr Theo Verboom
pMETB pGEM-T bearing the metBHp gene; Ap
r This study
pCYSK pGEM-T bearing the cysKHp gene; Ap
r This study
pMF1 pMETB deletion-insertion derivative; Apr Kmr This study
pCF2 pCYSK deletion-insertion derivative; Apr Kmr This study
pProEx-luxSEC pProEX HT containing luxS gene of E. coli MG1655 47
pProEx HT mtan pProEX HT containing pfs gene of E. coli 47
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one of these gene products in two different H. pylori strain
backgrounds (J99 and 11637). Each mutant was created using
a deletion/insertion approach, using the aphA3 cassette (kana-
mycin resistance) as a selectable marker (19). The general
approach to this mutagenesis strategy is shown in Fig. 2A, and
details are described in Materials and Methods. Mutants were
confirmed on the basis of PCR and DNA sequencing.
To avoid polar effects of disrupting either cysKHp ormetBHp,
we used a variant of aphA3 which lacks both the promoter and
terminator elements and which we have used successfully in
previous studies (46). Since luxS comprises the last of the genes
in this operon, we were able to use the V. harveyi AI-2 assay (3,
47) to demonstrate that disruption of either cysKHp or metBHp
did not block expression of downstream genes (Fig. 2B). As
predicted, insertion of aphA3 into the luxS gene abrogated
AI-2 production completely (Fig. 2B).
LuxSHp, CysKHp, and MetBHp are required for de novo cys-
teine biosynthesis in H. pylori. In order to determine the effects
of mutagenesis of cysKHp, metBHp, and luxSHp, we composed
various chemically defined media (CDM) based on the com-
plete CDM (cCDM) of Reynolds and Penn (31). This is a
versatile system which allows precise control of the composi-
tion of the medium. cCDM contained both of the sulfur-con-
taining amino acids, methionine and cysteine. We also made 4
variants of this medium, all of which lacked cysteine. One had
no additional source of sulfur (we refer to this hereinafter as
CDM), while the others contained either homocysteine
(CDM	HC), cystathionine (CDM	CTT), or potassium sul-
fide (CDM	S) (see Materials and Methods for concentra-
tions). Using these media with the wild type and the cysKHp,
metBHp, or luxSHp mutants of both H. pylori strain 11637
and J99, we found that all strains grew well in cCDM (Fig. 3A
to D for 11637l; J99 not shown). Upon omission of cysteine
(CDM), the wild-type strain still grew, although less well than
in the complete medium (Fig. 3A). In contrast, all three mu-
tants were auxotrophic for cysteine, with no growth detected
(Fig. 3B to D). These observations confirmed that wild-type H.
pylori is able to grow in the absence of cysteine and so pos-
sesses a cysteine de novo biosynthesis pathway. They also re-
vealed that cysKHp, metBHp, and luxSHp are all part of this
pathway.
Metabolic complementation of growth defects demonstrates
steps in the cysteine biosynthesis pathway catalyzed by Lux-
SHp, CysKHp, and MetBHp. We next examined which steps in
our proposed H. pylori reverse transsulfuration pathway
(RTSP) (Fig. 1) were catalyzed by LuxSHp, CysKHp, and
MetBHp. These experiments gave the same results for mutants
constructed in the 11637 and J99 backgrounds; the 11637 re-
sults are presented in Fig. 3B to D.
For the luxSHp mutant, adding homocysteine to the CDM
lacking cysteine improved growth of the luxSHp strain, and
CTT restored growth to levels seen with cCDM (CDM with
cysteine) (Fig. 3B). This implies that, as expected, LuxSHp is
required for the conversion of SRH to homocysteine.
The cysKHp mutant grew in cCDM (containing cysteine)
and in CDM lacking cysteine but containing CTT (CDM	CTT)
but not in CDM lacking cysteine (CDM) or CDM lacking
FIG. 2. Mutagenesis strategy and effect of cysKHp and metBHp disruption on autoinducer 2 (AI-2) levels. (A) Schematic representation of the
cysKHp-metBHp-luxSHp gene cluster and approximate locations of individual aphA3 (kanamycin resistance) cassette insertions, indicated in black.
The sequence lengths indicated in brackets are the deletion sizes in each gene. A putative 70 promoter lying upstream of cysKHp was identified
using promoter prediction algorithms found at http://www.softberry.ru/berry.phtml and http://www.fruitfly.org/seq_tools/promoter.html and is
shown as an arrow. Analysis of the predicted stem-loops found in the 3 untranslated regions of each of the three genes indicates the presence of
a number of putative rho-independent terminator sequences downstream of the luxSHp ORF but not in those of either cysKHp or metBHp. (B) Cell
supernatants of wild-type H. pylori strain 11637 (WT) and cysK, metB, and luxS mutants (grown for 24 h in Brucella broth) were examined for
the ability to induce bioluminescence in the V. harveyi reporter strain BB170. The AI-2 activity shown is the ratio of relative bioluminescence
(corrected by the OD600 of H. pylori growth) induced by the 1/10-diluted H. pylori cell culture supernatants over the negative control (NC), which
consisted of broth alone. A diluted in vitro-synthesized AI-2 sample was utilized as a qualitative positive control (PC) (8, 47). Bioluminescence
induced by WT, metBHp, and cysKHp strains was significantly greater than that induced by the luxSHpmutant, as determined by paired Student’s
t test (P  0.001). Error bars indicate the standard deviations within triplicate samples.
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cysteine but containing HC (CDM	HC) (Fig. 3C), suggesting
that CysKHp catalyzes the conversion of HC to CTT.
Finally, the metBHp mutant could grow only in cCDM,
indicating an absolute requirement for cysteine (Fig. 3D). This
would be consistent with MetBHp catalyzing the final step from
cystathionine to cysteine, although further experimentation is
needed to confirm this (see below).
In contrast to results for the wild type, none of the mutants
could grow in CDM lacking cysteine but containing potassium
sulfide (CDM	S) (data not shown). Thus, it seems that
CysKHp is not acting like CysK homologues in other bacteria
(which use sulfide to generate cysteine), in agreement with the
reported absence of the assimilatory sulfate reduction pathway
in H. pylori (10).
Taking these observations together, we propose that H. py-
lori generates cysteine from methionine via components of the
AMC, followed by reverse transsulfuration, with LuxSHp con-
verting SRH to homocysteine and CysKHp converting homo-
cysteine to cystathionine, which is finally converted to cysteine
by MetBHp.
Analysis of key metabolite pools confirms the proposed
pathway of cysteine biosynthesis and specifically identifies re-
action substrates. To investigate the individual steps in the
proposed cysteine biosynthetic pathway and specifically to es-
tablish the likely substrates for LuxSHp, CysKHp, and MetBHp,
we performed metabolite analyses of the wild-type and mutant
strains grown in cCDM (Fig. 4). Specifically, we measured the
relative levels of the AMC metabolites SAM, SAH, SRH, and
HC, plus CTT. Although methionine and cysteine were also
FIG. 3. H. pylori luxS, metB, and cysK strains show chemically complementable growth phenotypes. Growth of H. pylori strains 11637 (wild
type) (A), the luxS mutant (B), the metB mutant (C), and the cysK mutant (D) in complete CDM (cCDM) (circles), CDM lacking cysteine
(CDM) (squares), CDM lacking cysteine but containing homocysteine (CDM	HC) (triangles) and CDM lacking cysteine but containing
cystathionine (CDM	CTT) (diamonds). The mean OD600 values of triplicate culture samples are shown. Error bars indicate standard deviations
from the means.
FIG. 4. Analysis of key metabolites of the proposed cysteine
biosynthesis pathway. The H. pylori wild-type and cysK, metB,
and luxS mutant strains were grown in complete CDM (cCDM) in
triplicate and harvested after 24 h of incubation. Samples were
corrected for OD, and cell extracts were produced. Candidate me-
tabolites involved in the conversion of methionine to cysteine
through the RTSP were quantified individually. The fold change of
each metabolite was normalized to the level of the wild type unless
otherwise indicated (see below). Levels of metabolites that were
below the detection threshold were expressed as 0. SRH was de-
tected only in the luxSHp strain and was below the detection
threshold in the wild-type, cysKHp, and metBHp strains. There-
fore, the relative SRH level was expressed as 1 in the luxSHp strain
and as 0 in all other strains. Values given indicate activities derived
from triplicate cell extract samples of each H. pylori strain. Error
bars indicate standard deviations from the means.
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measured during this analysis, both amino acids were present
in excess in the growth medium (cCDM). As such, their rela-
tive levels were not seen to vary significantly between the
strains (data not shown).
For the luxSHp mutant, the first important finding was that
SRH was detectable in the cell extract whereas for the wild
type it was undetectable (Fig. 4). The other main differences
between the metabolite profiles of the luxSHp mutant and the
wild type were that HC and CTT were either undetectable or
virtually undetectable in the mutant (0% and 0.4% of wild-type
levels, respectively). This confirms that HC and CTT cannot be
synthesized in the absence of LuxSHp. Furthermore, the accu-
mulation of SRH confirms this to be the in vivo substrate of
LuxSHp.
For the cysKHp mutant, most strikingly, the levels of HC
were 11- to 12-fold greater than those in the wild type, sug-
gesting that this metabolite was accumulating in this strain.
Like the luxSHp mutant, the cysKHp mutant produced min-
imal levels of CTT. The latter observation confirms that
CysKHp is needed for the formation of CTT. The accumulation
of HC suggests that this is the substrate for the CysKHp reac-
tion. As an interesting aside, we found approximately 2-fold
more SAH in cell extracts from the cysKHp mutant than in
those from the wild type. This is discussed below.
Finally, in the metBHp mutant (unlike the case for all other
mutants), CTT was present and was at around 5-fold excess
relative to the level in the wild type, indicating that this me-
tabolite was accumulating in this strain. This suggests that CTT
is the substrate for the MetBHp reaction. Interestingly, HC was
also found to accumulate, although at a lesser level (2- to
3-fold), and, as for the cysKHp mutant, we saw around 2-fold
more SAH than in the wild-type extract. These findings may
indicate a weak feedback inhibition effect of CTT on CysKHp
and of homocysteine on PfsHp, the enzyme catalyzing the re-
action immediately prior to the LuxSHp reaction in the AMC.
Allosteric inhibition of metabolic enzymes by a downstream
metabolite(s) is recognized as a common means of regulation
of enzyme activity in prokaryotes; thus, these observations are
unsurprising.
Helicobacter pylori luxS is part of a three-gene cluster which
is of Gram-positive origin. Having demonstrated the metabolic
role of the cysK-metB-luxS gene cluster in H. pylori, we finally
turned our attention to its presence in other bacteria and to its
likely origin.
Analysis of the availableH. pylori genomes showed that in all
cases luxS is located downstream of the two other genes we
have examined, annotated as cysK and metB. cysKHp, metBHp,
and luxSHp lie in the same coding orientation. We found this
same arrangement of genes in Helicobacter acinonychis (re-
garded as the most closely related Helicobacter species to H.
pylori (7). However, in all other helicobacters and the related
Campylobacter jejuni and Wolinella succinogenes, this cluster
was absent, and homologues of cysK, metB, and luxS were
found in diverse genomic locations and were not adjacent to
one another.
Protein BLAST searches of CysKHp, MetBHp, and LuxSHp
revealed that their closest known homologues are found in
Enterococcus faecium, a Gram-positive organism (68%, 74%,
and 80% amino acid identities, respectively). Importantly, the
E. faecium genes exist as a cluster, with the genes lying in the
same order as in H. pylori/H. acinonychis. We conducted phy-
logenetic analyses using multiple amino acid sequence align-
ments of LuxS, CysK, and MetB from H. pylori, Helicobacter
hepaticus, Helicobacter cinaedi, Helicobacter bilis, Helicobacter
pullorum, Helicobacter canadensis, Helicobacter winghamensis,
Helicobacter acinonychis, W. succinogenes, C. jejuni, and E.
faecium. We also included candidate Gram-negative sequences
(E. coli) and two Gram-positive sequences, LuxS, MetB, and
CysK from Staphylococcus aureus and LuxS, MccA/YrhA, and
MccB/YrhB from Bacillus subtilis. We reconstructed phylog-
enies using sequences derived from the housekeeping gene
product, RecA, from all 14 organisms. Phylogenetic trees were
constructed using neighbor joining methods and are shown in
Fig. 5.
We found that with the housekeeping gene product RecA,
as expected, the helicobacters all occupy the same cluster,
which also contains the W. succinogenes sequence. Also as
expected, the C. jejuni sequence associates with this cluster but
is found to be isolated. The Gram-positive representatives
group together, and the E. coli sequence forms an independent
outgroup. We repeated this analysis with a further 7 house-
keeping gene products (encoded by aroE, atpA, efp, engA,
gapA, gyrA, and mutY), which all gave qualitatively similar
results, with all of the helicobacter sequences clustering to-
gether and the Gram-positive sequences forming separate
groups (data not shown). Conversely, with CysK, MetB, and
LuxS, theH. pylori andH. acinonychis sequences grouped more
closely with the Gram-positive sequences than with those of
the other Helicobacter species or species shown to be more
closely related to Helicobacter species by other phylogenetic
methods (7, 14).
These data suggest that in H. pylori, the three-gene cluster
cysK-metB-luxS exists as a conserved syntenic locus that was
acquired by horizontal gene transfer from a Gram-positive,
enterococcal bacterium after the division of H. pylori/H. aci-
nonychis from the other Helicobacter species but before their
division from each other.
DISCUSSION
LuxS is now generally understood to carry out at least two
functions, one in metabolism and one in cell-cell signaling (3,
8, 32, 44, 48). Bacterial signaling systems based on LuxS-gen-
erated AI-2 are known to regulate gene expression in several
members of the Enterobacteriales (23, 50), notably Vibrio spe-
cies. Many other bacteria also possess luxS homologues and
produce AI-2 but appear to lack an AI-2 sensory apparatus
(i.e., LuxP/Q and the Lsr system, respectively) (32), in agree-
ment with suggestions that in most species luxS fulfils primarily
a metabolic role in the AMC (32, 47–49).
In this context, H. pylori presents an interesting case: al-
though lacking homologues for the identified AI-2 receptors,
the bacterium is known to respond to exogenously added,
synthetic AI-2 (30), pointing toward a role of LuxS in cell-cell
signaling. On the other hand, Lee and coworkers (2006) pro-
posed that the reduced in vivo fitness observed for an H. pylori
SS1luxS mutant was caused by metabolic disturbances, pos-
sibly by a disruption of the metabolic flux through the AMC or
other LuxS-dependent pathways (20). Interestingly, previous
physiological work (26, 27, 31) and genome analyses have re-
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vealed that the AMC in H. pylori is incomplete, since the
organism is a methionine auxotroph that lacks the genes re-
quired for methylation of homocysteine (metE or metH) (10,
28, 41). This made us question whether LuxS in H. pylori had
any metabolic roles apart from generating AI-2 and if so, what
these roles could be.
Intriguingly, in all currently sequenced H. pylori strains, luxS
is part of a three-gene cluster that in addition to luxS contains
two other genes with putative functions in methionine and
cysteine metabolism (Fig. 2A). These genes, currently anno-
tated as metB and cysK, until now have been proposed to
encode cystathionine -synthase and cysteine synthase, respec-
tively (10). The gene cluster (cysK, metB, and luxS) is not only
conserved among H. pylori strains and H. acinonychis but also
is present in several Gram-positive bacteria (49), suggesting
that metBHp and cysKHp are not evolutionary relics of now-
inactive metabolic pathways but still fulfil a metabolic function
linked to that of luxSHp.
Our hypothesis that the cysK-metB-luxS cluster is responsi-
ble for cysteine formation was based on several considerations.
First, all H. pylori strains studied by Reynolds and Penn (1994)
and the vast majority of strains characterized by Nedenskov
(1994) were able to grow without cysteine (27, 31). Since the
organism is not capable of using sulfate as a sulfur source (10),
a hitherto-unidentified pathway must exist that makes use of
the reduced sulfur present in methionine to generate cysteine.
Second, the metabolic fate of the homocysteine generated in
the LuxS reaction is unclear. High concentrations of homocys-
teine are toxic in some organisms (33, 43). Third, only two
enzymatic steps are required to convert homocysteine to cys-
FIG. 5. Neighbor-joining phylogenetic trees based on comparison of LuxS, MetB, CysK, and the housekeeping gene product RecA from
Helicobacter pylori and other species. Primary amino acid sequences of proteins from H. pylori and their closest homologues from selected other
species were aligned using the ClustalW algorithm and Bioedit (13). These alignments were used to derive phylogenies based on neighbor-joining
methods using the Mega4 suite of programs (40). Bootstrap values were generated based on 1,000 replicates of each calculation (consensus
bootstrap trees had identical topologies). Dendrograms were produced indicating evolutionary relationships between the amino acid sequences of
CysK, MetB, LuxS, and RecA.
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teine in the so-called reverse transsulfuration pathway (RTSP)
present in some bacteria (for example, in B. subtilis and
Pseudomonas putida), where part of the AMC, including LuxS,
is known to contribute to methionine-to-cysteine conversion by
generating the required homocysteine (16, 45). In addition, the
genes in the B. subtilis cluster that show similarity to cysKHp
and metBHp have recently been shown to encode functional
cystathionine -synthase and cystathionine -lyase, respec-
tively, and have therefore been renamed MccA and MccB
(methionine-to-cysteine-conversion genes) (16).
The results of our study are straightforward and in full
agreement with the above hypothesis. First, we were able to
demonstrate that all genes of the cysK-metB-luxS cluster in H.
pylori (in both 11637 and J99) are required for cysteine prot-
otrophy: mutation of any one of these genes rendered the
respective strain auxotrophic for cysteine. Chemical comple-
mentation restored the growth of all mutants and also indi-
cated a sequential order for the involved enzymatic activities,
which is LuxS-CysK-MetB. Our results suggested that the true
physiological function of the cysKHp gene product lies in the
conversion of homocysteine to cystathionine; the latter is then
used by MetBHp to generate cysteine. This interpretation was
further corroborated and extended by metabolite profiling. In
full agreement with the proposed metabolic functions, the me-
tabolite pools of luxSHp mutants showed accumulation of
SRH and depletion of both homocysteine and cystathionine,
whereas cysKHp mutants accumulated homocysteine and
were depleted for cystathionine. metBHp mutants were the
only strains that accumulated cystathionine. Thus, it appears
that an RTSP is operational in H. pylori.
To unequivocally establish the nature of the reactions that
link homocysteine with cysteine in H. pylori will require puri-
fication and detailed characterization of CysKHp and MetBHp.
The latter enzyme has already been studied, but not with re-
spect to its physiological function. Kong et al. (18) cloned the
respective gene from H. pylori SS1 and purified the recombi-
nant protein. However, the enzymatic activity of MetBHp was
measured only using an unphysiological side reaction that is
observed for some enzymes in vitro in the presence of O-acetyl-
serine and in the absence of other substrates (18). Thus, the
true physiological role of MetBHp remained unclear. With
regard to CysKHp, a similar enzyme from Lactobacillus casei,
also annotated CysK, has recently been proposed to act as a
cystathionine -synthase, converting homocysteine to cystathi-
onine (17). CysKHp has up to now been thought to act as a
cysteine synthase that uses sulfide to generate cysteine (10).
However, our finding that sulfide cannot support growth of H.
pylori in the absence of cysteine, at least under our conditions,
suggests that CysKHp is solely dedicated to homocysteine con-
version. Thus, CysKHp appears to be a cystathionine -syn-
thase, and MetBHp appears to be a cystathionine -lyase. We
therefore suggest that the genes encoding these proteins be
renamed. Specifically, we suggest that cysKHp be renamed
mccA (methionine-to-cysteine-conversion gene A) and that
metBHp be renamed mccB.
The relevance of the established cysteine biosynthesis path-
way for the lifestyle, fitness, and virulence of H. pylori is not
clear. The reduced in vivo fitness observed for the H. pylori SS1
luxS mutant (20) may indeed be linked to its inability to con-
vert methionine to cysteine, although a role of AI-2 cannot be
excluded. H. pylori and other members of this genus have lost
the ability to reduce sulfate (10; our unpublished data). How-
ever, it can be assumed that they are well adapted to their
specific habitats, which therefore must provide sufficient re-
duced sulfur sources for these organisms to thrive. Presumably,
the conversion of homocysteine to cysteine removes a poten-
tially toxic metabolite and at the same time reduces the (en-
ergetically costly) need for cysteine uptake. On the other hand,
a similar effect would have been achieved had the organism
maintained a functional AMC.
Whatever the selective advantage gained, our genome com-
parisons revealed that the entire cysK-metB-luxS cluster was
obtained by horizontal gene transfer from a Gram-positive
bacterium closely related to E. faecium. Several previous anal-
yses already established the Gram-positive origin of luxSHp but
did not consider the remaining genes of the cluster (21). In-
terestingly, similar clusters exist in a number of Gram-positive
species (49), for instance, Oceanobacillus iheyensis, Clostridium
perfringens, and Clostridium botulinum. Intriguingly, in some
Bacillus species, notably B. subtilis, Bacillus cereus, and Bacillus
anthracis, similar clusters contain the pfs gene instead of luxS.
It thus appears that during the course of evolution, the com-
mon ancestor of H. pylori and H. acinonychis has lost its native
luxS gene and instead acquired a Gram-positive homologue
together with the ability to generate cysteine.
Finally, we would point out that in the absence of exogenous
cysteine, growth of H. pylori will be limited by its capacity to
generate this compound from homocysteine. Homocysteine
availability, in turn, is determined by the number of methyl-
ation reactions carried out by the cells (i.e., the number of
SAM molecules that can be converted to SAH and then fur-
ther to homocysteine via the action of Pfs and LuxS; see Fig.
1). Under these conditions, generation of the quorum-sensing
products comprising AI-2, at least in theory, is directly propor-
tional to growth of the population, and the resulting AI-2
concentration should thus provide a very accurate measure of
population density. It is now important to determine whether
the other phenotypes associated with luxS mutagenesis in H.
pylori are dependent on the homocysteine biosynthesis role of
LuxS or its role as the AI-2 synthase.
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Abstract
Background: LuxS may function as a metabolic enzyme or as the synthase of a quorum sensing signalling
molecule, auto-inducer-2 (AI-2); hence, the mechanism underlying phenotypic changes upon luxS inactivation is
not always clear. In Helicobacter pylori, we have recently shown that, rather than functioning in recycling
methionine as in most bacteria, LuxS (along with newly-characterised MccA and MccB), synthesises cysteine via
reverse transsulphuration. In this study, we investigated whether and how LuxS controls motility of H. pylori,
specifically if it has its effects via luxS-required cysteine metabolism or via AI-2 synthesis only.
Results: We report that disruption of luxS renders H. pylori non-motile in soft agar and by microscopy, whereas
disruption of mccAHp or mccBHp (other genes in the cysteine provision pathway) does not, implying that the lost
phenotype is not due to disrupted cysteine provision. The motility defect of the ∆luxSHp mutant was
complemented genetically by luxSHp and also by addition of in vitro synthesised AI-2 or 4, 5-dihydroxy-2,
3-pentanedione (DPD, the precursor of AI-2). In contrast, exogenously added cysteine could not restore motility to
the ∆luxSHp mutant, confirming that AI-2 synthesis, but not the metabolic effect of LuxS was important. Microscopy
showed reduced number and length of flagella in the ∆luxSHp mutant. Immunoblotting identified decreased levels
of FlaA and FlgE but not FlaB in the ∆luxSHp mutant, and RT-PCR showed that the expression of flaA, flgE, motA,
motB, flhA and fliI but not flaB was reduced. Addition of DPD but not cysteine to the ∆luxSHp mutant restored
flagellar gene transcription, and the number and length of flagella.
Conclusions: Our data show that as well as being a metabolic enzyme, H. pylori LuxS has an alternative role in
regulation of motility by modulating flagellar transcripts and flagellar biosynthesis through production of the
signalling molecule AI-2.
Background
Many bacteria release extra-cellular signalling molecules
(auto-inducers) to perform intercellular communication.
It is generally assumed that auto-inducers are employed
to regulate aspects of bacterial behaviour in response to
cell population density (so-called quorum sensing). This
includes changes in the expression of genes crucial for
bacterial survival or virulence [1,2]. Auto-inducer-2
(AI-2) production is widespread among bacterial species;
its formation is catalysed by the enzyme LuxS [3]. Many
Gram-positive and Gram-negative bacterial species pos-
sess LuxS, and in some it has been shown to catalyse
AI-2 production and to control quorum sensing (QS).
Good examples include Vibrio harveyi and Vibrio
cholera, where AI-2 has been shown to regulate density-
dependent bioluminescence and virulence factor produc-
tion, respectively [4,5]. luxS inactivation has also been
shown to cause phenotypic alterations such as biofilm
formation, changes in motility, toxin production, and
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reduced colonisation in various experimental infection
models [3,6].
In addition to its QS role, LuxS catalyses one of the
steps of the activated methyl cycle (AMC). The AMC is
a central metabolic pathway that generates the S-adeno-
sylmethionine (SAM) required by methyltransferases
allowing the widespread methylation of proteins and
DNA needed for cell function. It recycles the toxic pro-
duct of these reactions, S-adenosylhomocysteine (SAH),
to help provide the cell with sulphur-containing amino
acids [7]. As part of the AMC, the Pfs enzyme,
5’-methylthioadenosine nucleosidase/S-adenosylhomo-
cysteine nucleosidase converts SAH to S-ribosylhomo-
cysteine (SRH) which is subsequently converted
to homocysteine by LuxS. The precursor of AI-2, 4, 5-
dihydroxy-2, 3-pentanedione (DPD) is generated as a
by-product of this reaction. Through a process of dehy-
dration and spontaneous cyclisation, some or all of the
DPD is rearranged into a cocktail of chemically related
molecules known as AI-2, including 4-hydroxy-5-
methyl-3 (2H) furanone, (2R, 4S) -2-methyl-2, 3, 3,
4-tetrahydroxy-tetrahydrofuran and furanosyl borate die-
ster. These have been shown to function as signals of
communication between bacteria [3,8,9]. In some organ-
isms, the AMC is different. For example, in Pseudomo-
nas aeruginosa, LuxS and Pfs are replaced by a single
enzyme (SAH hydrolase) which converts SAH to homo-
cysteine in a one step reaction without the concomitant
production of DPD [7].
Helicobacter pylori, a Gram-negative bacterium which
causes peptic ulceration, gastric cancer and gastric
mucosa-associated lymphoid tissue (MALT) lymphoma,
contains a luxS homologue and produces AI-2 [10-12].
luxSHp (HP010526695; JHP0097J99) is positioned next to
housekeeping genes mccAHp (HP010726695; JHP0099J99)
and mccBHp (HP010626695; JHP0098J99) on the H. pylori
chromosome, in a putative operon [13-15]. Data from
our laboratory have demonstrated that the AMC of
H. pylori is incomplete, and that LuxSHp, MccAHp and
MccBHp constitute the sole cysteine biosynthetic path-
way in this bacterium via a reverse transsulphuration
pathway (RTSP) [15].
To date, the mechanisms underlying phenotypic changes
exhibited as a result of luxSHp inactivation remain elusive.
Two ∆luxSHp mutants have been shown to form biofilms
more efficiently than the parent strain, indicating a possi-
ble but counterintuitive role of luxSHp in biofilm reduction
[16]. A subsequent study demonstrated that ∆luxSHp
mutants in two strains lost growth-phase-dependent regu-
lation of the gene encoding the major flagellin FlaA, and
that cell culture supernatant containing AI-2 could
increase flaA transcription [17]. Studies by two indepen-
dent groups looked at fitness of ∆luxSHp mutants in vivo
using mouse and gerbil models, respectively [18,19]. The
motility of ∆luxSHp mutants was diminished and bacterial
fitness reduced in co-infection experiments. Restoration of
luxSHp by genetic complementation partially restored
these phenotypes [18,19]. The authors argued that the
decreased fitness in the ∆luxSHp mutant was most likely
due to the disruption of the cycle of SRH consumption
and homocysteine synthesis and that AI-2 seemed unlikely
to be a QS signal molecule [18]. More recently however,
Rader et al. reported that luxSHp disruption affected flagel-
lar morphology in the absence of one of the transcriptional
regulators (s28, flgS or flgM), and that this could be com-
plemented upon the addition of DPD. They reported that
loss of luxSHp caused decreased transcription of the flagel-
lar regulator flhA, and that expression of flhA was induced
by DPD [20]. This complementation through the addition
of exogenous DPD resurrected the possibility of LuxS-
dependent signalling in H. pylori.
There are several possible mechanisms whereby a
motility defect could be associated with loss of luxSHp.
Firstly, reduced flagellar structural gene transcription
and related protein synthesis would lead to loss of fla-
gella. Secondly, normal flagella structures may be
synthesised in the ∆luxS mutant but lack of a functional
motor may prevent rotation. Thirdly, both motor and
flagellum may be functional, but unable to respond to
tactic signals, leading to aimless movement.
In this study, we set out to distinguish between the
mechanisms underlying the alteration in motility of
∆luxSHp mutants, and to clarify whether this originated
from a disruption of metabolism or QS. To do this,
electron microscopy was employed to examine flagellar
assembly and the levels of individual components of fla-
gella were assessed at a transcriptional and translational
level. Our demonstration here of the lack of motility
defects in mutants disrupted in components of the
RTSP other than LuxS, coupled to the inability of
cysteine to complement the motility defect of the
∆luxSHp mutant, shows that disruption of cysteine bio-
synthesis is not the mechanism underlying the reduction
in motility. In contrast, we show that exogenously added
AI-2 (or DPD) influences motility via regulating flagellar
gene transcription (and thus the number and length of
flagella). This supports the existence of an additional
role for LuxS in H. pylori as a signalling molecule
synthase.
Methods
Strains and growth culture conditions
All strains used in this study are listed in Table 1. DH5a
was used in the production of proteins needed for AI-2
biosynthesis and cloning [21]. V. harveyi BB170 was
used in the bioluminescence bioassay as a reporter
strain [22]. E. coli strains were routinely grown in Luria-
Bertani (LB) (Bacto) broth or on agar plates at 37°C.
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V. harveyi was grown in LB or AB medium [23] at 30°C,
also under normal atmospheric conditions. H. pylori
strains were routinely grown and maintained on Colum-
bia blood agar plates (No.2, with 5% [v/v] horse blood;
Oxoid) or grown in Brucella broth (BB) (Bacto) contain-
ing 7% (v/v) fetal bovine serum (Gibco). H. pylori J99
was incubated at 37 °C for 24 h to 72 h as required in a
MG500 VAIN-cabinet (Don Whitley Scientific) in an
atmosphere of 5% CO2, 86% N2, and 6% O2 (all v/v).
For motility experiments the method of Wand et al.
[24] was used to achieve motile cultures for analysis, see
below. Antibiotics were used at the following concentra-
tions: ampicillin at 100 μg/ml, kanamycin at 30 μg/ml.
Molecular biology methods
Preparation of plasmid DNA, DNA ligation, gel electro-
phoresis and transformation of E. coli strains were per-
formed in accordance with standard methods [25]. All
PCRs were performed with Taq DNA polymerase
(Roche Diagnostics, Lewes, UK). TA cloning was carried
out using the pGEM-T vector system (Promega, Madi-
son, WI). Plasmid DNA was extracted using the
QIAquick spin miniprep kit (QIAGEN, UK). DNA frag-
ments were purified from agarose gel using a QIAquick
gel extraction kit (QIAquick, UK) according to the man-
ufacturer’s instruction. H. pylori genomic DNA was iso-
lated as described previously [26]. DNA sequencing was
conducted using standard fluorescent dye terminator
chemistries, and analysis performed using the Applied
Biosystems 3730 DNA Analyzer system (Geneservice,
Cambridge, UK, Applied Biosystems Inc, Foster City,
CA.). Results were analysed using the Bioedit software
suite [27].
Construction of the complemented ∆luxS+ strain
H. pylori J99 wild-type was transformed with the plasmid
pGEMTluxSXN396 containing a km-sacB construct
encoding kanamycin resistance (Kmr) and (5%) sucrose
sensitivity (Sucs) [17]. Disruption of the chromosomal luxS
gene was accomplished by natural transformation, allelic
exchange, and screening for kanamycin-resistance as pre-
viously described [15], resulting in the J99 ∆luxS mutant
strain. The presence of the km-sacB cassette was verified
by amplifying fragments of H. pylori chromosomal DNA
Table 1 Strains and plasmids used in this study
Strains/Plasmids Description Reference
Strains
Vibrio harveyi
BB170 luxN :: Tn5 AI-1 sensor negative; AI-2 sensor positive [43]
Escherichia coli
DH5a endA1 recA1 gyrA96 thi-1 hsdR17(rk
- mk
+) relA1 supE44∆(lacZYA-argF) U169 F- F80dlacZ∆M15 deoA phoA l- [21]
DH5a LuxS DH5a containing the plasmid pProEx-luxSEC [8]
DH5a Pfs DH5a containing the plasmid pProEx HT mtan [8]
Helicobacter pylori
J99 (ATCC700824) Wild-type motile strain [44]
J99 ∆luxS J99 derivative; ∆luxS :: km; Kmr [15]
J99∆luxS-F J99 derivative; ∆luxS :: km-sacB; Kmr Sucs This study
J99 ∆luxS+ J99∆luxS-F derivative; ∆luxS :: km-sacB replaced with original luxS locus; Sucr Kms This study
J99 ∆mccA J99 derivative; ∆mccA :: km; Kmr [15]
J99 ∆mccB J99 derivative; ∆mccB :: km; Kmr [15]
J99 ∆flhB J99 derivative; ∆HP0770 Lys13 to Glu347; Kmr; non-motile [24]
CCUG 17874* Wild-type strain [29]
17874 ∆flaA 17874 derivative; ∆flaA :: cat; Cmr Paul O’Toole
17874 ∆flgE 17874 derivative; ∆flgE :: km; Kmr [30]
Plasmids
pGEMT Commercial TA cloning vector; Ampr Promega
pGEMTluxSXN396 pGEM-T with inserted 26695 luxS; ∆luxS :: km-sacB; Sucs Kmr [17]
pGEMTluxS pGEM-T with inserted full-length luxS fragment This study
pProEx-luxSEC pProEX HT containing the luxS gene of E. coli MG1655 [8]
pProEx HT mtan PProEX HT containing the pfs gene of E. coli [8]
* CCUG 17874 is identical to the type strain NCTC 11637, isolated by B. J. Marshall at Royal Perth Hospital, May 1982 [29].
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using primers luxS-F/luxS-R (forward, 5’>GTG GCT TTA
GCG GGA TGT TTT<3’; reverse, 5’>GCGA ACA AAT
CCC CGC TG<3’) and DNA sequencing. The J99 ∆luxS
was then transformed with plasmid pGEMTluxS (encod-
ing wild-type luxS), and transformants in which km-sacB
had been replaced with the introduced original luxS locus
were selected for sucrose resistance on medium containing
5% sucrose and screened for kanamycin sensitivity. The
presence of the original luxS gene was verified by amplify-
ing fragments on H. pylori chromosomal DNA using pri-
mers luxS-F/luxS-R and DNA sequencing.
Bacterial growth curves and V. harveyi bioluminescence
assay
Bacterial broth cultures were started from a blood agar
plate culture, diluted to an OD600 nm of 0.05 in fresh BB
medium, and grown at 37°C in a VAIN-cabinet with
shaking. OD600 nm measurements were taken at the 6 h,
24 h, 48 h and 72 h time points, and at the same time
cell suspensions were harvested and filtered through a
0.2 μm pore size filter. The AI-2 activity in cell free
supernatants (CFS) was tested as previously described
using the V. harveyi reporter strain BB170 [9,22]. Briefly,
an overnight V. harveyi culture was diluted 1:2500 in
fresh AB medium [23]. CFS samples were diluted 1:10
in the AB medium containing BB170 into the 96 well
bioluminescence plates to give a final volume of 200 μl
and were incubated at 30°C. The bioluminescence and
optical density were determined at 30 min intervals for
at least 8 h using a luminometer (Anthos Labtech
LUCY 1.0). AI-2 activity alterations in bioluminescence
were expressed as induction (n-fold) over the negative
control.
Motility assay
Plate motility assay of H. pylori was performed in Bru-
cella broth medium (BD Biosciences), supplemented
with 7% (v/v) fetal bovine serum (Gibco), 0.35%-0.45%
(w/v) agar (No.1, Oxoid) and the indicator, 40 μg/ml tri-
phenyl tetrazolium chloride (Sigma, UK). Inclusion of
this indicator made it easier to see the small recombi-
nant colonies. Plates were seeded with 5 μl H. pylori
liquid culture (forming a circle with 3 mm diameter)
standardised to an OD600 nm of 1.0 and were incubated
at 37°C for up to 7 days under the conditions described
above. The motility halos were recorded using a digital
camera and the area of each halo was measured using a
GS-800 Calibrated Densitometer (Biorad).
Motility analysis was also carried out by direct obser-
vation under phase-contrast microscopy using a Nikon
Eclipse E600 after cells were grown in co-culture condi-
tions as used by Wand et al. [24]. Briefly, co-cultures of
H. pylori-human gastric adenocarcinoma (AGS) cells
were prepared (described below). After 24 h, 10 μl
culture was placed onto a microscope slide and covered
with a coverslip and freely-motile H. pylori cells were
analysed under the microscope.
Plate motility bioassay using chemically defined
media (CDM)
The liquid chemically defined media were prepared as
previously described [15,28]. 60 ml of sterile chemically
defined media were added to 40 ml of molten 1% Oxoid
No. 1 agar base to make 0.4% semi-solid chemically
defined agar. Cysteine supplemented plates (CSP) were
made by adding cysteine to the molten agar, shortly
before it set. The final concentration of cysteine was
1.0 mM, which was non-limiting for H. pylori growth.
The centre of each plate was seeded with one-day incu-
bated H. pylori cells and was incubated for 5 days under
the conditions described above. The motility halos were
recorded using a digital camera and the area of each
halo was measured using a GS-800 Calibrated Densit-
ometer (Biorad).
Motility assay with AI-2 complementation
AI-2 was synthesised enzymatically as described pre-
viously using purified proteins LuxSE. coli and PfsE. coli
[8]. For complementation of the ∆luxSHp motility phe-
notype, soft motility agar plates (0.4% w/v) were made
as previously described. Bioluminescence activity of the
AI-2 product was quantified using the V. harveyi bioas-
say and compared to CFS from H. pylori wild-type
broth culture standardised to an OD600 nm of 1.0 at the
time point in the growth curve that maximal AI-2 activ-
ity was measured. 1/400 diluted in vitro synthesised
AI-2 product shows the same level of bioluminescence
as seen in the H. pylori wild-type CFS in the V. harveyi
bioassay. Therefore, in the complementation experiment
AI-2 was added to motility plates to a final concentra-
tion of 0.25% (v/v). 24 h H. pylori cultures were seeded
individually onto the centre of each motility plate and
incubated for 5 days. The area of outward migration
was recorded with a digital camera and measured using
a GS-800 Calibrated Densitometer (Biorad).
Tissue culture and bacterial co-culture
All chemicals were obtained from Gibco, UK. AGS cells
were grown in nutrient mixture Ham’s F-12 supplemen-
ted with L-glutamine (200 mM) and fetal bovine serum
(Gibco) (10% v/v) in a 37°C incubator containing 5%
CO2. After cells had grown to confluency, a 1 in 5 or 1
in 8 dilution was added to a 75 cm2 flask containing
fresh media mix and incubated in the same conditions
as before to allow cells to re-grow to confluency.
AGS cells were counted using the trypan (0.35% v/v)
blue dye method. Cells were seeded at a density of 1 × 105
cells/ml into 6 well plates and grown to 80% confluency.
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The cell-media mix was removed and replaced with 2 ml
fresh F-12 media. Plates were inoculated with 24 h
H. pylori liquid cultures standardised to an OD600 nm of
0.1 and incubated for one day in a microaerobic environ-
ment. Bacterial cells were then analysed using a phase-
contrast Nikon Eclipse E600 microscope and electron
microscopy.
Electron microscopy (EM)
H. pylori cells were pre-grown as described above for
motility analysis. 15 μl of culture was allowed to settle
on a carbon formvar grid (Agar Scientific) for 1 min.
The suspension was removed and the grid washed by
addition of 15 μl of Phosphate Buffered Saline (PBS) for
an additional minute. This was removed and the cells
stained with 0.5% Phospho-tungstic acid (PTA) pH 7.0
for 1 min. Grids were examined and pictures taken
using a JEOL JEM1010 Transmission Electron Micro-
scope. We quantified changes, rounding to the nearest
5% and quote means ± SD. Essentially, three groups of
H. pylori cell samples prepared on different dates were
examined. Each group of samples contained wild-type,
∆luxS and ∆luxS+ cells treated and not treated with
DPD. For each group, 100 H. pylori cells from each cul-
ture sample were examined.
Cysteine and DPD complementation experiments
Cysteine from Sigma products was dissolved in distilled
water according to the manufacturer’s recommendation.
Synthetic DPD was purchased from Omm Scientific Inc.
DPD (AI-2) activity was quantified with the biolumines-
cence bioassay and compared to wild-type H. pylori
grown to an OD600 nm of 1.0, at which maximal AI-2
activity was obtained. To test for complementation of
motility, DPD (at a physiological concentration of 150
μM) and non-limiting cysteine (1.0 mM) were added
individually to bacteria-AGS cell co-cultures. DPD was
added after 10 h of incubation and once again after 18 h
of incubation. Cysteine was added from the beginning of
incubation. Bacterial motility and cells were observed
and visualized by phase-contrast microscope and EM,
respectively. For gene transcription studies, DPD
(150 μM) and cysteine (1.0 mM) were also added (in the
same way) individually to H. pylori liquid cultures of dif-
ferent genotypes. After 24 h, RNA was extracted and the
transcript levels of genes of interest were measured.
Protein electrophoresis and western blotting
H. pylori wild-type, its ∆luxSHp mutant, the complemen-
ted ∆luxSHp
+ mutant and controls (H. pylori wild-type
17874 [29], and derived mutants ∆flaA (a kind gift from
Paul O’Toole) and ∆flgE [30]) were grown in Brucella
broth at 37°C for up to 24 h, at which point high levels
of AI-2 activity were detected. To exclude global
differences in protein production between strains, we
corrected our loading for numbers of bacteria rather
than for total protein levels. To do this, 24 h liquid
(Brucella broth) culture of each strain was adjusted to
OD600 nm of 1.0. A 500 μl cell sample of each strain was
then centrifuged at 5500 rpm for 1 min. Culture super-
natants were removed and cell pellets were fully resus-
pended in 1 ml sterile PBS. 100 μl protein sample was
collected. The same volume of 2 × sample buffer was
added and boiled for 10 min. SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and subsequent immuno-
blotting were carried out as described previously under
standard conditions [25]. The gel contained 10% acryla-
mide. 4 μl protein stock from each strain sample was
loaded into each well of the SDS-PAGE gel. For immu-
noblotting, proteins were transferred from SDS-PAGE
gels to nitrocellulose paper by the methanol Tris-glycine
system described by Towbin et al. [31]. To see whether
similar amounts of protein were loaded using our meth-
odology, membranes were inspected following Ponceau
red staining prior to immunoblotting; protein levels
appeared similar on each membrane by inspection. The
blots were incubated with rabbit polyclonal antibodies
against H. pylori flagellin and hook protein (a generous
gift from Paul O’Toole) [32]. Bound antibodies were
detected using secondary anti-rabbit IgG alkaline phos-
phatase conjugate antibody (Sigma, UK). The blots were
developed using the BCIP/NBT substrate system (Dako,
UK). The quantitative scan of the protein bands was
performed using a GS-800 Calibrated Densitometer
(Biorad). The reflective density (RD) of each protein
band was measured using the Quantity One 4.6.5 soft-
ware (Biorad).
RNA extraction and transcription analysis
RNA was isolated from H. pylori cells grown in BB
medium for 24 h. Cultures were treated with RNA pro-
tection reagent (QIAGEN, UK) and RNA was extracted
using RNeasy mini kit (QIAGEN, UK). Contaminating
genomic DNA was removed using a DNA free kit
(Ambion). Synthesis of cDNA was performed using
Ominiscript RT kit (QIAGEN, UK) and random hexam-
ers (Roche, Germany). Quantitation of transcripts of
selected genes of interest was accomplished by quantita-
tive reverse transcription-PCRs (qRT-PCRs) using
Rotor-gene 3000. Primers utilised in RT-PCRs are listed
in Table 2. All RT-PCR reaction mixtures contained
12.5 μl of SYBR Green Mix (QIAGEN, UK), 5 μl of
gene specific primers, 2 μl cDNA template (cDNA was
diluted 10-fold prior to adding into the RT-PCR reac-
tions) and RNase free water to a final volume of 25 μl.
The amplification program was 95°C for 15 min,
followed by 35 cycles of 95°C for 15 sec, 56°C for
60 sec, and 72°C for 30 sec. All samples, including the
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controls (16 S rRNA and no-template), were run in tri-
plicate. Transcript levels of each gene were normalised
to the 16 S rRNA in each sample. The relative quantity
of transcription of each gene was obtained using Pfaffl’s
analytical methodology.
Statistics
Statistical analysis was by Student’s t test.
Results
The H. pylori ∆luxS mutant lost the ability to produce
AI-2 while the wild-type, ∆mccAHp and ∆mccBHp mutants
did not
Our previous study has demonstrated that luxSHp,
mccAHp and mccBHp genes comprise a reverse transul-
phuration pathway in H. pylori, which is the sole
cysteine biosynthesis pathway [15]. We then wanted to
determine whether these mutants in a motile strain of
H. pylori, J99, would be useful in differentiating whether
H. pylori motility was affected by luxS associated AI-2
production or by cysteine provision. Firstly, we needed
to establish whether mutations in mccHp genes in our
candidate motile strain J99 changed expression of
luxSHp and AI-2 biosynthesis. To do this, H. pylori J99
wild-type and derived ∆mccAHp, ∆mccBHp, and ∆luxSHp
mutants were grown in Brucella broth containing serum
(10% v/v). Once they reached logarithmic growth phase,
AI-2 activity in the culture supernatant was measured
using the V. harveyi AI-2 bioassay previously described
[4,8]. As expected, the wild-type produced AI-2 in a
growth dependent manner, with AI-2 accumulating dur-
ing the late logarithmic phase, and reaching maximal
levels in the stationary phase. During stationary phase,
AI-2 levels decreased and were almost undetectable by
72 h. Similar data were obtained with ∆mccAHp and
∆mccBHp mutants, despite the fact that the ∆mccBHp
mutant grew slightly less well than the other mutants
and the wild-type. The ∆luxSHp mutant, unlike the wild-
type and the other two mutants, yielded almost unde-
tectable levels of bioluminescence at each time point,
indicating that the production of AI-2 is luxSHp-depen-
dent and that insertion of a kanamycin cassette (aphA3)
into mccAHp and mccBHp did not affect expression of
the downstream gene luxSHp (Figure. 1A).
Deletion of luxSHp abolishes motility while the ∆mccAHp
and ∆mccBHp mutants remained motile
To investigate whether motility of H. pylori was affected
by cysteine biosynthesis, we first compared the motility
of H. pylori wild-type with ∆luxSHp, ∆mccAHp and
∆mccBHp mutants. To do this, a 24 h liquid culture of
each strain was spotted onto each quarter of a semi-
solid agar plate and incubated for up to 7 days. The
resulting motility halo areas were quantified after 3, 5
and 7 days of incubation. Halo areas that surrounded
the wild-type, ∆mccAHp and ∆mccBHp strains kept
increasing during continuous incubation, although the
∆mccAHp strain was slightly delayed in comparison to
the others. After 7 days of culture, the ∆luxSHp mutant
remained almost non-motile and produced a signifi-
cantly (p < 0.001) reduced motility halo compared to
wild-type, ∆mccAHp and ∆mccBHp strains in 3 indepen-
dent repeat experiments (Figure. 1B). After 7 days, the
wild-type, ∆mccAHp and ∆mccBHp mutants produced
halos of (mean ± SD) 8.5 ± 0.6 mm, n = 4; 5.6 ± 0.9
mm, n = 4; and 7.8 ± 0.6 mm, n = 4 increases in dia-
meter, respectively, all significantly greater than the
∆luxSHp mutant which produced a halo size of 1.1 ± 0.1
mm, n = 4. These results revealed that the reduction in
motility was likely a result peculiar to luxSHp mutation
rather than due to disruption of cysteine biosynthesis.
Genetic complementation or exogenous AI-2 can restore
the motility defect of the ∆luxSHp mutant, but exogenous
cysteine addition cannot
To rule out the possibility that second site mutations in
the ∆luxSHp mutant were inhibiting motility, genetic
complementation was performed to create the ∆luxSHp
+
strain (see Materials and Methods). The non-motile
∆flhB mutant was used as a negative control [24]. 24 h
cultures of wild-type, ∆luxSHp, ∆luxSHp
+ and ∆flhBHp
strains grown in Brucella broth were individually spotted
onto normal motility plates. After 5 days of incubation,
the mean halo diameter of the ∆luxSHp
+ strain was
6.9 ± 0.2 mm, n = 4, which was slightly larger than that
of the wild-type (4.7 ± 0.7 mm, n = 4). The ∆luxSHp
Table 2 Primers utilised in quantitative RT-PCR
Primers Sequence (5’-3’)
16S_F CGA TGA AGC TTC TAG CTT GC
16S_R ATA GGA CAT AGG CTG ATC TC
flaAF CAG GTT CGT ATC GCT ACA GGC
flaAR ATC ACT TCT GCT AAC ACG CCG
flaBF ACT GGG ATT GGG GCG TTA
flaBR TCA ACC TCC CGTCAG CGT C
flgEF GCT CAG GCA CGA TCA CTC TAA
flgER AAC GCC ATG AAA GGT CTT AAT AC
flhAF TCA TTG GAG GGT TTT TAG TGG
flhAR GGT GCG AGT GGC GAC AAT
motAF TGA GTT TAG AGG GGC GAG TG
motAR CCA GTA ATG AGC GGC ACC
motBF TTC AGG GAA AGA AGA AGA GCA A
motBR TCA AAC AGC AAA CTA GAG AAA A
fliIF ACG AGC GAT GAT AGC CCT TTA
fliIR ACC GAT TTC TCT TTG AGC CAT
ureAF GAT GAT GTG ATG GAT GGT GTG G
ureAR TAA GAA CAA CTC ACC AGG AAC C
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and ∆flhBHp mutants showed non-motile phenotypes
(Figure. 2A).
To examine whether AI-2 can influence the motility of
H. pylori, we assessed the motility of the wild-type,
∆luxSHp and ∆flhB mutants on AI-2 supplemented
plates (ASP). The ASP was prepared using 0.4% soft
agar containing in vitro synthesised AI-2 (0.25% v/v).
The buffer control plate (BCP) was also produced using
0.4% soft agar into which was added the buffer control
solution (0.25% v/v) produced in parallel to in vitro AI-2
synthesis (buffer containing no AI-2). After 5 days of
incubation, the halo size of the wild-type on ASP
increased by 11.2 ± 0.7 mm, n = 4, compared with a
5.4 ± 0.2 mm, n = 4 increase on the non-supplemented
Figure 1 The ∆luxSHp mutant of H. pylori strain J99 lacks AI-2 and is non-motile unlike other mutants deficient in cysteine
biosynthesis. (A) AI-2 production in J99 wild-type (black column), ∆luxSHp (red column), ∆mccBHp (blue column) and ∆mccAHp (white column)
mutants was measured. Strains were grown in Brucella broth, and aliquots were removed at 24 h, 30 h, 48 h and 72 h to assess the optical
density (wild-type, square; ∆luxSHp, diamond; ∆mccBHp, circle; ∆mccAHp, triangle) and the amount of AI-2 in the filtered culture supernatant using
the V. harveyi bioassay. AI-2 activity is shown as a relative bioluminescence (corrected by OD600nm of H. pylori) in the presence of H. pylori culture
supernatants over the negative control (Brucella broth alone). A diluted in vitro synthesised AI-2 sample was utilised as a qualitative positive
control [8]. Bioluminescence induced by wild-type, ∆mccBHp, and ∆mccAHp strains was significantly greater than that induced by the ∆luxSHp
mutant, as determined by paired Student’s t-test (p < 0.001). The lines represent the growth (OD, righthand axis) and the bars represent the AI-2
activity (bioluminescence, lefthand axis). (B) 5 μl of liquid culture (24 h) of the wild-type, ∆luxSHp, ∆mccBHp and ∆mccAHp mutants was seeded on
each quarter of a soft agar plate. After 3, 5 and 7 days of incubation, the motility halo of each strain was recorded using a digital camera. All
experiments were done in triplicate: a representative experiment is shown and the mean results are presented in the text.
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plate (compare Figure. 2A or the right panel of Figure.
2B with the left panel of Figure. 2B). Whilst the ∆luxSHp
mutant was non-motile on the BCP, the halo increased
by 4.6 ± 0.4 mm, n = 4 on ASP (Figure 2B). The control
strain ∆flhBHp mutant remained non-motile on the ASP
(Figure. 2B).
Having established an influence on motility for one of
the chemicals reliant on LuxSHp function (AI-2), we
sought to establish whether another (cysteine) would
have a similar influence. Our previous studies revealed
that exogenous cysteine rescues growth defects of
mutants unable to complete cysteine biosynthesis via
the RTSP of H. pylori (∆luxSHp, ∆mccAHp and ∆mccBHp
mutants) in chemically defined broth [15]. Chemical
complementation of motility was thus performed using
chemically defined plates supplemented with 1.0 mM
cysteine. Methionine was added to these plates as the
sulphur source since all known H. pylori strains are
methionine auxotrophs. After 5 days of incubation,
wild-type H. pylori and ∆mccAHp and ∆mccBHp mutants
formed motility halos of 4.9 ± 0.3 mm, n = 4; 3.6 ±
0.6 mm, n = 4; and 4.3 ± 0.9 mm, n = 4 increases in
diameter, respectively. The ∆luxSHp mutant remained
non-motile (Figure. 2C).
Taken together, these data indicate that the motility
defect of the ∆luxSHp mutant was restored either
Figure 2 AI-2, but not cysteine rescues the motility defect of the ∆LuxSHp mutant. (A) Wild-type, ∆luxSHp, and ∆luxSHp
+ bacteria were
seeded onto soft plates composed of normal medium. The non-motile ∆flhB mutant served as the negative control. (B) Wild-type, ∆luxSHp and
∆flhBHp bacteria were seeded onto motility plates supplemented with in vitro synthesised AI-2. Wild-type and ∆luxSHp were also seeded on
motility plates containing buffer control solution used for in vitro AI-2 synthesis. (C) Wild-type, ∆luxSHp ∆mccAHp and ∆mccBHp strains were
seeded onto chemically defined motility plates supplemented with cysteine. After 5 days of incubation, the motility halo of each strain on each
plate was recorded using a digital camera and the area of each halo was measured using a GS-800 Calibrated Densitometer (Biorad).
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genetically or chemically with AI-2, but not with exo-
genous cysteine. This suggests that luxS and AI-2 play a
role in enhancing bacterial motility, rather than an
intact cysteine biosynthesis pathway, implying a likely
role of luxSHp in signalling.
∆LuxSHp mutants have altered flagella morphology
and motility patterns
Motility plates effectively indicate motility phenotypes of
the population, but do not give any indication of the
structure of the motility organelles (flagella), or the
motility pattern of individual cells. To characterise
the phenotypes underlying the decreased ability of the
∆luxSHp mutant to swarm in soft agar, we examined
motility of individual bacterial cells using phase-contrast
microscopy and also the flagellar morphology of the
cells using electron microscopy. Cells tested included
wild-type, ∆luxSHp and ∆luxSHp
+, all grown in the pre-
sence and absence of DPD and cysteine. All cells were
grown in co-culture with human gastric adenocarcinoma
(AGS) cells for 24 h before testing, as previous experi-
ments in our laboratory have shown that this gives
highly reproducible results in H. pylori motility
experiments.
Phase-contrast microscopy revealed that > 40% of
wild-type and ∆luxSHp
+ cells were motile; whereas less
than 2% of ∆luxSHp cells were motile. When grown
with exogenous DPD, motile cells again made up > 40%
of the population for wild-type and ∆luxSHp
+ cells, but
now also made up > 40% of the population for ∆luxSHp
cells. Cultures of the ∆luxSHp grown with exogenous
cysteine consistently contained less than 2% motile cells.
To exclude the possibility that the restoration of motility
of ∆luxSHp cells was due to an effect of DPD on AGS
cells rather than on H. pylori, we set up a control sam-
ple in which the wild-type and ∆luxSHp mutant were
co-cultured individually with AGS cells that had been
treated with DPD overnight. DPD was washed off with
the media before co-culturing. As expected, both wild-
type and ∆luxSHp cells in these control cultures showed
very similar motility phenotypes to those co-cultured
with normal AGS cells, indicating that DPD is a func-
tional signalling molecule to H. pylori cells rather than
it working through affecting eukaryotic cells. Moreover,
the approximate speed of motile ∆luxSHp cells was visi-
bly lower compared to the wild-type, ∆luxS+ and all cell
samples plus DPD.
Electron microscopic images (Figure. 3) showed that
all samples tested (wild-type, ∆luxSHp and ∆luxSHp
+,
grown in the presence or absence of DPD) produced a
flagellar filament of some kind in the majority of bacter-
ial cells, but those of the ∆luxSHp strain were consis-
tently short and usually fewer in number. In our
experiments, nearly all of the wild-type cells tested had
flagella (95% ± 3%, n = 3) and most of these had multi-
ple flagella, which were usually at one pole and typically
3-4 in number (90% ± 3%, n = 3) (Figure. 3A). In con-
trast, fewer ∆luxSHp cells tested had flagella (70% ± 5%,
n = 3) and these were typically shorter and also fewer in
number (30% ± 5%, n = 3 of cells had only one or two
short flagella (Figure. 3B)). The complemented ∆luxSHp
+
cells were similar to wild-type, with nearly all cells pos-
sessing 3-4 normal long flagella at least one pole (95% ±
3%, n = 3) (Figure. 3C). Addition of DPD to ∆luxSHp
cells also converted them to a wild-type morphology,
with the vast majority producing 3-4 wild-type length
flagella usually present at a single pole (95% ± 3%,
n = 3) (Figure. 3E). Addition of DPD to wild-type cells
had little significant effect with nearly all remaining fla-
gellate as before (95% ± 3%, n = 3) although more cells
were seen with a flagellum at both poles (Figure. 3D).
Addition of DPD to the ∆luxSHp
+ cells had a similar
effect, with more cells with flagella at both poles
(Figure. 3F).
Mutation of luxSHp resulted in the decreased production
of flagellar proteins FlaA and FlgE
The reduced number and length of flagella in ∆luxSHp
cells observed by electron microscopy could emanate
from a number of different changes in the proteome. As
previous work had suggested possible involvement of
major flagella proteins, we investigated these first by
immunoblotting whole cell lysates. Cell lysates were
adjusted so that protein from equivalent numbers of
bacteria was loaded (see Materials and Methods), and
probed with anti-flagellin (FlaA and FlaB) and anti-FlgE
(hook protein) antiserum (Figure. 4). In practice, FlaB
levels were very similar between all wild-type and
mutant strains and were not shown to vary in our sub-
sequent transcription analysis. Our main aim here was
to compare ratios of flagella proteins between wild-types
and mutants, so we expressed results of other flagella
proteins (FlaA and FlgE) relative to FlaB levels within
each strain. H. pylori wild-type 17874, and derived
mutants (∆flaA and ∆flgE) were used as positive and
negative controls, respectively. In our experiments, four
repetitions were included, when the reflective density
(RD) of each protein band was measured using Quantity
One 4.6.5 software (Biorad).
We found that all strains tested produced FlaB at
approximately the same level (Figure. 4). The reflective
density of the FlaB bands of the wild-type, ∆luxSHp
mutant and the complemented ∆luxSHp
+ mutant were
(means ± SD) 0.210 ± 2.0E-03 RD, n = 4; 0.204 ± 5.8E-
04 RD, n = 4; and 0.207 ± 5.8E-04 RD, n = 4, respec-
tively. We expressed all other results (FlaA and FlgE)
relative to FlaB in each strain. Mutagenesis of LuxSHp
reduced the expression of FlaA relative to FlaB (from
Shen et al. BMC Microbiology 2010, 10:210
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mean 1.60 in the wild-type to 1.23 in the ∆luxSHp
mutant, p < 0.01), and complementation increased the
ratio back to wild-type levels (mean 1.70 in the
∆luxSHp
+ mutant, p < 0.01 compared with the ∆luxSHp
mutant). Next, we examined FlgE expression, and a
similar trend was found (wild-type FlgE:FlaB ratio mean
0.74; ∆luxSHp mutant 0.51; complemented ∆luxSHp
+
mutant 0.77; p < 0.01 for differences between ∆luxSHp
mutant and wild-type and complemented stains). These
data show that FlaA and FlgE synthesis was reduced
relative to FlaB in the ∆luxSHp mutant and these
changes were restored by genetic complementation.
AI-2 regulates the transcription of flagellar genes
Previous reports have provided evidence that luxSHp-
dependent QS may occur to modulate motility via tran-
scriptional regulation of flaA or flhA [20]. We utilised
quantitative RT-PCR (qRT-PCR) to screen for altera-
tions in transcription of these and other genes involved
in flagellar assembly to extend our understanding of the
regulatory mechanisms that might be involved. To
exclude an effect of cysteine biosynthesis, exogenous
addition of cysteine was also undertaken. The concen-
tration of cysteine was non-limiting to H. pylori growth.
16 S rRNA transcription was used for normalization and
ureA served as a non-flagella linked gene control
(Figure. 5D).
The flagellar genes tested included several from differ-
ent regulatory hierarchy positions in flagellar synthesis
[33]: class 1 genes flhA (encodes flagellar regulator com-
ponent), motA and motB (encode flagellar motor pro-
teins); class 2 genes flaB (encodes hook-proximal minor
flagellin) and flgE (enodes flagellar hook protein); and
class 3 gene flaA (encodes major flagellin). fliI (encodes
membrane-associated export ATPase of the flagellar
basal body) was also examined (Figure. 5).
For class 1 genes tested, flhA showed a consistent pat-
tern of 1.75 fold reduced transcription (p < 0.001), and
both motA and motB showed a consistent pattern of 2
fold (p < 0.001) reduced transcription in the ∆luxSHp
mutant compared to the wild-type (Figure. 5A).
For class 2 genes tested, flgE was 1.5 fold (p < 0.001)
Figure 3 luxSHp/DPD modulates flagellar morphogenesis. H. pylori cells were co-cultured with AGS cells. Cells were stained with 0.5%
photungstate (PTA). Scale bars represent 2 μm. (A) wild-type, (B) ∆luxSHp, (C) ∆luxSHp
+, (D) wild-type with DPD, (E) ∆luxSHp with DPD and (F)
∆luxSHp
+ with DPD. DPD was added after 10 h of incubation and once again after 18 h of incubation during co-cultures.
Figure 4 Mutation of luxSHp causes altered flagellin and hook
protein production. Cell lysates of the strains indicated were
subjected to immunoblotting with anti-flagellin (FlaA and FlaB) and
anti-hook protein (FlgE) together [32]. The proteins were measured
in wild-type, ∆luxSHp, ∆luxSHp
+ cultures grown in Brucella broth at
37°C for 24 h. H. pylori strain 17874 wild-type [29] served as the
positive control. Mutants in flaA (a kind gift from Paul O’Toole) and
flgE [30] derived from this strain (17874∆flaA and 17874∆flgE) served
as negative controls for identifying FlaA and FlgE, respectively.
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down-regulated in the ∆luxSHp mutant; while flaB did
not exhibit any significant change. flaA was the only
class 3 gene tested, which was 3.5 fold (p < 0.001)
down-regulated in the ∆luxSHp mutant compared to the
wild-type (Figure. 5B). Additionally, the transcript of fliI
was also significantly (1.5 fold, p < 0.001) decreased in
the mutant (Figure. 5C).
The reduced transcription of flhA, motA, motB, flgE,
flaA and fliI was restored genetically by the complemen-
tation of the mutant with the wild-type luxSHp gene.
Also, 150 μM DPD was sufficient to restore the tran-
scription of these genes in the ∆luxSHp mutant to levels
similar to the wild-type (Figure. 5E). Although Figure 5E
shows that 50 μM and 150 μM DPD induced almost the
same level of bioluminescence as the wild-type, we
chose to use 150 μM DPD in the complementation
experiment because this concentration was shown to be
more reproducible (it has the smaller error bar). In
wild-type cells, addition of DPD markedly increased
transcription of motA, motB, flaA and flaB, whilst flhA,
flgE and fliI only showed a marginal increase. Exogenous
addition of cysteine to the ∆luxSHp mutant did not
significantly increase transcription of any of the genes
studied; suggesting that addition of cysteine was not
able to restore the transcription of flagellar genes (data
not shown). Consistent with the analysis of protein
levels, these RT-PCR data indicate that luxSHp disrup-
tion has a greater effect upon transcription of flaA than
of flaB. Taken together, these data suggest that the
effect of LuxS in cysteine metabolism does not regulate
expression of flagellar genes, and that the effects on
flagellar gene transcription are likely through AI-2
production.
Discussion
The function of luxSHp is controversial due to putative
roles both in signalling and metabolism. Disruption of
cysteine biosynthesis by independent mutations that had
Figure 5 luxSHp/DPD modulates H. pylori flagellar gene transcription. Transcript levels of (A) flhA, motA, motB; (B) flaB, flgE, flaA; (C) fliI were
determined by qRT-PCR normalised to the levels of the 16 S rRNA gene. (D) Relative expression of ureA was utilised as a non-flagella gene
control. The Y axis shows the relative transcriptional level of each gene in each strain normalised to the level of the same gene in the strain
control (which is J99 wild-type in every case). Values are mean activities of triplicate RNA samples of each strain. Transcript levels were measured
in wild-type and ∆luxSHp cultures grown with or without DPD (150 μM) and in ∆luxSHp
+ cultures grown without DPD. (E) AI-2 activity (using the
previously-described V. harveyi BB170 bioluminescence assay [4]) in DPD solution (at concentrations of 50 μM, 150 μM or 500 μM) and in cell
free culture supernatant (24 h) of H. pylori wild-type, ∆luxSHp and ∆luxSHp
+ strains grown in the Brucella broth (starting OD600 nm of 0.05).
Negative control is Brucella broth alone. A diluted in vitro synthesised AI-2 sample was utilised as a qualitative positive control [8]. Error bars
indicate standard deviation.
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no influence on AI-2 production did not alter motility.
In contrast, the motility defect of a ∆luxSHp mutant of
H. pylori was genetically complemented by luxSHp, or
chemically complemented by the addition of exogenous
AI-2 but not by exogenous cysteine. The processes
underlying the loss of motility of the ∆luxSHp mutant
were manifested by fewer and shorter flagella that pre-
sumably derived from the altered flagella protein pro-
duction and the modulated expression of a number of
genes linked with flagella assembly and function.
Previous studies have shown that mutations of luxSHp
in H. pylori diminished motility on soft agar. The altered
motility phenotype was restored completely by genetic
complementation with luxSHp or significantly restored by
metabolic complementation with wild-type CFS [18-20].
In contrast to our study, in Osaki et al. and Rader et al.’s
studies complementation of luxSHp was performed by
placing luxSHp at a second site in the chromosome rather
than at the original locus [19,20]. Like these previous
reports, our study shows that abolished motility of J99
∆luxSHp mutation was restored entirely by complementa-
tion with the luxSHp gene and significantly by in vitro
synthesised AI-2. The previous studies, with complete
complementation of motility with luxSHp through inser-
tion at a new chromosomal locus, argue against polar
effects of luxSHp mutagenesis on other genes which influ-
ence motility. Our study, with complementation with
luxSHp through creating a revertant results in similar
levels of LuxSHp to wild-type and thus better shows that
the phenotypes attributed to the mutant were not due to
secondary mutations elsewhere in the chromosome.
Furthermore, having demonstrated that MccAHp and
MccBHp function consecutively to convert the product
of LuxSHp (homocysteine) into cysteine as part of the
RTSP [15], we reasoned that inactivation of any of these
three enzymes would have a similar influence upon
cysteine biosynthesis, whilst only the ∆luxSHp mutant
would be devoid of AI-2. Thus, if the reduced motility
of the ∆luxSHp mutant derived from disrupted cysteine
biosynthesis, mutants in mccAHp and mccBHp would
have a similar motility defect. Therefore, we performed
an experiment to exclude the possibility that the effect
on motility was due to non-specific secondary metabolic
effects of LuxSHp. To do this, wild-type, ∆luxSHp,
∆mccAHp and ∆mccBHp strains were inoculated on the
same motility plate, allowing the production of AI-2 and
the biosynthesis of cysteine to be isolated from each
other. As expected, only the ∆luxSHp mutant was non-
motile. This, for the first time, suggests that motility of
H. pylori cannot be affected by disrupting the cysteine
provision pathway, but can be blocked by the loss of
luxSHp itself. By using a chemically defined medium, we
confirmed the provision of cysteine had no effect on
motility of H. pylori.
Earlier publications have suggested that AI-2 may not
act as a signal in some bacteria but instead may simply
be a by-product of the important AMC pathway [9]. In
support of this, in some bacteria, production of AI-2
does appear to be associated with metabolic rather than
regulatory phenomena [34]. However, data from our
motility bioassays using both motility plates and micro-
scopy demonstrate that in H. pylori AI-2 (or DPD) con-
trols motility. In our experiments, the shorter flagella
observed in the mutant could result from the observed
alteration in the FlaA:FlaB ratio as previously described
[35,36]. However, proving this would require extensive
immuno-EM analysis with anti-FlaA and anti-FlaB anti-
sera, which is beyond the scope of this work. As flaA
has been confirmed to be essential for motility in
H. pylori while flaB is a structural subunit of the flagel-
lar filament which increases motility [35,36], the change
of the ratio between flagellins FlaA and FlaB may be
one factor resulting in the abolished motility of the
∆luxSHp mutant. Also, LuxSHp/AI-2 appears to affect
the position of flagella, suggesting that LuxSHp/AI-2
may affect genes involved in the formation of flagella at
the cell poles.
The reduced expression of flagellar motor genes
(motA and motB) which control flagellar rotation may
be a further factor contributing to slower motility of the
∆luxSHp mutant although it could also be caused by the
lower flagellar number requiring fewer motor units to
encircle each flagellar base. Thus it is likely that the fla-
gella in the ∆luxSHp strain are too short and too few to
form effective flagellar propellers to produce Helicobac-
ter movement. This is in contrast to a previous report
where truncated flagella were only reported in G27
strains that also lacked one of the transcriptional regula-
tors (s28, flgS or flgM) and where wild-type length fla-
gella were reported for the ∆luxSHp mutant alone [20].
However, surprisingly in that report, the addition of
DPD to the double mutants lengthened the flagellar
filaments.
Mutants defective in flhA were previously described as
being defective in flagellar apparatus assembly and in
motility. Recently Rust and coworkers (2009) reported
that the anti-sigma factor for s28, FlgM, interacts with
FlhA at the base of the Helicobacter flagellum and this
interaction modulates the expression of flagellar genes
by s28 [37]. The decrease in flhA expression, seen in our
∆luxSHp mutant could explain the change in flagellar
length but not via a FlgM-dependent pathway as seen
by Rader et al. [20], as Rust and coworkers report that
FlgM levels were wild-type in a ∆flhA mutant in Helico-
bacter strains N6 and 88-3887 [37].
Both Rust and co-workers [37] and Neihus and co-
workers [33] show that FlaB is not regulated by the
same regulatory pathway as FlaA, and as FlaB levels in
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our ∆luxSHp mutant concur with this, the short flagella
we observe in the ∆luxSHp mutant are likely to be pre-
dominantly composed of FlaB (normally hook-proximal)
flagellins. These may be extended, to give functional
length propellers by synthesis and assembly of FlaA in
wild-type filaments and in filaments from luxSHp-com-
plemented ∆luxSHp
+ bacteria or ∆luxSHp bacteria+DPD
which have longer flagella.
FlaB and FlgE are both part of the regulon that is con-
trolled by the FlgS/FlgR two component system and the
sigma factor s54 (RpoN) [33]. Interestingly, though no
significant change in FlaB was found, FlgE production as
well as its gene expression was affected by loss of LuxS/
AI-2. This suggests that luxS inactivation might affect
transcription of the same class of flagellar genes differ-
ently. One possibility is that the FlgR/FlgS-s54 regula-
tory complex might have different effects on the same
class of genes when affected by loss of LuxS; another
possibility is that there may be additional regulation
from the other regulator genes, for example flhF.
Flagellar assembly uses a secretion apparatus similar
to type III secretion systems. This is dependent upon
export chaperones that protect and transport structural
subunits using the membrane-associated export ATPase,
FliI [38,39]. Therefore, the decreased transcription of fliI
might be another factor in blocking motility via shor-
tened filament length in the ∆luxSHp mutant as Helico-
bacter fliI mutants are non-motile and synthesise
reduced amounts of flagellin (FlaA, FlaB) and hook pro-
tein (FlgE) subunits [38].
In our experiments, the motility defect, down-regu-
lated flagellar gene expression and reduced synthesis of
flagellar proteins in the ∆luxSHp mutant were due to
loss of AI-2 only, and not to the metabolic effect of
luxSHp on biosynthesis of cysteine. These results suggest
that LuxS/AI-2 is likely to be a functional signalling sys-
tem contributing to control motility in H. pylori. How-
ever, it is still uncertain whether AI-2 functions as a
true QS signal in H. pylori, in part because there are no
genes encoding proteins that can be confidently identi-
fied as components of an AI-2 sensory and regulatory
apparatus in H. pylori [13,40]. Also, we cannot exclude
the possibility that AI-2 acts through other undefined
effects and not as a signalling molecule, although as it is
known to have similar effects through signalling in
other bacteria, this appears unlikely.
Campylobacter jejuni also possesses a luxS homologue
and produces AI-2. Inactivation of luxS in a C. jejuni
strain (81-176) also resulted in reduced motility and
affected transcription of some genes [41]. However,
despite its effect on signalling, AI-2 does not function as
a QS molecule in C. jejuni (NCTC 11168) during expo-
nential growth in vitro when a high level of AI-2 is pro-
duced [42]. Thus, so far there is no good evidence to
ascertain whether AI-2 functions as a true QS signal in
this species. In H. pylori, Lee et al. and Osaki et al.
looked at fitness of ∆luxSHp mutants in vivo using mouse
and gerbil models, respectively [18,19]. The authors did
not favour a QS or even a signalling explanation for the
reduced fitness mechanisms but both speculated that it
might be caused by metabolic disturbances upon loss of
luxSHp [18,19]. However, it could potentially be explained
by reduced signalling leading to reduced motility, and
given the ecological niche of H. pylori there would be
logic to a signalling (perhaps even QS) system increasing
motility. For example, we speculate that if a microcolony
of H. pylori in a particular area of the stomach reached a
critical size it would be potentially advantageous for fla-
gellar biogenesis to be enhanced so that highly motile
bacteria could disseminate to new regions of the sto-
mach. If this hypothesis was confirmed, it would have
important implications for H. pylori virulence and for the
spread of infection within and between people.
Conclusions
Our study suggests that as well as being a metabolic
enzyme in the reverse transsulphuration pathway,
H. pylori LuxS has a second role in regulation of moti-
lity by modulating flagellar transcripts and flagellar bio-
synthesis. This is achieved through production of the
signalling molecule AI-2, rather than the metabolic
effect of LuxS in cysteine biosynthesis.
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